TW386033B - A skin permeant pharmaceutical compositions - Google Patents

A skin permeant pharmaceutical compositions Download PDF

Info

Publication number
TW386033B
TW386033B TW83104284A TW83104284A TW386033B TW 386033 B TW386033 B TW 386033B TW 83104284 A TW83104284 A TW 83104284A TW 83104284 A TW83104284 A TW 83104284A TW 386033 B TW386033 B TW 386033B
Authority
TW
Taiwan
Prior art keywords
weight
agent
percutaneous absorption
water
ingredients
Prior art date
Application number
TW83104284A
Other languages
Chinese (zh)
Inventor
Akira Nakagwa
Hideshi Oda
Munehiko Hirano
Koki Shoho
Tetsuro Tateishi
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Priority to TW83104284A priority Critical patent/TW386033B/en
Application granted granted Critical
Publication of TW386033B publication Critical patent/TW386033B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Description

經濟部中央揉準局貝工消費合作社印製 A7 B7 修正本6 補充 * 五、發明说明(58 ) 透明質酸銷 〇 . 1重量% 對羥基苯甲酸甲酯 0 . 1重蛋% 甘草酸 0 . 0 1重里% 3-L-MP 0 . 0 5重量% 精製水 7». 74童量 % . 撅拌混’合以上成分,含浸在不雜 布後,g設以離型膜 。裁切成所定形狀調製為含浸型片 狀袋裝劑。 营掄俐82 鈿取型络奘割 聚乙烯醇 20 · 0重量% 羧甲基鐵雒素 3 . 0重童% 氣化鈦 8 . 0重量% 1 , 3-丁二酵 5 . 0重量% 三十碩烷 3 . 0重量% POE ( 10)壬基苯醚 〇 . 5重置% 對羥基苯甲酸甲酯 0 . 1重量% 鈣化酚 〇 . 〇 1重置% 3-L-MP 0 . 1重量% 精製水 60 . 29重量% 搜拌混合以上成分調製成剥取型袋裝劑。 th較例7 乳狀袋裝劑 除不混合3 - L - Μ P以外,仿實施例 4 1相同混合及裂法調 製成乳狀袋裝剤。 fch較例8 粘箸劑型Η狀袋裝劑 除不混合3 - L - Μ Ρ以外,仿實施例 80相同混合及製法調 -60- (請先W讀背面之注意事項再填寫本頁) 本紙張尺度逍用中國國家橾準(CNS ) A4規格(210X297公釐) 經濟部中央揉準肩負工消费合作社印装 A7 _ B7_ 五、發明説明(1 ) 〔産業上之利用領域] 本發明僳颶於包含有效成分之溶解劑及該溶解w之外 用製薄。詳言之,其傜用於粥_(cataPlasBa)等經皮吸 收_之蕖效成分或有鼸於菊_脂溶性粉末之溶解_,具 有優異之有效成分溶解性,及高度安全性,安定佳*相 溶性,同時為無奧而有清欲威之溶屏雨,以及含有該溶 解劑之外用製薄。 〔既有技術〕 以往曾霣試各稼將藥物以經皮圾收並期望能獲得治療 效果之方法。鼸於此種經皮趿牧製_,其重要課題為, 如何有效率地進行從藥物(第效成分)之基薄籌出,即 自藥物之基繭轉移至皮虜。通常,使用某種特定蕖物嘗 試以製繭設計時,由於基劑中之藥物溶解不很充分•産 生結晶化等,致降低蕖物之囅出而鮮少獲得充分之治療 效舉。其中,理定蕖物之最適當溶解劑,乃為製劑設計 上之主要因素,因選擇溶解劑,致蕖物之溶解不充分, 減低從基劑釋放而廣被於患部之移動性,而無法發揮相 當之治療效果β 如今,使用做為藥物之溶解,,包括有醇類,乙二酵 類,部分之界面活性薄,薄荷油等精油琴,勞他命頓, 水欏酸甲酯,水揚酸乙二酵,肉豆蔻酸^丙酯等為代表 之脂肪酸_等》 例如,持開©56- 1 54 4 1 3M公報掲示將菲»芙羅芬 (Flurbiprofen)溶解於葙烯条物質或脂肪酸酯,由該水 本紙張尺度逋用中β困家樑率(CNS 规格(210X297公釐) - - Γ .<請先Μ讀背面之注f項再填寫本頁) 訂- 修正 # #每4.含.屬曰 A7 補充 B? 五、發明説明(奴) 试驗例A (皮虜安全性試驗) 針對實施例1~ 4及比較例1〜3之粥繭•進行皮虜安全 試驗》 就身讓康僅之男女2 5名進行封明式間歎試驗,觀察Μ 雄後1小畤及經通24小時後皮虜之變化程度,依卞述標 華評估皮虜《激程度,结果如表3〜4所示·· -:在皮虜上不雄有變化 +··皮虜上有明顯红色 ±:在皮虜上發生檝薄紅色++:皮虜上有鑀重之斑疹 表 3 (#¾¾ 由之注 f本買 i袁· 艟濟?夹揲率為Λ工坊费合作社印«. 利離後之 經遇時間 評估 試櫬 + + + 士 一 合計 (人; 性宰(%> 士以上 1小時 實施拥1 0 0 0 25 25 0.0 1小時 實施例2 0 0 1 24 25 4.0 1小時 實鉋锊3 0 0 0 25 25 0.0 1小畤 實施例4 0 0 0 25 25 0.0 1小時 比較#i 1 0 0 2 24 25 8.0 1小時 比較供2 0 0 1 24 25 4.0 1小畤 比較拥3 0 0 3 25 25 12.0 -63- 訂 -良. 本纸張尺度逋用中國國家橾準(CNS》Α4规格(2丨0X297公釐) 經濟部中夬橾準局貝工消费合作社印装 A7 _B7_ 五、發明説明(2 ) 中油型乳化薄輿水性基薄裂成外用消炎鎮痛_,特醑昭 5*7-98209號公報記載將因諾美逋辛(IndoBetacin)溶解 於一元酵,多元酵等製作消炎鎮痛外用 惟此等溶解薄,其溶解力不充分而發生析出结晶,因 有奥味而其使用受到限制,由於輿基_之相溶性差而産 生結絮狀,因而有引起經時分解或發生著色等安定性問 題,同時,溶解劂對皮虜之刺激而引起不檐快之副作用 等,致獾得不十分《意之結果β 另一方面,雖企麵霄試在粥劑中含以脂肪性粉末或水 不溶性粉末(以下略稱為脂溶性粉末)以供使用,然通 常之粥薄大部分為水溶性基劑,因此非常缺乏對脂溶性 粉末之溶解性,致有困難在基劑中溶解,或在製造畤雄 然以溶解狀態存在,但仍有經時析出结晶之安定性問題, 〔發明所欲解決之商題〕 本發明之目的旨在於解決上述之課題,而提供一種具 有優異之有效成分溶解作用,且有安全性,安定性,离 相溶性溶解劑,以及含有該溶解劑之外用製 [解決問題所用之手段〕 本發明之目的,因使用3-L-2氧基丙垸-1, 2-二酵( 朗稱為3-L-MP)做為有效成分之溶解爾印可連成β 亦即,本發明你以3-L-I氣基丙烷-1, 2-二酵(3-L-ΜΡ)為有效成分之溶解_,及含有該溶解劑舆有效成分 之外用製劑。 本發明所諝之有效成分,僳指經皮吸收W所用之藥效 本紙》•尺度遄用中•國家揉準(CNS > Α4规格(210X297公釐) (請—之注衰再^本ί 訂 線- A7 B7 修正 本於年法 月1日 五、發明説明(62 ) 表 剝離後之 經過時間 評估 試樣 + + + 土 — 合計 (人) 陲性率(% ) 士以上 2 4小時 實施例1 0 0 0 25 25 0.0 2 4小時 實施例2 0 0 0 2 5 25 0.0 2 4小時 實施例3 0 0 0 25 25 0.0 2 4小時 實施例4 0 0 0 25 25 0.0 2 4小時 比較例1 0 0 1 24 25 4.0 24小時 fcb較例2 0 0 0 25 25 0.0 2 4小時 比較例3 0 0 1 24 25 4.0 請 A Η A 之· 注 項 再 f 本 頁 订 如上所述,本實施例1〜4之粥劑對皮虜之安全性極高 試醅例4 (對人之經皮吸收性試驗) 將實施例4,比較例2之檢體打眼成3X3C· 2並貼附Printed by the Central Bureau of the Ministry of Economic Affairs, Shellfish Consumer Cooperative, A7, B7, Amendment 6 Supplement * V. Description of the invention (58) Hyaluronic acid sales 0.1% by weight, methyl paraben 0.1% by weight, glycyrrhizic acid 0 0 1% by weight 3-L-MP 0. 05% by weight purified water 7 ». 74% by weight of children. 混 Mix and mix the above ingredients, impregnated with non-miscellaneous cloth, g is set with a release film. It is cut into a predetermined shape to prepare an impregnated sheet-like bagging agent. Yingyingli 82 Scooping-type castrated polyvinyl alcohol 20 · 0% by weight Carboxymethylferricin 3.0% by weight Child gasified titanium 8. 0% by weight 1, 3-butanediase 5.0% by weight Triacontane 3.0% by weight POE (10) nonylphenyl ether 0.5 reset% methyl parahydroxybenzoate 0.1% by weight calcified phenol 0.0% reset by 3-L-MP 0. 1% by weight of purified water 60. 29% by weight Search and mix the above ingredients to prepare a peeling bagging agent. th Comparative Example 7 Milky Bagging Agent Except that 3-L-MP was not mixed, the same mixing and cracking method as in Example 41 was used to prepare a milky bagging. fch Comparative Example 8 Except that 3-L-Μ P is not mixed with the viscous pouch type, the same mixing and preparation method as in Example 80 is adjusted to -60- (please read the precautions on the back before filling this page) Paper size is in accordance with China National Standards (CNS) A4 (210X297 mm) printed by the central ministry of the Ministry of Economic Affairs and consumer cooperatives A5 _ B7_ V. Description of the invention (1) [Industrial fields of use] The thinner is used in addition to a dissolving agent containing an active ingredient and the dissolving agent. In detail, it is used as an effective ingredient for percutaneous absorption such as porridge (cataPlasBa) or as a solution for chrysanthemum fat-soluble powder. It has excellent solubility of active ingredients, high safety, and good stability. * Compatibility, meanwhile, it is a dissolving rainy screen that has no odor and is clear, and thinner for external use containing the dissolving agent. [Existing Technology] In the past, various methods have been tried to collect medicines as percutaneous waste and hope to obtain a therapeutic effect. The main issue of this kind of percutaneous animal husbandry is how to efficiently raise the base of the drug (the effective ingredient), that is, transfer it from the base cocoon of the drug to the skin. In general, when a certain cocoon is used to try to design a cocoon, due to insufficient dissolution of the drug in the base, crystallization, etc., it is possible to reduce the exudation of the cocoon and rarely obtain sufficient therapeutic effects. Among them, the most suitable dissolving agent for tincture is the main factor in the design of the formulation. Due to the choice of the dissolving agent, the dissolution of the tincture is insufficient, which reduces the release from the base agent and is widely used in the affected part, and cannot be used. Play a considerable therapeutic effect β Nowadays, it is used as a drug to dissolve, including alcohols, adipic acid, some of the interfacial activity is thin, essential oils such as peppermint oil, lactone, methyl hydrolysate, water Fatty acids represented by adipic acid, myristic acid, propyl ester, etc. "For example, hold open © 56- 1 54 4 1 3M Bulletin states that the phenanthrene» Flubiprofen is dissolved in the pinene substance or Fatty acid esters, from the beta ratio in the paper size (CNS specification (210X297 mm)--Γ. Please read the note f on the back before filling out this page) Order-Correct # #Each 4. Contains, belongs to A7, supplement B? 5. Description of the invention (slave) Test example A (piper safety test) For porridge cocoons of Examples 1 to 4 and Comparative Examples 1 to 3 • Peel safety Test "Let the 25 males and females of Kang Zhi conduct the Fengming-style sigh test. From time to time, the degree of change of Pirup was evaluated according to Biaohua. The degree of agitation is shown in Table 3 ~ 4.--There is a change in the appearance of Pi Xiong. A thin red ++ appears on the skins: there is a heavy spot on the skins. Table 3 (# ¾¾ Note from this book? Yuan? Help? The rate of stamping is Λ Workshop Fee Cooperative Cooperative «. Lili Evaluation of the subsequent experience time + + + Total number of persons (person; Sexual slaughter (% > 1 hour or more) Implementation 1 0 0 0 25 25 0.0 1 hour Example 2 0 0 1 24 25 4.0 1 hour Planing 3 0 0 0 25 25 0.0 1 Small Example 4 0 0 0 25 25 0.0 1 hour comparison #i 1 0 0 2 24 25 8.0 1 hour comparison for 2 0 0 1 24 25 4.0 1 0 0 3 25 25 12.0 -63- order-good. This paper size is based on China National Standards (CNS) A4 (2 丨 0X297 mm) Printed on the AFC _B7_ V. Description of the invention (2) Medium oil type emulsified thin water-based base is thinly cracked into external anti-inflammatory and analgesic _, Special Publication No. 5 * 7-98209 records that IndoBetacin is dissolved in mono-enzyme and multi-enzyme Anti-inflammatory and analgesic preparations for external use only have such thin dissolution, insufficient solubility and precipitation of crystals, and their use is limited due to the smell. Due to the poor compatibility of the base group, flocculation occurs, which may cause aging. Stability problems such as disintegration or coloration, meanwhile, the discomfort of dissolving the irritated skin with irritated skin and causing side effects such as quick eaves, etc., is not very satisfactory. "Intentional results β On the other hand, although it is tried in porridge Contains fatty powder or water-insoluble powder (hereinafter abbreviated as fat-soluble powder) for use, but most of the porridge is usually a water-soluble base, so it lacks solubility in fat-soluble powder. Dissolved in base, or existed in a dissolved state during manufacture, but still has the problem of stability of crystal precipitation over time. [Problem to be solved by the invention] The object of the present invention is to solve the above problems and provide A dissolving agent with excellent dissolving effect of active ingredients, safety, stability, discompatibility, and an external use containing the dissolving agent [means for solving problems] The present invention Purpose, because the use of 3-L-2 oxypropane-1, 2-diferment (referred to as 3-L-MP) as the active ingredient of solubilized Erin can be linked to β, that is, in the present invention, you use 3- LI gas-based propane-1, 2-dienzyme (3-L-MP) is a dissolving active ingredient, and a preparation for external use containing the solubilizing agent and the active ingredient. The effective ingredients used in the present invention refer to the medicinal paper used for transdermal absorption. ”• Standards in use • National rubbing standards (CNS > Α4 size (210X297 mm) Alignment-A7 B7 revised version on January 1, 2005. Description of the invention (62) Elapsed time evaluation sample after the table is peeled + + + Soil-Total (person) Property rate (%) More than 24 hours to implement Example 1 0 0 0 25 25 0.0 2 4 hours Example 2 0 0 0 2 5 25 0.0 2 4 hours Example 3 0 0 0 25 25 0.0 2 4 hours Example 4 0 0 0 25 25 0.0 2 4 hours Comparative Example 1 0 0 1 24 25 4.0 24 hours fcb comparative example 2 0 0 0 25 25 0.0 2 4 hours comparative example 3 0 0 1 24 25 4.0 Please A Η A of · Notes and f The porridge preparations of Examples 1 to 4 are extremely safe for skin test. Example 4 (Percutaneous Absorption Test on Humans) The specimens of Example 4 and Comparative Example 2 were punched into 3X3C · 2 and attached.

在健康志願人8名之上背部,經8小時後回收,依HP LC \ 法定置酮蒲凡Uetoprofen)之殘童。两於人體之吸收率 • * 之換算,定*法以及HPLC條件僳如下述· ⑴人體趿收率=(1-殘初期含量)X100 ⑵定麗法:將所回收之檢體以70b1中醇進行2小時之還 流萃取,萃取後之100·1甲酵即做為HPLC用試樣· -64- 本紙張尺度逋用中國國家橾準(CNS > Α4规格(2丨0X297公釐) \ 經濟部中央揉準扃属工消费合作社印装 經濟部中央揉準為負工消费合作社印«. A7 B7 五、發明説明(3 ) 成分或粥_所用之脂溶性粉末《> 本發明所用之3-L-i(P乃為習知物質,例如特醑昭58-88 3 3 4號所記載之具有清涼作甩物質。特閭昭60- 2 5 90 8 號記載有優異清浪效果之化粧品,對皮虜具有很高之安 金性。惟無有使用此物質為蕖效成分等有效成分加以溶 解之例子,況且試用經由溶解此物質将藥效成分經皮吸 收,乃為本發明者所首先發現,僳屬一項嶄新之卓見。 Μ於本發明經皮吸收_3-L-MP之含董,對外用製爾之 總量僳在〇 . 〇 0 1 ~ 2 0重量%之範釀,較佳者在0 . 1〜1 0重 量%之範圏。如含曇超遇2 0重量%時則頗難獲得安定之 製劑》 鬭於本發明外用製劑所用一種經皮吸收_之藥效成分 ,並無特別限制,可遵擇使用以往習知之藥&成分中之 任何一種》此種_效成分,例如為蒲蓮蘇隆 (predinisolone),德美薩隆(dexaaethasone),餛可露 松(hydrocortisone),氣西陵丙 _ (fluocinolone acetοnide }戊酸美速尚(valeric acid bethaaethasone) ,二丙酸美達尚(dipropionic acid bethanethasone} ,丁 酸苦美達尚(butyric acid clobetasone),软泊酸 蒱麗蘇睡(succinic acid prednisolong)等類固酵糸抗 炎症劑,因多美速辛(indo»etacine),二若芙那克 (<1 i e 1 〇 f e n a c },衣布蒲凡(i b u p r 〇 f e η > ,酮蒱凡 (fcetoprofen),拂非纳酸(fluphenanic acid),柯托拉 克,弗露比普羅汾(flurbiprofen),富比那克,斯普鐮 本纸張尺变逍用中國國家橾準(CNS > A4规格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 第8310428491♦利案人i ^皮吸收試驗補充例中文本 對人鳗之經皮吸收試驗 試驗方法 在5位健康成人之左右前腕屈倒以白色凡士林作成1.4X 1.4ca之匾劃,在此匾鼷内使液狀製劑之實施例69, 73及 74以微注筒非密封 塗覆部之製劑以含 而插入於25ml燒瓶 重複洗淨回收操作 後即刻進行回收操 m 1定容量再以超音 收液置入於試管, 分別塗覆以2 0 w 1。‘ 有酒精•水(1 : 1 中。套合以漏斗從漏 3次,成為回收液。 作做為初期含量。回 波處理1小時後隔夜 添加50« 1含有内部 t小時後將殘存在 )之纱布檫拭3次 斗脚部注入以酒精 以相岡方式在塗佈 收液以酒精做成25 放置。採取1 Bl回 爱準物質之酒精溶 液,經由ACROLC 13遇濾後依以下所示條件由HPLC測定藥 物置,並基由其殘存量求出經皮吸收量(率)。On the upper back of 8 healthy volunteers, they were recovered after 8 hours, and they were disabled children according to HP LC \ Legal Ketone Pufan (Uetoprofen). The absorption rate of the human body • Conversion of *, method of determination and HPLC conditions are as follows: ⑴ Yield of the human body = (1-residual initial content) X100 : Dingli method: the recovered sample is 70b1 in alcohol. After performing reflux extraction for 2 hours, the 100 · 1 formazan after extraction was used as the sample for HPLC · -64- This paper size is in accordance with China National Standards (CNS > Α4 size (2 丨 0X297 mm) \ Economy The Ministry of Economic Affairs and the Ministry of Economics and Industry Cooperative Cooperative Printing is printed by the Ministry of Economic Affairs and the Ministry of Economic Affairs and the Ministry of Economics and Economics. It is printed by the Ministry of Economic Affairs and Consumer Cooperatives «. A7 B7 V. Description of the invention (3) Ingredients or porridge _ Fat-soluble powder used" > 3 used in the present invention -Li (P is a conventional substance, for example, a substance with a cooling effect described in Japanese Patent No. 58-88 3 3 4. Japanese cosmetic No. 60- 2 5 90 8 describes a cosmetic with excellent wave-clearing effect. Pirup has a very high level of safety. However, there are no examples of using this substance as an effective ingredient to dissolve the active ingredient. Moreover, the trial of dissolving this substance to absorb the effective ingredient through the skin was first discovered by the inventors. , Is a new insight. Μ in the present invention percutaneous absorption of 3-L-MP, The total amount of external preparation is 0.001 to 20% by weight, preferably 0.1 to 10% by weight. If the content exceeds 20% by weight, it is quite good. Difficult to obtain stable preparations "There is no particular limitation on a transdermal absorption active ingredient used in the external preparation of the present invention, and any one of the conventionally known drugs & ingredients" such an active ingredient can be used in accordance with this, Examples are predinisolone, dexaaethasone, hydrocortisone, fluocinolone acetοnide, valeric acid bethaaethasone, and meda dipropionate. Dipropionic acid bethanethasone}, butyric acid clobetasone, succinic acid prednisolong and other steroidal anti-inflammatory agents, such as indo »etacine , ≪ 1 ie 1 〇fenac}, ibupr 〇fe η >, fcetoprofen, fluphenanic acid, Kotorak, Frou Birprofen (flurbiprofen) The ruler is used in accordance with the Chinese National Standard (CNS > A4 size (210X297 mm) (Please read the precautions on the back before filling out this page) Order 8310428491 ♦ Case Study i ^ Supplementary Example of Skin Absorption Test Test method for percutaneous absorption test of eel on the forearm of 5 healthy adults. A white plaque of 1.4X 1.4ca was made with white petrolatum. In this plaque, Examples 69, 73, and 74 of the liquid preparation were microinjected. The preparation of the non-sealed coating part of the cylinder was inserted into a 25ml flask, and the washing operation was performed immediately after repeated washing and recovery operations. The volume was fixed at a fixed volume, and then placed in a test tube with a supersonic receiver, and each was coated with 20 w 1. 'Alcohol and water (1: 1. Set the leakage from the funnel 3 times to become the recovery liquid. As the initial content. Add 50 «overnight after 1 hour of echo treatment, and it will remain after t hours) Wipe the gauze wipes 3 times with buckets and inject alcohol with the Aioka method to apply and collect the solution with alcohol and leave it at 25. A 1-bl alcohol solution of quasi-substance was taken. After ACROLC 13 was filtered, the drug was measured by HPLC under the conditions shown below, and the percutaneous absorption (rate) was calculated from the residual amount.

HPLC之條件 • _ Pump : Model 60C0A (Waters) Injector ·‘ WISP 712 (Waters) Detector i Laubda-ααχ modal (Waters) Integrator ; &-2500 (Hitachi) Column oven i TCM (Waters) Column : TSE-gel ODS-60TM (T0S0) 4.6mtfn X.D.# >< 15cm ( 5pm ) Mobile phase : Acetate buffer (pH 3.2): CH^CN = Flow rate : 1.0 ml/min UV detection ; 254 nm Column temp* : 35 *C 經濟部中央揉準局貝工消費合作社印製 A7 __£7_-_ 五、發明説明(4 ) 汾,普拉箱普羅汾(9^11〇91>〇{811), If 普羅汾(thiaprofen) ,羅奇普魯汾,提尼塔布等非類固酵抗炎症劑以及其酯 衍生物,托拉尼拉斯得(tranilast),阿澤拉斯榘,酮 帝汾(ketotifen),衣普拉斯得,愛美拉斯亨等抗變醮 性二苯非拉明(diphenhydramine),氛苯非拉明 (chlorphearaaine),普 SI 美逋辛(pr'o^ethazine),三 皮麗那命(tripelenaiine)等抗組胺繭,氛普鑼馬嗪 (c h 1 〇 r p r 〇 a z i n e > ,尼托拉澤潘(n i t r a z e p a > ,二阿襻 潘(diazepa·),甜霜比妥(phenobarbital),想瑟品 Ueserpine)等中椹神經作用_,胰島素,睪脂Μ (testosterone),諾爾益斯酮(norethisterone},甲基-益斯酮(·β1;1ΐ3Γΐ testosterone),普羅葛酮(progesterone) ,«二酵(Estradiol)等激素劑,枯勞尼神,利血平 (Reserpine),硫酸脚(guanethidine sulfate)等抗离 血壓症劑,洋地黃毒素(digitoxin),狄各新(digoxin) 等強心殤,普魯皮纳諾鹽酸鹽(propranolol hydrochloride),普魯卡因醸较鼸酸 IK (procainaaide hydrochloride),阿價馬林(ajaaline),品都酵 (Pindolol)等抗不整脈用劑,磷基甘油(nitroglycerin) ,硝酸異山梨糖_(isosorbide dinitra/e),鹽酸罌粟 * 素(papaverine hydrochloride),視非力平(nifedipine) 等冠狀血管擴張劑,力多卡因(lidocaine),胺基笨酸 酷(benzocaine), Η 酸普魯卡因(procaine hydrochloride),四卡因(tetracaine)等局部麻醉薄, 本纸張尺度逍用中國國家椹準(CNS ) Λ4规格(210X297公釐) (請先Μ讀背面之注f項再填寫本荑) 订 經濟部中央揉準局里消*合作社印製 A7 B7五、發明説明(5 ) m 味( ο r P h i n e ),阿斯匹 β ( a s P r i η),可待因(C 〇 d e i n e ) ,乙醛醯胺(a c e t a n i 1 i d),氨基比林(a i η o p y r i n e)等 鑛痛爾,益倍利爽<eperioone>,紮砂利嗉,托魯倍利 爽(tolperisone),伊那倍利爽,普力二酵等骨格筋嫌 缓剤,乙釀笨胺.硝基呼拉爽(nitrofurazone)〆五徽 素.(pentaiycin),萊基茶(naphthyliate ),米可娜唑 ( i c ο n a ζ ο 1) , » 麻可娜唑,苦魯三麻唑(c 1 〇 11» i a ζ ο 1 e ) ,鹽酸沃徳非因,蘇活唑等抗真菌劑,卜氰尿唯啶<5-fluorouracil),勿斯兒非因(busulfan),放線菌素 (actinoayciu),絲裂徽素等抗惡性讀瘤劑 ,鹽酸鐵若利嗪,鹽酸琏基酪寧(oxybutyrin hydrochloride)等尿失禁症劑,尼托拉西伯姆 (nitrazepa·),美撲羅帕美德(eeprobaBate)等籲痼藥 (a a t i e p i 1 e p t i c a g e n t),氣諾奇薩藏(c h 1 〇 r ζ ο X a ζ ο n e) ,麗波杜巴等抗巴金生氏病(autiparkinson's diseases agent),尼古丁(nicotin)等禁煙補助爾,尚 包含有雒生素類,前列腺素(Prostaglandin)等,當然 並不受其限制 本發明之經皮圾收劑的劑型無有持別限制,——般句用 以往外用黼所使用之薄型,例如粥繭,释蕾繭,膠劑, * 乳薄,醪狀乳劑,液劑,嗔霧劑,儲量^阽附劑,擦涮 等等任意劑型之經皮趿收 其次,玆針對本發明之經皮圾收爾之應用例以粥»典 硬蕾甬逐加說明之。 -7- (請先聞讀背面之注意事項再填寫本頁)Conditions for HPLC • _ Pump: Model 60C0A (Waters) Injector ODS-60TM (T0S0) 4.6mtfn XD # > < 15cm (5pm) Mobile phase: Acetate buffer (pH 3.2): CH ^ CN = Flow rate: 1.0 ml / min UV detection; 254 nm Column temp *: 35 * C Printed by the Central Government Bureau of the Ministry of Economic Affairs, Shellfish Consumer Cooperative A7 __ £ 7 _-_ V. Description of the Invention (4) Fen, Plagen Proven (9 ^ 11〇91 > 〇 {811), If ), Roche Prufen, Tinitab, and other non-steroidal anti-inflammatory agents and their ester derivatives, tranilast, Azeroth, ketotifen, clothing Prasat, Emerasian and other anti-mutagenic diphenhydramine (chlorinearamine), chlorphearaaine, pr'o ^ ethazine, tripyramine (Tripelenaiine) and other antihistamine cocoons, ch 1 〇rpr 〇azine >, Nitorazeppan epa >, diazepa, diazepa, phenobarbital, Ueserpine, etc., nerve function, insulin, lipid M (testosterone), norethisterone (norethisterone), Methyl-estrone (· β1; 1ΐ3Γΐ testosterone), progesterone, «Estradiol and other hormones, cumulone, reserpine, guanethidine sulfate, etc. Anti-hypertensive agent, digital heart toxin (digitoxin), digoxin (digoxin) and other strong heart palpitations, propranolol hydrochloride, procaine and IK (procainaaide hydrochloride) , Anti-impulsive agents such as ajaaline, pindolol, nitroglycerin, isosorbide dinitra / e, papaverine hydrochloride, depending on Coronary vasodilators such as nifedipine, lidocaine, benzocaine, procaine hydrochloride, tetracaine, etc. This paper is standard for China Furniture Standard (CNS) Λ4 specification (210X297 mm) (please read the note f on the back before filling in this card) Order the Central Government Bureau of the Ministry of Economic Affairs * Cooperative printed A7 B7 V. Invention Description (5) m taste (ο r P hine), aspirin β (as Pr η), codeine (C odeine), acetanilide (acetani 1 id), aminopyrine (ai η opyrine) and other mineral pain Er, Ibexicone < eperioone >, Zazaritan, Tolperisone, Ininabyl, Puli Yeast and other bones are too slow, ethyl brewed benzylamine. (Nitrofurazone) 〆 五 徽 素. (Pentaiycin), naphthyliate, miconazol (ic ο na ζ ο 1), »Maconazol, Kusamazol (c 1 〇11» ia ζ ο 1 e), antifungal agents such as wolfofine hydrochloride, sulozole, buprofen < 5-fluorouracil), busulfan, actinoayciu, mitotic Anti-malignant tumor-reading agents such as Huisu, urinary incontinence agents such as ferrozine hydrochloride, oxybutyrin hydrochloride, nitrazepa ·, mepolopam EeprobaBate, aatiepi 1 epticagent, qi 1 ozr ζ ο X a ζ ο ne, Lipoduba and other anti-parkinson's disease agents (autiparkinson's diseases agent), nicotine (Nicotin) and other non-smoking subsidies, including biotics, prostaglandin (Prostaglandin), etc., of course, there is no restriction on the dosage form of the transdermal garbage collector of the present invention. The thin type used in the past for external application, such as porridge cocoons, bud-releasing cocoons, glues, * milk thin, cream-like emulsions, liquids, mists, reserves ^ attach agent, rubbing and other percutaneous forms Secondly, the application examples of the transdermal garbage collection of the present invention are described one by one with porridges »code hard buds. -7- (Please read the notes on the back before filling in this page)

C 訂 -声- 本紙張尺度逍用中國鬮家橾準(CNS ) Μ规格(210X297公釐) 經濟部中夬揉率扃負工消费合作社印製 Α7 Β7 五、發明説明(6 ) 例如粥雨,供考盧及其經時安定性,轉放性,經皮圾 收性,皮着安全性配合水溶性离分子多價酵與水做為基 雨形成為親水性基薄· 親水性基薄所用之水溶性离分子供瘢宜使用明繆,酪 朊,後合凝朦,轉精,矽藻酸納•可溶性澱粉,_基澱 粉,葡聚糖羧甲基繼維素,羧甲基繼缝素銪,聚乙烯酵 ,聚璣氣乙烷,聚丙烯酸,聚丙烯醯胺,聚丙烯酸銷, 聚乙烯吡咯烷,羧乙烯聚合物,聚乙烯醚,甲氣乙烯馬 來酸酐共聚物,異丁烯馬來酸酐共聚物,N-乙烯乙酵胺 ,N-乙嫌乙醯胺輿丙烯酸及/或丙烯酸鹽共聚物之1種 或2種以上加以遵擇。此時,水溶性高分子之配合量為 全體製«之1〜30重量%,次佳者為1-20重董%,而最 佳者為1〜15重量%»如少於1重量%時則其黏度變低 而無法保存其保型性,而多於3 0重量%時,則其黏度變 离,致降低混練時或塗裝時之作業性。 多元酵可缠宜遘取取乙二酵,丙二酵,二丙二酵,聚 丙二酵,1, 3-丁二酵,1, 4-丁二酵,異丁二酵,甘油 ,二甘油,山梨糖酵之1種,或視有必要可遘擇二種以 上,其混配量為10〜90重]19U,宜為10〜70重量%,而 最佳為20〜6 0重量%»如少於1〇重董則其保湛性不 足,而多於90重量%時則對水溶性髙分^之溶解性有影 響〇水的混合量為1〇〜重量%,最好為20〜8 0重量% ,将水溶性高分子溶解,而彰顳出其增粘性,集凝性, 及保型性。 -8 - 本紙張Λ度逍用中國國家棣準(CNS ) A4规格(21〇><297公釐) ---_------^--.装-- * - (請先Η讀背面之注$項存填窝本頁) 訂C Order-Sound-This paper size is in accordance with China Standards (CNS) M specifications (210X297 mm) Printed by the Ministry of Economic Affairs and the Consumers Cooperatives A7 Β7 5. Description of the invention (6) For example porridge rain For Kalou and its stability over time, transferability, transdermal garbage collection, skin safety, water-soluble ionomer multivalent enzyme and water as the base rain to form a hydrophilic base and a thin hydrophilic base For the use of water-soluble ionomers for scars, it is suitable to use Mingmiao, casein, post-coagulation, refining, sodium diatomate • soluble starch, _-based starch, dextran carboxymethyl followin, carboxymethyl follow Suturin, Polyvinyl Yeast, Polyethylenethane, Polyacrylic Acid, Polyacrylamide, Polyacrylic Pin, Polyvinylpyrrolidine, Carboxyvinyl Polymer, Polyvinyl Ether, Methyl Ethylene Maleic Anhydride Copolymer, Isobutylene One or two or more of maleic anhydride copolymer, N-vinylacetin, N-ethylacetamide and acrylic acid and / or acrylate copolymers shall be selected. At this time, the compounding amount of water-soluble polymer is 1 to 30% by weight of the whole system, the next best is 1 to 20% by weight, and the best is 1 to 15% by weight. »If less than 1% by weight Then its viscosity becomes low and its shape retention cannot be preserved, and when it is more than 30% by weight, its viscosity becomes off, which reduces workability during kneading or coating. Multi-fermented yeast can be obtained from glutarate, malonate, dimalonate, polymalonate, 1,3-butanal, 1, 4-butanal, isobutanal, glycerol, diglycerol , 1 type of sorbose, or 2 or more types can be selected if necessary, and its mixing amount is 10 ~ 90 weight] 19U, preferably 10 ~ 70% by weight, and most preferably 20 ~ 60% by weight » If it is less than 10 weight percent, its maintainability is insufficient, and when it is more than 90% by weight, it has an influence on the solubility of the water-soluble mash ^ The mixing amount of water is 10% by weight, preferably 20%. 80% by weight, dissolves the water-soluble polymer, and reveals its thickening, coagulating, and shape-preserving properties. -8-This paper is used in China National Standard (CNS) A4 specification (21〇 > < 297mm) ---_------ ^-. Packing-*-(Please First read the note on the back of the page.

I A7 _ B7___ 五、發明説明(7) 再者,視其所霱而添加上逑必要成分,以多價金屬化 合物做為交職繭,具鼸而言,包括有氬《化鉬,氰化钃 ,氬《化0,氨化0,硫酸鋁,硫酸鉅软,硫酸鋸鉀, 矽酸鉬酸鎂,二羥基鋁氨基醋酸酶等,又,其他之交嫌 爾傈在分子中至少具.有2梅以上琛《基之化合物;具鼸 而言,包括有乙二酵二«基乙醣_,聚乙二酵二β基乙 醯醚,丙二酵二«基乙醯醚,聚丙二酵二《基乙釀醚, 聚四甲二酵二氨基甲釀醚,丙三酵聚氨基乙醣醵,山梨 糖酵酐聚氛基乙醣醚,三羥甲基丙烷聚氛基乙醯醚,五 赤麵酵聚氨基乙醒醚,向苯二酚二氛基甲醯醚,新戊基 乙二酵二氨基甲睡儀,1, 6-己烯二酵二氨基乙醯醚等 ,可適酋地混合一種或二種以上交聯劑^ 又,其他可逋宜摻混以离嶺土,氣化鋅,二《化鈦, 陶土,矽藻土,合成矽酸鋁等填充_,百里番酚,對羥 基苯甲酸甲酯Uethylparaben),對羥基苯甲酸乙酯等 防腐劑,維生素丙,硬脂酸酯,二丁羥基甲苯,丁羥基 替香醚,五倍子酸酯,維生素戊,雒生素戊乙酸酯,乙 二胺四醣_納等抗氣化2-羥基-4-甲氧苯並苯酮, 對«基笨酸乙酯,2-(2-羥基-2-甲苯)苯並三唑,乙 二酵水楊酸鼸,水榍酸甲酸,水楊酸笨$等紫外線趿收 _,山梨糖酵酐脂肪酸_,甘油基脂肪^醣,癸甘油脂 肪酸醮,聚氣乙烯山梨糖酵酐脂肪酸酯,聚乙二酵脂肪 酸酯,聚氣乙烯烷基醚等乳化薄等一種或二種以上。 此粥爾之支持觼,重要者像遘定不影響藥效成分薄放 本紙張尺度逋用中國·家樑準(CNS > A4規格(210X297公釐) 面 之· 注 !(滅 頁 訂 經濟部中夬揉率局胄工消费合作社印製 經濟部中央揉率局Μζ工消费合作社印製 A7 B7 五、發明説明(8) 之素材。亦即,必須為不舆蘗效成分相互作用及被吸箸 者為宜•例如可選擇聚乙烯,聚丙烯,聚氯乙烯,聚酯 ,耐睡,聚氨基甲酸乙酯等之薄膜或Η材,或為其多孔 發泡臞,布,不鐵布,亦可為其薄膜或Η材輿多孔 龌,發泡鼸,布.,不鐵布之稹層品》又,.剝離被备物可 » . · 探用聚乙烯,聚丙烯,聚酯或以砂酮做成離型處理或剝 離紙等》 其次,玆針獬此粥蕹之製造方法加以説明,可由習知 之製法而容易製造》 例如,(Α)理擇二枯勞勿那克(diclofenac),酮替魯 非因(ketoprofen),彿非纳酸(fluphenanic acid),提 尼塔布,羅奇普羅汾,柯托拉克,富比那克,斯普魯汾 ,因多美連幸(indonetacine)以及其酯衍生物或_作為 藥效成分之非類固酵消炎鏔痛藥可用3-L-MP加以溶解》 如有必要可添加以安定化薄,抗«化劑,紫外線吸tt薄 ,乳化Μ ,防腐劑,抗菌_等》(B)水溶性聚合物以多 元酵,水混合,分散並溶解,形成為均勻之混練物<»其 次將(Β>加入於(Α)均勻分散直接延展於支持臛,或將其 延展於經由剝離處理之紙張或薄膜,然後再鹽著轉寫在 所用支持釀而可逕加製造。又,醑於上_製造法各基薄 ,藥效成分或其他成分之摻涯順序,即i實例加以概述 ,惟其混合順序並不受其限制。 奮廉俐1 粥薄 (A) 本纸張尺度適用中國國家揉準(CNS ) Α4规格(210X297公釐) (請先閱讀背面之注f項再填寫本頁) 訂 A7 B7 五、發明説明(9 ) 3-L-MP 1 . 0重置 % 二枯努勿那克(diclofenac) 0.5重量% (B) 精 製 水 48 .5重 量 % 明 腰 8 • 0M 量 % 离 嶺 土 1 • 0重 量 % 甘 油 35 .0重 量 % 聚 丙 烯 酸 納 2 .0重 量 % 聚 乙 烯 醇 3 .0重 量 % 氫 氣 化 鋁 1 • 0重 董 % 溶 解 上 述 成 分 9 攪 拌 而 獾 得 均 勻 之 混 煉 物, 使用 延 展 機 將 其 塗 佈 在 聚 丙 烯 不 纗 布 上 厚 度 約 1 咖 ,再 覆蓋 以 聚 丙 烯 薄 膜 9 切 斷 成 所 預 定 大 小 做 成 製 劑 A S. 旃 例 2 粥 剤 (A ) 3- L-MP 2 • 0重 JS % 羅 奇 普 羅 汾 1 .0重 * % 百 里 香 酚 0 .1重 量 % (B ) ! 精 製 水 f 62 .4重 悬 % 明 睡 .J· 3 • 0重 置 % 氣 化 鈦 1 • 0重 量 % 丙 三 醇 25 • 0重 Λ % 聚 丙 烯 酸 納 3 .0重 量 % 經濟部中央橾準局貞工消費合作社印製 . , - C (請先:8讀背面之注意事項再楼寫本I ) -11- 本紙張尺度適用中國國家揉準(CNS ) Λ4规格(210X297公釐) A7 B7 五、發明説明(l〇 ) 1 . 0重量% 1 . 0重量% 0 . 5重 Μ % 使用延展機將其 3 . 0重量% (請先聞讀背面之注意事項再填寫本頁) 羧甲基鑛維素 乙二酵二氨基乙醒醚 山梨糖酵酐脂肪酸酯 溶解以上成分,攪拌得均勻混煉物 塗佈在聚醣不嫌布上厚度約0.5»·,然後覆蓋以寮乙烯 膜,切斷成所定大小,做成製劑》 奮施例3 粥劑 (Α)I A7 _ B7___ V. Description of the invention (7) Furthermore, depending on what is needed, add the necessary ingredients and use polyvalent metal compounds as the cocoon. In particular, it includes argon "molybdenum, cyanide" Krypton, argon "Hydrogenation 0, ammoniation 0, aluminum sulfate, giant sulfuric acid, potassium sulphate, magnesium molybdate silicate, dihydroxyaluminum aminoacetate, etc., and the other interfering substances are at least in the molecule. There are more than 2 plums of "base compounds; specifically, including ethylene glycol bis-acetylglycol_, polyethylene glycol bis-β-ethyl acetate, malonyl bis-ethyl acetate, polypropylene Yeast 2 "Ethyl Ethyl Ether, Polytetramethylene Ester Diamino Ethyl Ether, Glyceryl Polyamino Ethyl Glycogenate, Sorbitan Anhydride Poly Ethyl Glycol Ether, Trimethylol Propane Ethylate , Pentaerythrogenic enzyme polyaminoethyl ether, hydroquinone diamino methyl ether, neopentyl ethylene diamino methyl ether meter, 1, 6-hexene diamino diamino ethyl ether, etc. It is suitable to mix one or more cross-linking agents ^ In addition, the other may be admixed with fillers such as liolin, gasified zinc, titanium, ceramic, diatomite, synthetic aluminum silicate, etc., hundred in Preservatives such as phenol, methyl parahydroxybenzoate, ethyl parahydroxybenzoate, vitamin C, stearates, dibutyl hydroxytoluene, butyl hydroxytearyl ether, gallic acid esters, vitamin pentamate, biotics Anti-gasification 2-hydroxy-4-methoxybenzophenone, pentylacetate, ethylenediaminetetraose, etc., 2-ethyl 2-benzylbenzoate, 2- (2-hydroxy-2-toluene) benzo Triazole, oxalic acid salicylic acid, salicylic acid, formic acid, salicylic acid, etc. UV, sorbitan fatty acid_, glyceryl fatty acid sugar, decyl glycerol fatty acid, polyethylene vinyl sorbose One or two or more kinds of emulsified thinners such as enzyme fatty acid esters, polyethylene glycol fatty acid esters, and polyethylene gas alkyl ethers. The support of this congee is important. It is important that the paper does not affect the medicinal ingredients of the thin paper. The paper uses China · Jialiang Zhun (CNS > A4 size (210X297 mm)). Note! Printed by the Ministry of Economic Affairs and the Consumers Cooperatives of the Ministry of Economic Affairs and printed by the Central Ministry of Economic Affairs and the Consumers ’Cooperatives of the Ministry of Economic Affairs, printed A7 and B7. 5. The material of the invention description (8). It is suitable for suckers. For example, you can choose polyethylene, polypropylene, polyvinyl chloride, polyester, sleep-resistant, polyurethane, etc. films or materials, or porous foamed cloth, cloth, non-iron cloth. It can also be porous film, foamed film, cloth, and non-iron cloth for its film or material. Also, peeling off the articles can be made ». · Probing polyethylene, polypropylene, polyester or Release processing or peeling paper with sand ketone, etc. "Secondly, the manufacturing method of this porridge is explained, and it can be easily manufactured by the conventional manufacturing method." For example, (A) dilofenac ), Ketoprofen, ketoprofen, fluphenanic acid, tinitab, Luo Profen, Kotorak, Fubinac, Sprufen, indonetacine and its ester derivatives or _ non-steroidal anti-inflammatory and analgesic drugs as effective ingredients can be used 3-L- MP to dissolve. ”If necessary, add stabilizers, anti-chemical agents, UV absorbers, emulsifiers, preservatives, antibacterial agents, etc. (B) Water-soluble polymers are mixed with multiple enzymes, water, dispersed and dispersed. Dissolve and form into a homogeneous kneaded material. Next, add (B) to (Α) to disperse and directly extend to the support 臛, or extend it to the paper or film that has undergone the peeling treatment, and then rewrite it with salt. Supports brewing and can be added to manufacture. In addition, the above-mentioned manufacturing method is based on thin, medicinal ingredients or other ingredients in the order of mixing, that is, the example is summarized, but the mixing order is not limited by it. Fenlian Li 1 Congee thin (A) This paper size is applicable to China National Standard (CNS) A4 size (210X297 mm) (Please read the note f on the back before filling this page) Order A7 B7 V. Description of invention (9) 3- L-MP 1.0 reset% dilofenac 0.5% by weight (B) fine Water production 48.5% by weight Waist 8 • 0M Amount% Liolin 1 • 0% by weight Glycerin 35.0% by weight Polyacrylic acid sodium 2.0% by weight Polyvinyl alcohol 3.0% by weight Aluminium hydride 1 • 0 Dissolve the above ingredients by stirring 9% to obtain a homogeneous kneaded material. Use a spreader to coat it on a polypropylene non-woven cloth with a thickness of about 1 cup, and then cover it with a polypropylene film 9 and cut to a predetermined size. Formulation A S. Example 2 Congee (A) 3- L-MP 2 • 0 weight JS% Rochprofen 1.0 weight *% thymol 0.1 weight% (B)! Purified water f 62. 4 resuspension% sleep. J · 3 • 0 reset% titanium vaporized 1 • 0% by weight glycerol 25 • 0% Λ sodium polyacrylate 3.0 % By weight Printed by Zhengong Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs.,-C (please read the precautions on the back of the book before reading the book I) -11- This paper size applies to China National Standards (CNS) Λ4 specifications ( 210X297mm) A7 B7 V. Description of the invention (10) 1.0% by weight 1.0% by weight 0.5% by weight 5% Using a stretcher to read 3.0% by weight (please read the precautions on the back before reading) (Fill in this page) Carboxymethylazine diaminoethane diethyl ether ether sorbitan fatty acid ester dissolves the above ingredients, stir to obtain a homogeneous kneaded material coated on polysaccharides, the thickness is about 0.5 »,, Then, it was covered with a vinyl film, cut to a predetermined size, and made into a preparation. Fen Example 3 Porridge (Α)

3-L-MP 0 . 5重量% 0 . 2重董% 4 2 . 3重量% 5 . 0重董% 3.0重量% 40 . 0重董% 2 . 0重量% 2 . 5重董% 1 . 5重量% 衣布蒲凡(i b u p r 〇 f e η) 乙基抽拉免(ethyl paraben) (B) 訂 精製水 泉_ 甲氧乙烯馬來酸酐共聚物 合成矽酸鋁 丙三酵 聚丙烯酸 聚乙烯酵 氳氣化0 經濟部中央揉準局只工消費合作社印裝 溶解上逑成分,攪拌得均勻混煉物,f用延展機,将 其塗佈在聚氛基甲酸乙酯膜上厚度約liw,再覆蓋以聚 酯膜,切蹐成所定大小,做成製痢。 g掄例4 粥劑 (A) -12 本紙張尺度逍用中國國家搮準(CNS ) Λ4规格(210X297公釐) A7 B7 (锖先《讀背面之注$項弄填寫本頁) 訂 經濟部中央橾率局工消费合作社印裝 五、發明説明(11 )3-L-MP 0.5% by weight 0.2% by weight Dong 42.3% by weight 5.0% by weight 3.0% by weight 40% by weight 2.0% by weight 2.5% by weight 1.5% 5% by weight ibupr 〇fe η ethyl paraben (B) Custom-made water spring _ methoxyethylene maleic anhydride copolymer synthetic aluminum silicate polyacrylic acid polyacrylic acid polyethylene fermentation Vaporization 0 The Central Kneading Bureau of the Ministry of Economic Affairs only prints and dissolves the ingredients on the top of the consumer cooperative and stirs them to obtain a homogeneous kneaded material. Using a spreader, it is coated on a polyurethane film with a thickness of about liw. Cover it with a polyester film and cut it into a predetermined size. g Example 4 Congee (A) -12 The paper size is in accordance with China National Standards (CNS) Λ4 specification (210X297 mm) A7 B7 (first read the "$" on the back and fill out this page) Order the Ministry of Economic Affairs Printed by the Central Consumers' Bureau of Industrial and Consumer Cooperatives 5. Description of Inventions (11)

3-L-MP 酮蒱凡(ketoprofen) (B) 精製水 N-乙烯乙醯胺 丙三酵 聚丙烯酸 羧甲基織維素 矽酸擊酸鎂 丙三酵脂肪酸酯 溶解上述成分,攙拌, 其塗佈在聚酯之不嫌布上 ,切斷成所定大小,做成 比较例1 粥劑 (A) 枯努他命頓 司蒱勞非因(sporofen) (B) 精製水 明騮 皂土 丙三醇 褐藻酸納 聚環氣乙烯 2 . 0重 Μ % D . 5重量% 36 . 0重量% 5 . 0 Μ « % 50 . 0重量% 3 . 0重量% 1 .0重 Μ % 1 . 5重量% 1 . 0重量% 得均勻混練物。使用延展機將 厚度約1丨丨,再覆蓋以聚酯膜 製剤》 1 . 0重量% 〇 .8重董% 54 . 2重量% #. 6 . 0 重 Μ % 5 . 〇重量% 25 . 0重量% 2 . 0重 ft % 4 . 0重量% -13- 本纸張又度適用中國國家揉準(CNS ) Α4规格(210X297公釐) 五、發明説明(l2 ) A7 B7 經濟部中央橾率局貝工消费合作社印装 硫酸鋁 聚乙二酵脂肪酸酯 溶解上述成分,攪拌得均勻混煉物 塗佈在聚氰乙烯膜上厚度約0.3 ,切斷成所定大小,做成製劑β fcb »例2 粥1« (A) 水揚酸丙三酵 酮蒱凡(Ketoprofen) (B) 精製水 N-乙烯乙醏胺 丙三酵脂肪酸酷 甘油 聚丙烯酸 羧甲基纖維素 矽酸鋁酸鎂 溶解上述成分,攪拌得均勻混練物 在聚酯之不嫌布上厚度約1 ,再覆 成所定大小,做成製劑。 t:h較例3 粥劑 (A) 丁烯乙二醇 薄荷油 1 . 5重量% 0 . 5 重 JK % ,使用延展機將其 再覆設以聚丙烯禊 2 . 0重董% 0 . 5重量% 36 . 0重量% 5 . 0重量% 1 . 0重量% 50 . 0重量% 3 . 0重量% 1 . 0重量% 1 . 5重量% 。使用延展機塗佈 蓋以聚酯膜,切斷 4 . 0重董% 1 . 0重董% 請先ΪΒ讀背面之注意Ϋ-項再%本頁 睬· 14 本纸張尺度逍用中國國家搮準(CNS 规格(210X297公釐> A7 B7 五、發明说明(工3) 籩 奇 普 魯 汾 〇 · 5重曇 % (B) «1 製 水 47.5重董 % 明 膠 3·〇重曇 % 离 嶺 土 1 - ok Μ % 甘_油 - 35· 〇重蓋 % 聚 丙 烯 酸 m 3.0重量 % 羧 乙 嫌、聚 合 物 2·5重董 % 期 精 2·〇重量 % 山 梨 耱 酵 酐 聚 m 基 乙 酵 黼 〇·5重董 % 溶 解 以 上 成 分 » 攪 拌 得 均 勻 混 煉 物 9 使 用 延展機將 其 塗 佈 在 聚 丙 烯 之 不 織 布 上 厚 度 約 1 醐 > 然 後 覆蓋以聚 酯 薄 膜 9 切 斷 成 所 定 大 小 > 做 成 製 劑 〇 再 者 9 硬 膏 劑 之 混 合 組 成 例 如 可 遵 用 (a)二枯努勿 那 克 (die 1 〇 f e na c ) » 麵 蒲 Λ (k ;e t op »r 〇 • f e ,n) » 弗露比普 羅 汾 (f1ur b ip Γ 0 fen) » 提 尼 塔 布 » 羅 奇 普 魯 汾 ,柯托拉 克 » 富 fcb 那 克 $ 斯 普 羅 汾 以 及 其 酯 衍 生 物 或 鹽 等做為蕖 效 成 分 之 非 類 固 醇 消 炎 鎮 痛 蕖 9 (b)併用松香酯衍生物以 及 3- L- MP所 形 成 之 溶 解 爾 > (C )以苯乙烯- 異 戊間二烯 - 笨 乙 烯 分 段 物 之 共 聚 物 做 為 基 本 聚 合 物 Z 丙 烯条黏著 » ((〇從軟化剤或習知之硬膏繭基劑中_宜蘐擇應方。 硬 膏 劑 之 支 持 體 可 選 用 對 所 釋 放 非 類 固 酵 消 炎鎮痛蕖 之 蕖 效 成 分 不 具 影 m 之 聚 丙 烯 布 或 聚 m 布 〇 聚 酯布最好 傺 由PET (聚乙烯對酞酸酯)或PBT (聚丁烯對酴酸_) $ -15- 本紙張尺度逋用中國國家揉準(CNS > A4规格(210X297公釐) 經濟央揉率局貝工消费合作杜印製 A7 _B7_ 五、發明说明(14 ) 製成之布料。欲提离非類固酵消炎鎮痛藥之釋放性,以 支持釀和非類固酵消炎鑛痛蕖之两不産生相互作用者為 宜,即以不吸著藥效成分為必要條件,基此觀黠,最適 當之支持鐮聚合物組成為聚丙烯,PET或PBT。並因使用 聚丙烯,PET或PBT所形成之支持釀,常因在支持ϋ不吸 著有蕖效成分,因而潁示有良好之釋放性。 此種硬蕾劑,採用设及樓方向50%伸長時慝力之平均 值為〇.3kg/c·以下之伸编性,故可貼附在屈曲部,非但 有簡便使用性,而且可«著皮虜之伸移而伸缠,減少資占 附時之磨擦與壓迫副作用》 關於此硬蕾劑,其所彰顯之特激為,藉由松番08$$ 物與3-L-MP之特定比例混合,大幅改善舆藥效成分之溶 解性。间時可大幅提高蕖效成分之釋出。其中,_&成 分,例如充分溶解非類固酵消炎鑛痛藥所薄出構成tt· 其非類固酵消炎鑛痛藥/松香釀衍生物/3-L-MP為1/2 〜25/1〜10 (重量比),在此範園内顯示有良好之非類 固酵消炎鏔痛藥之溶解性與釋放性。其中松香醣衍&物 為,将各種松香酯化,加水或經精製而製成,依酯之種 類,而有甲酯,甘油酯,季戊四酵酯等,具髏而言,有 _驥丸,AA-G,Η, HP (荒川化學公司産釋),柏斯益斯 連-L, S, P (播磨化成公司産製 > ,斯酯A-75(荒川 化學公司産製),KE-311(荒川化學公司産製),哈考 林D (赫克力斯公司産製 >,歐拉兒85,105 (赫克力斯 公司産製)等。 -16- 本纸張尺度逍用t國國家樑準(CNS ) Λ4規格(210X297公釐) (請先閱讀背面之注f項再填寫本筲) 訂 經濟部中央搮率肩貝工消费合作社印裝 A7 B7_ 五、發明説明(Η ) 此硬膏薄之基本聚合物,因考盧及皮虜安全性,藥效 成分釋放性,對皮慮之阽著性而可逋時遘擇習知物質使 用,例如,考嫌及非類固酵消失鎮痛藥之釋放待定,以 採用極性低之苯乙烯-異戊間二烯-苯乙烯分段物共聚物 為佳。具鼸而言,宜例示有加里弗力克斯TB-llflt,ΪΚ -1111,TRM112, TR-1117(施露化學公司産製),索 兒布連4 28 (穽利MK得路兒公司産製)等》如上述, 雖以使用苯乙烯-異戊两二烯-苯乙烯分段聚合物為最佳 實例,然可和聚異丁烯併合使用。軟化劑乃為将基礎聚 合物之苯乙烯-異戊間二烯-苯乙烯分段共聚物加以可塑 化,及軟化,維持對皮虜適度之附著性者。該等軟化》 可使用杏仁油,橄欖油,山茶子油,柿子油,花生油, 流動石蠟等β其混合比依苯乙烯-異戊間二烯-苯乙烯分 段聚合物10G重量份為計宜為150〜350重置份。 蕖效成分之混合量雖無特別限制,惟基於賦與治療時 有效量之釋出,利用率之考量以70〜1200// g/c·2者為 佳。鼸於此等藥效成分,松番酯衍生物,3-L-MP,苯乙 烯-異間戊二烯-苯乙烯分段共聚物及軟化劑總量中各成 分最好之混合比例,僳如下述。 亦即,最佳之混合比例為,_效成分〜10重Μ% * ,松香酯衍生物5〜70重量%, 3-L-MP 0.5〜15重董% ,苯乙烯-異戊間二烯-苯乙烯分段共聚物5〜40重量% ,軟化剤10〜75重量%。 此硬膏劑可依由習知之製造方法而容易獲得,例如使 -17- 本紙張尺度逋用中两國家揉準(CNS ) Α4规格(210X297公釐) I I I I —I —I— I (請先Μ讀背面之注$項再填寫本頁) -訂 A7 B7 混合機,在 分段共聚物 加混合藥效 或不嫌布, 以所要之支 的之範園内 劑,氣化防 胺劑,防腐 苯乙烯分段共聚物 五、發明説明(l6 ) 用捏和機,混煉機等 -異戊間二烯-苯乙烯 物加熱混合,随卽添 在聚丙烯或聚釀織布 之紙鬼或薄膜後套覆 並在不損及本發明目 種添加例如安定 紫外線圾枚薄,抗組 收促進等》 v m m 5 硬膏薄 苯乙烯-異戊間二烯-聚異丁烯 粘著賦與劑(松香酯3-L-MP ketoprofen (B) Refined water N-ethylene acetoamine glycerol polyacrylic acid carboxymethyl weavesin silicic acid magnesium magnesium glycerol fatty acid ester Dissolve the above ingredients, stir It was coated on a polyester cloth, cut to a predetermined size, and made into a comparative example. 1 Congee (A), kutamine, sporofen (B), refined hydrangea soap Naglycerol Alginate Sodium Polycyclic Gas Ethylene 2.0% by weight 6% by weight D. 5% by weight 36.0% by weight 5.0% «% 50.0% by weight 3.0% by weight 1.0% Μ% 1 5% by weight 1.0% by weight to obtain a uniform kneaded product. Using a stretcher, the thickness is about 1 丨 丨, and then covered with a polyester film. 1.0% by weight 0.8% by weight 54.2% by weight #. 6.0% by weight 5% 5.0% by weight 25.0 Weight% 2.0 Weight ft% 4.0 Weight% -13- This paper is again applicable to the Chinese National Standard (CNS) A4 (210X297 mm) 5. Description of the invention (l2) A7 B7 Central Ministry of Economic Affairs The local shellfish consumer cooperative printed the aluminum sulfate polyethylene glycol fatty acid ester to dissolve the above ingredients, stir to obtain a uniform kneaded material coated on a polyvinyl cyanide film with a thickness of about 0.3, cut to a predetermined size, and prepare a preparation β fcb » Example 2 Porridge 1 «(A) Ketoprofen (B) purified water N-ethylene acetamide glycerol fatty acid cool glycerin polyacrylic acid carboxymethyl cellulose magnesium aluminosilicate dissolved The above ingredients are stirred to obtain a uniformly kneaded material having a thickness of about 1 on a polyester cloth, and then coated to a predetermined size to prepare a preparation. t: h Comparative Example 3 Porridge (A) Butene ethylene glycol peppermint oil 1.5% by weight 0.5% by weight JK%, using a stretcher to cover it again with polypropylene 禊 2.0% by weight Dong 0%. 5% by weight 36.0% by weight 5.0% by weight 1.0% by weight 50% by weight 3.0% by weight 1.0% by weight 1.5% by weight. Use a stretcher to coat the cover with a polyester film and cut off 4.0% of the weight% 1.0% of the weight%% Please read the note on the back side first-item again% of this page Standards (CNS specifications (210X297 mm > A7 B7) V. Description of the invention (Engineering 3) Qi Pu Lufen 0.5 weight% (B) «1 water production 47.5 weight director% gelatin 3.0 weight% Liloline 1-ok Μ% 甘 _ 油-35 · 〇 heavy cover% polyacrylic acid m 3.0% by weight carboxyethyl acetate, polymer 2.5% by weight% period fines 2.0% by weight sorbic anhydride polymide Acetyl acetate 0.5% by weight of the above ingredients dissolved »Stir well to knead the mixture 9 Use a spreader to coat the polypropylene non-woven fabric with a thickness of about 1 醐 > Then cover it with a polyester film 9 and cut to a predetermined size Size > Formulations 0 and 9 Mixture of plaster can be used, for example (a) die 1 〇fe na c »face Λ (k; et op» r 〇 • fe, n) »F1ur b ip fen 0 fen» mention Nitab »Roche Prufen, Kotorak» Fcb-rich $ Sprofen and its ester derivatives or salts as non-steroidal anti-inflammatory analgesics 9 (b) and rosin ester derivatives And 3-L-MP dissolve. (C) Using styrene-isoprene-benzyl ethylene segment copolymer as the basic polymer Z propylene strip adhesion »((〇from softening 剤Or in the conventional plaster cocoon base, you should choose the recipe. The plaster's support can be made of polypropylene cloth or polyester cloth that has no effect on the released non-steroidal anti-inflammatory and analgesic ingredients. The cloth is best made of PET (polyethylene terephthalate) or PBT (polybutylene terephthalate) $ -15- This paper size is based on Chinese national standard (CNS > A4 size (210X297 mm)) The Central Bureau of the Bureau of Shellfish Consumer Cooperation Du printed A7 _B7_ 5. Description of the invention (14) Fabrics made. To improve the release of non-steroidal anti-inflammatory and anti-inflammatory analgesics, it is advisable to support the non-interaction between non-steroidal and anti-inflammatory anti-inflammatory analgesics, that is, to not absorb the active ingredients as a necessary condition. From the perspective, the most suitable support for the sickle polymer composition is polypropylene, PET or PBT. And because of the use of polypropylene, PET or PBT to form a support brew, often because the support does not absorb effective ingredients, so it shows good release. This kind of hard bud has a stretchability of 0.3 kg / c · or less when the 50% elongation in the building direction is used, so it can be attached to the flexion, which is not only easy to use, but also « Extending and entanglement with the skin, reducing the friction and oppression side effects of capital occupation. "About this hard bud, the special excitement it manifests is, through Songfan 08 $$ 物 and 3-L-MP 的Mixing at a specific ratio can greatly improve the solubility of the active ingredients. Time can greatly improve the release of effective ingredients. Among them, _ & ingredients, for example, fully dissolve the non-steroidal anti-inflammatory mineral pain medicine, which constitutes tt · its non-steroidal anti-inflammatory mineral pain medicine / rosin brewer derivative / 3-L-MP is 1/2 to 25 / 1 to 10 (weight ratio), which shows good solubility and release properties of non-steroidal anti-inflammatory and anti-inflammatory drugs. Among them, rosin sugar derivatives are made by esterifying various rosins, adding water or refining. Depending on the type of ester, there are methyl esters, glycerol esters, pentaerythritol esters, etc. In terms of skeletons, there are _骥 丸, AA-G, Η, HP (produced by Arakawa Chemical Co., Ltd.), Perth Essence-L, S, P (manufactured by Harima Chemical Co., Ltd.), and ester A-75 (manufactured by Arakawa Chemical Co., Ltd.) , KE-311 (manufactured by Arakawa Chemical Co.), Harcolin D (manufactured by Hercules >), Euler 85, 105 (manufactured by Hercules), etc. -16- This paper Standards and Standards for National Standards of China (CNS) Λ4 (210X297 mm) (Please read the note f on the back before filling in this card) Order the Central Ministry of Economic Affairs' shoulder-shoulders consumer cooperative print A7 B7_ V. Invention Explanation (Η) The basic polymer of this plaster is based on the safety of Kalou and Pirup, the release of medicinal ingredients, and its susceptibility to dermatological considerations. The release of non-steroidal disappearing analgesics is yet to be determined. It is better to use a low-polar styrene-isoprene-styrene segmented copolymer. There are Gary Flix TB-llflt, ΪΚ-1111, TRM112, TR-1117 (manufactured by Shilu Chemical Co., Ltd.), Solvail 4 28 (manufactured by Mili Deluer Co., Ltd.), etc. "As mentioned above, although The best example is using styrene-isoprene-styrene segmented polymer, but it can be used in combination with polyisobutylene. The softener is to separate the styrene-isoprene-styrene of the base polymer. Para-copolymers can be plasticized and softened to maintain moderate adhesion to the skin. For such softening, almond oil, olive oil, camellia oil, persimmon oil, peanut oil, flowing paraffin, etc. can be used. 10G parts by weight of ethylene-isoprene-styrene segmented polymer is preferably 150 ~ 350 replacement parts. Although the mixing amount of the effective ingredients is not particularly limited, it is based on the release of the effective amount during the treatment. , The consideration of utilization rate is preferably 70 ~ 1200 // g / c · 2. 鼸 These medicinal ingredients, pineoperyl derivatives, 3-L-MP, styrene-isoprene-benzene The best mixing ratio of each component in the total amount of ethylene segmented copolymer and softener is as follows. That is, the best mixing For example, the effective ingredient is ~ 10% by weight%, rosin ester derivative is 5 ~ 70% by weight, 3-L-MP is 0.5 ~ 15% by weight, styrene-isoprene-styrene segmented copolymer 5 ~ 40% by weight, softened by 10 ~ 75% by weight. This plaster can be easily obtained by conventional manufacturing methods, such as -17- this paper size (CNS) Α4 size (210X297) (Mm) IIII —I —I— I (please read the note on the back and fill in this page first)-order A7 B7 mixer, add mixed medicine effect to the segmented copolymer or not too bad, with the required support The range of internal agents, gasification antiamines, anti-corrosive styrene segmented copolymer V. Description of the invention (16) Use a kneader, mixer, etc.-isoprene-styrene to heat and mix, and then Add it to the paper ghost or film of polypropylene or poly woven cloth and cover it without damaging the purpose of the present invention, such as stable ultraviolet light, thin film, anti-assembly promotion, etc. vmm 5 plaster thin styrene-isoprene Diene-polyisobutylene tackifier (rosin ester)

流動石蠟 3-L-HP 酮知芬(ketotifen) 120〜160Ό下將苯乙烯 輿軟化甯及松香酯衍生 成分與3-L-MP直接延展 或覆設以經由離型處理 持鑊或經由轉寫由箸, 添加蕖理上可接受之各 止爾,香料,《充_ , 薄,抗__,或經皮吸 22.5重量% 5 . 0重董% 1 5.0重量% 56 . 0重覺% 1 . 0重董% 0 . 5重蠹% 經濟部中央橾準為貞工消费合作社印製 將上述各成分加熱攢拌後展延在支持體上,諝製成含 有酮知芬(Ketotifen)之蕖膣帶 m m me 硬蕾薄 丙烯樹脂条溶劑型威壓接著_ # 77.0重量% 摩 (商品名:NISSETSU PE-300) '(換算成固形分) 3-L-HP 15 . 0重董 % 硝酸異雙脱水山梨糖醇 8.0重董% 混合以上各成分,將其展延在支持驩上,蒸發溶薄I, 本纸張尺度逋用中國國家橾準(CNS > A4规格(210X297公釐) 五、發明税明(l7 ) A7 B7 鼸製成含有硝酸異雙脱水山梨糖酵蕖膠帶〇 窗掄锎7_ 硬膏» 砂_粘著薄 89.0重量% (商品名:bio-psa X7- 292 0 ) (換算成固形分) 3-L-HP 7 · 0M Λ % 枯勞尼神 4.0重量% 攪拌混合以上各成分,將其延展在支持腰上,蒸發溶 劑,調製成含有枯勞尼神之藥睡帶。 fcfc 例4 硬膏_ 矽_粘著劑 96.0重董% (商品名:NISSETSU PE-300 ) (換算成固形分) 枯勞尼神 4.0重量% 攪拌混合以上各成分,将其延展在支持鱧上,蒸發溶 劑,調製成含有枯勞尼神藥醪错。在實施例7中除溶解 劑3-L-MP以外之處方做為比較例1。 請 先 Μ 面_ 之 注Flowable paraffin 3-L-HP ketotifen 120 ~ 160 将, directly extend or overlay styrene softening and rosin ester-derived components with 3-L-MP to hold or transfer through release treatment From 箸, add the reasonably acceptable ingredients, spices, filling, thin, anti-_, or percutaneous absorption 22.5% by weight 5.0% by weight 1 5.0% by weight 56.0% by weight 1 0% by weight% 0.5% by weight The central government of the Ministry of Economic Affairs prints for the Zhengong Consumer Cooperative to heat and mix the above ingredients and spread them on the support to make it into a product containing Ketotifen膣 带 mm me Hard Bud Thin Acrylic Resin Strip Solvent Type Pressure Adhesive_ # 77.0wt% Mo (Product Name: NISSETSU PE-300) '(Converted to solid content) 3-L-HP 15.0 wt% Double sorbitan 8.0 wt% Blend the above ingredients, extend it on the support, evaporate and dissolve thin I. The paper size is in accordance with China National Standards (CNS > A4 size (210X297 mm). 5 、 Invention taxation (l7) A7 B7 鼸 Made with iso-nitrate sorbitan glucosamine tape 〇Window〇7_ Plaster »Sand_Adhesive thin 8 9.0% by weight (brand name: bio-psa X7- 292 0) (converted to solid content) 3-L-HP 7 · 0M Λ% cumanis 4.0% by weight Stir and mix the above ingredients to extend it to the support waist The solvent was evaporated to prepare a medicated sleeping tape containing kuranuishen. Fcfc Example 4 Plaster_silicone_adhesive 96.0% by weight (trade name: NISSETSU PE-300) (converted to solid content) kuranuishin 4.0% by weight of the above ingredients are stirred and mixed, extended on a support tincture, and the solvent is evaporated to prepare a drug containing cumani, which is used in Example 7. Except for the solvent 3-L-MP, it is used for comparison. Example 1. Please note first

II

訂 經濟部中央揉準f工消費合作社印製 hh » 例 R 矽酮粘着劑 (商品名:BIO-PSA X7-2920) 肉豆寇酸異丙酯 祜勞尼神 89·〇重置% (換算成固形分} 7.0重麗% » 4.0重躉% 攪拌混合以上各成分,將其延展在支^腰上,蒸發溶 颟,調製成含有枯勞尼神藥腰帶。又,實施例7之溶解 _3-L-MP以肉豆蔻酸異丙酯加以取代者做為比較例2 ^ 實旃例8 硬音薄 19 本纸張尺度遑用中國國家揉準(CNS ) A4规格(2丨0X297公釐) % Α7 Β7 五、發明説明(18 ) 25.0重量% 59 . 0重量% 5 . 0重量% • v 10 . 0重董% 苯乙烯-異戊間二嫌-苯乙燦分段共聚物 (商品名:加里弗力庫斯TR_1107) 流動石鐵 松香釀衍生物 (商品名:酯謬AA_G)Ordered by the Central Ministry of Economic Affairs, Japan, Japan, and Japan, printed by hh »Example R Silicone Adhesive (BIO-PSA X7-2920) Isopropyl myristate 祜 Raunishen 89 · 〇 Reset% (conversion Solid content} 7.0% by weight% »4.0% by weight% The above ingredients are stirred and mixed, extended on the support waist, evaporated to dissolve, and prepared into a belt containing cumani miracle medicine. In addition, the dissolution of Example 7_ 3-L-MP was replaced by isopropyl myristate as a comparative example 2 ^ Example 8 Hard sound sheet 19 This paper size is in accordance with China National Standard (CNS) A4 (2 丨 0X297 mm) )% Α7 Β7 V. Description of the invention (18) 25.0% by weight 59.0% by weight 5.0% by weight • v 10.0% by weight% styrene-isoprene-benzene-styrene-block copolymer (commodity Name: Gary Fricus TR_1107) Flowing stone iron rosin derivative

3-L-HP 二枯努勿那克(diclofenac) 1·〇簠量% 以上處方以捏和機混合後,直接延展於ΡΒΤ嫌布,上 部覆Μ以期裡做成硬膏涮❶ 啻偷拥9 硬蕾劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 20.0重量% (商品名:加里弗力庫斯TR-1107) 43 . 5重量% 10 . 0重量% 21 . 5重量% - ':· . C (請先珀讀背*之注f項再秦寫本頁) 流動石皤 聚異丁烯(商品名:匹斯達播庫斯) 松番酯衍生物(商品名:ΚΕ-311) 3-L-MP 4.0重董 % 二枯努勿那克(diclofenac) 1.0重董% 經濟部中央揉率局貝工消费合作社印製 由攆拌機混合上述處方,将其延展在預先施予剝雄處 理之塑謬腠,上面覆設以PET嫌布加以壓著轉寫,做成 硬膏薄I β 塞施例10 硬膏_ 苯乙烯-異戊間二烯-苯乙烯分段共聚物 21.0重量% (商品名:加里弗力庫斯TR 1107) 流動石蟠 63.0重量% 本纸張尺度逋用中B國家揉準(CNS > A4规格(210X297公釐) 五、發明説明(l9 ) A7 B7 松香酯衍生物(商品名:0-311) 3-L-MP 土枯努勿那寒(diclofenac) 用捏和機混合以上處方,將其延展於預先施設以剝離 處理之塑謬膜,上部覆蓋以PBT不織布加以壓着輅寓, 做成硬蕾_。 奮施桷11 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 30.0重量% (商品名-加里弗力庫斯TR 1111) 流動石孀 松香酯衍生物(商品名:釀謬H) 10 . 0重 ft % 4 . 0重量% 2 . 0重量% (請先《讀背面之注$項再填寫本買) 經濟部中央樣率爲負工消费合作社印裝 3-L-MP 57 . 0重董% 7 . 0重量% 5.0重量% 二 枯 勞 勿 那克 (diclofenac) 1 .0重 量 % 用 捏 和 機混 合上述處方,將其 延 展 在 預先施 予剝 離 處 理 之 塑 驂 膜上 ,上面覆蓋以聚丙 烯 不 嫌 布加以 壓箸 轉 寫 > 做 成 硬 蕾薄 〇 富 直 M. 11 -硬 音劑 苯 乙 烯 -異戊間二烯-苯乙烯分段 共 聚 物 15 .0重 Λ % (商品名- 加里 弗力庫斯TR 1 1 11) 聚 異 丁 烯 (益克遜化學公司産 製) 5 .0重 量 % 流 動 石 蟠 .* 1 23 .0重 量 % 松 番 酯 衍 生物 (商品名:酯謬 H) 42 • 0重 量 % 3- L- MP 1 0 . 0重 量 % 二 枯 努 勿 那克 (diclofenac) 5 .0重 曼 % -2 1 本紙張AA逋用中國國家橾準(CNS )八4胁(210X297公釐) 訂 -^- 經濟部中央榇率货工消費合作社印裂 A7 __B7 _五、發明説明(2〇) 用捏和機混合上述處方,将其延展在 理之塑膠膜,上面覆羞以聚丙烯鐵布加 成硬膏_ » 窗施相I 13 硬膏薄 苯乙烯-異戊間.二烯-苯乙烯分段聚合物 (商品名-加里弗力摩斯TR-1112) 流動石蠛 松香酯衍生物(商品名:呼拉耳105) 3-L-HP 二枯勞勿那克甲酯 (diclofenac aethyl ester) 仿實施例8之方法製造,做成硬音劑 富施例14 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段聚合物 (商品名:加里弗力庫斯TR-1107) 流動石纖 松香_衍生物(商品名:酯醪AA-6) 3-L-HP 醑 81 凡(k e t ο p r 〇 f e η) 仿實施例9之方法製造,做成硬膏爾 奮雄例15 硬膏剤 苯乙烯-異戊間二烯-苯乙烯分段聚合物 (商品名:加里弗力庳斯TR-1107) 流動石蟠 預先施予剌離處 以壓着轉寫,做 18 . 〇Μ 量 % 54 . 5簠悬% 18.5重董% 6 . 0重董% 3 . 0重量% 25 . 0重量96 68.0重量% 5 . 0重量% 1 . 5重量% 0 . 5重 Μ % 20 . 0重董% 43 . 5重量% 22- 本纸張尺皮逋用中國國家揉準(CNS ) Α4规格(210X297公釐) (婧先闭讀背面-之注I項*本頁)3-L-HP diclofenac 1 · 〇 簠% by weight The above prescription is mixed with a kneader and then directly stretched on the PBS cloth, and the upper part is covered with M to make a plaster. Hard bud styrene-isoprene-styrene segmented copolymer 20.0% by weight (Trade name: Gary Fricus TR-1107) 43.5% by weight 10.0% by weight 21.5% by weight- ': ·. C (please read the note f of the note * and then write this page on Qin). Flowing stone polyisobutylene (trade name: Pistacast). Pinosyl derivative (trade name: ΚΕ-311 ) 3-L-MP 4.0 wt% diclofenac 1.0 wt %% Printed by the Bakery Consumer Cooperative of the Central Rubbing Bureau of the Ministry of Economic Affairs, mixing the above prescription with a blender and extending it in advance The absurdity of the male exfoliation process is covered with a PET cloth and pressed to transfer it to make a thin plaster. Β Example 10 Plaster _ styrene-isoprene-styrene segmented copolymer 21.0 weight % (Trade name: Gary Flicks TR 1107) Flowing stone 63.0% by weight. This paper size is suitable for B countries (CNS > A4 size (210X297 mm)) Description of the invention (19) A7 B7 rosin ester derivative (trade name: 0-311) 3-L-MP diclofenac Mix the above prescription with a kneader and extend it to a pre-applied to peel off The processed plastic film is covered with PBT non-woven fabric and pressed into the upper part to make a hard bud. Fen Shi 桷 11 Plaster styrene-isoprene-styrene segmented copolymer 30.0% by weight (brand name -Gali Filicus TR 1111) Flowing stone rosin ester derivative (trade name: Brewing error H) 10.0 weight ft% 4 .0 weight% 2. 0 weight% (please read the "$" on the back side first) Please fill in this again) The central sample rate of the Ministry of Economic Affairs is printed on 3-L-MP 57.0% by weight of consumer cooperatives, 7.0% by weight, 5.0% by weight, dilofenac 1.0% by weight Mix the above prescription with a kneader, and stretch it on a plastic film that has been previously subjected to a peeling treatment, which is covered with a polypropylene film and pressed and transliterated > made into a thin hard bud 〇 富 直 M. 11- Styrene-isoprene-styrene segmented copolymer 15.0 wt.% (Trade name-Gary Fricus TR 1 1 11) polyisobutylene (manufactured by Exxon Chemical Co., Ltd.) 5.0 wt.% Flow ballast. * 1 23.0 wt.% Sorbitan Derivatives (Trade name: Ester H) 42 • 0% by weight 3- L- MP 1 0. 0% by weight diclofenac 5.0% by weight -2 1 This paper AA is used in China National Standards of Standards (CNS) Ya 4 threats (210X297 mm) Order-^-The Central Ministry of Economic Affairs rate of goods and workers' consumer cooperatives printed A7 __B7 _V. Description of the invention (2) Mix the above prescription with a kneader and mix Plastic film stretched on the top, covered with polypropylene iron cloth to add plaster _ »窗 施 相 I 13 plaster, thin styrene-isoprene. Diene-styrene segmented polymer (brand name-Galiveri Morse TR-1112) Flowing stone rosin ester derivative (trade name: Hula 105) 3-L-HP diclofenac aethyl ester Manufactured in accordance with the method of Example 8 and made Hard sound agent rich example 14 plaster plaster styrene-isoprene-styrene segmented polymer (trade name: Gary River Library) TR-1107) Flowing stone fiber rosin _ derivative (trade name: ester 醪 AA-6) 3-L-HP 醑 81 (ket ο pr 〇fe η) Manufactured in the same manner as in Example 9 to make a hard paste Male Example 15: Plaster styrene-isoprene-styrene segmented polymer (Trade name: Gary Fritz TR-1107) The flow stone was pre-applied to the separation area for pressure transfer, making 18. 〇 量 % 54.5% Hanging% 18.5wt% 6% 6.0wt% 3 3.0wt% 25.0wt96 68.0wt% 5.0wt% 1.5wt% 0.5wt% 20 .0% by weight. 43.5% by weight. 22- The paper ruler of this paper uses Chinese National Standard (CNS) Α4 size (210X297 mm) (Jing first closed the back-Note I item * page)

五、發明説明(21 ) A7 B7 經濟部中央梯準局貝工消費合作社印製 松香醏衍生物(商品名:KE-311) 3-L-MP 酮蒱凡(k e t ο p r 〇 f e η ) 仿實施例lfl之方法製造,做成硬資剤 奮施例16 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TR-1〗11) 聚異丁烯(益克遜化學公司産製) 流動石蟠 松香酯衍生物(商品名:醏膠H> 3-L-MP 酮蒱凡(ketoprofen) 仿實施例11方法製造,做成硬蕾劑β I施例17 硬膏爾 笨乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:蘇不列418) 聚戊烯 流動石蠘 松香酯衍生物(商品名:KE-311) 3-L-MP 弗露比普羅汾(flurbiprofen) 仿實施例12之製法,做成硬膏劑。 奮旃例18 硬音劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 30 . 5重蛋% 3 . 0重董% 3. 0重 JK % 15.0重量% 7 . 0重量% 23 . 0重:ft % 40 . 0重量% 10 . 0重 Μ % 5 . 0重量% 28 . 0重躉% 5 . 0 重;fil % 57 . 7重]1 % 7 . 0重量% 1 . 8重董% 〇.5重量% 21 . 0重量% (請先站讀背面之注$項再填寫本頁)V. Description of the invention (21) A7 B7 Printed rosin tincture derivative (trade name: KE-311) 3-L-MP ketone tincture (ket ο pr 〇fe η) Example 16 Manufactured by the method of lfl and made into hard materials. Example 16 Plaster styrene-isoprene-styrene segmented copolymer (Trade name: Gary Fricus TR-1〗 11) Polyisobutylene (Manufactured by Yixun Chemical Co., Ltd.) Flowing stone rosin ester derivative (trade name: Capsin H > 3-L-MP ketoprofen) Manufactured in accordance with the method of Example 11 to make a hard bud β I Example 17 Plasma styrene-isoprene-styrene segmented copolymer (commercial name: Sobril 418) Polypentene flow rosin rosin ester derivative (commercial name: KE-311) 3-L- MP flurbiprofen was prepared in the same manner as in Example 12. Fenbin Example 18 Hard tone agent styrene-isoprene-styrene segmented copolymer 30. 5 weight egg% 3 .0 weight Dong% 3. 0 weight JK% 15.0 weight% 7. 0 weight% 23.0 weight: ft% 40. 0 weight% 10. 0 weight M% 5. 0 weight% 28.0 weight 5%. 0 heavy fil% 57. 7 weight] 1% 7.0 wt% 1.8 wt% weight Dong 〇.5% 21.0 wt% (please read the back side of the injection station and then fill $ item page)

C 訂 2 3- 本纸張尺度逍用中國國家橾準(CNS ) A4規格(210X297公釐) 經濟部中央揉準局貝工消費合作社印裝 A7 _B7_五、發明説明(22 ) (商品名:加里弗力庫斯TR-1107) 流動石蟠 松香酯衍生物(商品名:KE-311) 3-L-MP 弗Λ比普羅汾(flurbiprofen) 仿實施例9之製法,做成硬膏麵。 實施例J 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TR-1107) 流動石蠼 松番酯衍生物(商品名:KE-311) 3-L-MP 弗露比普羅汾(flurbiprofen) 仿實施例10之製法,做成硬蕾薄I。 窖掄例20 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段聚合物 (商品名:加里弗力庫斯TR-1107) 苯乙烯-異戊間二烯-苯乙烯分段聚合物 (商品名:加里弗力庫斯TR-1111) 流動石蠛 松香酯衍生物(商品名:酯驪- AA-(〇 3-L-MP 弗露 tfc 普羅汾(flurbiprofen) 仿實施例12之製法,做成硬音劑。 66.8重 ft % Ί .2重董% 4 . 0重量% 1 . 0 k 量 % 2 1 . 0重量% 45.0重 * % 2 0 . 0重量% 9 . 0重量% 5 . 0重量% 1 1 . 0重量% 1 1 . 〇重量% 44 . 0重 ft % 6 . 0重量% 7 . 0重查% 1 . 0重置% {請先閱讀背面之注f項再填窝本頁) 訂 -24- 本紙法尺度逋用中國國家標準(CNS ) A4规格(210X297公釐) 經濟部中央橾準局貞工消費合作社印製 A7 _ B7五、發明説明(23 ) 富施例21 硬蕾劑 笨乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力克斯Τ β - 11 0 7 ) 流動石蟠 松香醣衍生物(商品名:0-311) 3-L-MP 羅奇普魯汾 仿實施例11之製法,得硬蕾劑〇 奮施例22 硬蕾劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力克斯TR-1111) 流動石蠟 松香酯衍生物(商品名:酷驂 Η) 3-L-MP 羅奇普魯汾 仿實施例11之製法,做成硬膏劑。 奮旃例23 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段聚合物 (商品名:加里弗力庫斯TR-1112) 流動石蟠 松香醏衍生物(商品名:酯腠 H) 3-L-MP 羅奇普魯汾 仿實施例12之製法,做成硬膏劑。 30 . Q重量% 56 . 0重量% 8.量 % 5 . 0重董% 1 . 0重量% 1 2 . 0重量% 28 . 0重董% 40 . 0重董% 12.0重 ft % 8 . 0重量% 21 . 0重量% 50 . 0重量% 20 . 5重量% 5 . 5重量% 3 . 0重量% (請先聞讀背面之注意事項再填寫本頁) -25- 本紙張尺度適用中國國家揉準(CNS ) Λ4规格(2丨0X297公釐) 經濟部中央標準局w;工消費合作社印裝 A7 _B7_五、發明説明(24 ) 奮餉例24 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TR-1111) 流動石蠛 松香酯衍生物(商品名:KE-311) 3-L-MP 羅奇普’魯汾鈉 仿實例9之製法,做成硬蕾劑β 奮撫柄25 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯ΤΒ-1107) 流動石蠛 松香酯衍生物(商品名:酯膠 Η) 3-L-MP 羅奇普魯汾鈉 仿實施例10之製法,得硬膏劑。 奮施例26 硬膏劑 笨乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TR-1107) 聚異丁烯(益克遜公司産製) 流動石蠟 f * 松番酯衍生物(商品名:哈考林D> 3-L-MP 羅奇普魯汾 仿實施例11之製法,做成硬資剤。 -26- 本纸張尺度逍用中國國家揉準(CNS ) Λ4规格(210X297公釐) % 量 I 0 % %%% 董*量董 «Β -ΕΒ V3 ^33 % % % % % Μ 董量量 Μ 重 重重重重 % % % % % % *量董量量董 重 重重重重重 Γ--------^---- (請先聞讀背*-之注1項再1^本頁) 經濟部中央揉準局貝工消费合作社印製 A7 __B7_五、發明説明(25 ) 奮施例27 硬蕾劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TR-1111) 流動石蠟 .松番酯衍生物(商品名:KE-311) 3-L-MP 柯托拉克 仿實施例9之製法,做成硬膏劑。 1施例2S 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TR-1107) 流動石_ 松香酯衍生物(商品名:醋膠H) 3-L-MP 柯托拉克 仿實施例11之製法,做成硬膏劑。 奮掄例29 硬音劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯T8-1112) 流動石皤 松香酯衍生物(商品名:酯膠H) 3 - L - Μ P 柯托拉克妥美達命 仿實施例12之製法,做成硬膏劑。 2 0 . 0重量% 38 . 0重量% 30 . 0£ « % 8 . 0重;I % 4 . 0重董% 28 . 0重量% 57 . 5重董% 9 . 0重量% 4 . 5重量% 1 . 0重量% 2 1 . 0重量% 53 . 0重量% 10 . 0重量% 1 4 . 0重量% 2 . 0重量% (請先閱讀背而之注$項再填窝本頁) 訂 -27- 本紙張尺度逋用中國國家標準(CNS > Α4规格(210X297公釐) 五、發明説明(26 ) A7B7 經濟部中央梂準局貝工消费合作社印製C Order 2 3-This paper size is in accordance with China National Standards (CNS) A4 specifications (210X297 mm) Printed by the Central Government Bureau of the Ministry of Economic Affairs, Shellfish Consumer Cooperatives A7 _B7_ V. Description of the invention (22) (Product name : Gary Fricus TR-1107) Flowing stone rosin ester derivative (trade name: KE-311) 3-L-MP Flurbiprofen The method of Example 9 was followed to make a plaster surface. Example J Plaster styrene-isoprene-styrene segmented copolymer (trade name: Gary Fricus TR-1107) flow lycopentaspinate derivative (trade name: KE-311) 3-L -MP flurbiprofen Imitated the method of Example 10 to make a hard bud thin I. Example 20 Stiffener styrene-isoprene-styrene segmented polymer (Trade name: Gary Fricus TR-1107) Styrene-isoprene-styrene segmented polymer ( Trade name: Gary Fricus TR-1111) Flowing stone rosin ester derivative (trade name: Ester-AA- (〇3-L-MP 弗罗 tfc flurbiprofen) The manufacturing method of Example 12, Made of hard sound agent. 66.8 ft% Ί .2 heavy Dong% 4. 0% by weight 1.0 k% by weight 2 1. 0% by weight 45.0% by weight *% 2 0% by weight 9.0% by weight 5. 0% by weight 1 1.1% by weight 1 1.1% by weight 44.0% by weight ft% 6.0% by weight 7.0% rechecked% 1.0 reset% {Please read the note f on the back before filling the nest (This page) Revision-24- This paper method standard uses Chinese National Standard (CNS) A4 specification (210X297 mm) Printed by A7 _ B7 of the Central Industrial and Commercial Standards Bureau of the Ministry of Economic Affairs, Zhengong Consumer Cooperative, V. Invention Description (23) Rich Examples 21 Hard bud agent stupid ethylene-isoprene-styrene segmented copolymer (trade name: Gary Frix T β-11 0 7) mobile stone rosin derivative (trade name: 0-311) 3 -L-MP Roach Prufen The method of Example 11 yields a hard bud agent. Example 22 The hard bud agent styrene-isoprene-styrene segmented copolymer (trade name: Gary Frix TR-1111) is derived from a flowing paraffin rosin ester. (Trade name: Cool) 3-L-MP Rochprofen followed the method of Example 11 to make a plaster. Fenxi Example 23 The plaster styrene-isoprene-styrene segment Polymer (trade name: Gary Fricus TR-1112) Flowing stone rosin rosin derivative (trade name: ester 腠 H) 3-L-MP Rochipulfen imitates the method of Example 12 and makes it hard 30. Q% by weight 56.0% by weight 8.% by weight 5.0% by weight 1.0% by weight 12.0% by weight 28.0% by weight 40.0% by weight 12.0% by weight ft% 8 0% by weight 21.0% by weight 50.0% by weight 20.5% by weight 5.5% by weight 3.0% by weight (Please read the precautions on the back before filling out this page) -25- This paper size applies China National Standards (CNS) Λ4 specification (2 丨 0X297 mm) Central Bureau of Standards, Ministry of Economic Affairs; Industrial and Consumer Cooperative Cooperatives Printing A7 _B7_ V. Description of the invention (24) Fen example 24 plaster styrene-iso M-diene-styrene segmented copolymer (Trade name: Gary Fricus TR-1111) Flowing stone rosin ester derivative (Trade name: KE-311) 3-L-MP Rochp 'Lufen sodium A method similar to that of Example 9 was used to make a hard bud agent β fenfu handle 25 plaster plaster styrene-isoprene-styrene segmented copolymer (trade name: Gary Fricus TB-1107) flowing stone rosin Ester derivative (trade name: Ester Capsule) 3-L-MP Rochprofen sodium following the method of Example 10 to obtain a plaster. Fenshi Example 26 Plaster Stupid ethylene-isoprene-styrene segmented copolymer (Trade name: Gary Fricus TR-1107) Polyisobutylene (manufactured by Exxon) Flow paraffin f * Matsuba Ester derivative (trade name: Hacolin D > 3-L-MP Roch Prufen imitates the manufacturing method of Example 11 to make hard assets. -26- This paper is standardized by the Chinese national standard (CNS ) Λ4 specification (210X297 mm)% Quantity I 0% %%% Dong * Quantity «B -EΒ V3 ^ 33%%%%% Μ Quantity MV heavy%%%%%% * Quantity Heavy Γ -------- ^ ---- (Please read and read back * -Note 1 and then 1 ^ This page) Printed by A7 __B7_ Description of the invention (25) Fen Example 27 Hard bud styrene-isoprene-styrene segmented copolymer (trade name: Gary Fricus TR-1111) Flow paraffin. Pinosyl derivative (commodity Name: KE-311) 3-L-MP Kotorak followed the method of Example 9 to make a plaster. 1 Example 2S Plaster styrene-isoprene-styrene segmented copolymer (trade name) : Gary Fricus TR-1107) Flowing Stone _ Rosin ester derivative (trade name: vinegar H) 3-L-MP Kotorak followed the method of Example 11 to make a plaster. Fenxi Example 29 Hard tone agent styrene-isoprene-benzene Ethylene Segmented Copolymer (Trade name: Gary Fricus T8-1112) Flowing stone rosin ester derivative (Trade name: Ester Gum) 3-L-MP P Kotorak Tometa Fame Example 12 The production method is made into plaster. 20.0% by weight 38.0% by weight 38.0 £ «% 8.0% by weight; I% 4.0% by weight 28.0% by weight 57.5% by weight 9 0% by weight 4.5% by weight 1.0% by weight 21.1% by weight 53.0% by weight 10.0% by weight 14.0% by weight 2.0% by weight (please read the back note first) Refill the items on this page) Order-27- This paper size is in accordance with Chinese national standard (CNS > A4 size (210X297mm)) 5. Description of invention (26) A7B7

窨施例30 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TR-1111) 流動石蟠 松番瞻衍生物(商品名:畜拉兒105) 3-L-MP 柯托拉克 仿實施例11之製法,做成硬奢劑。 審施例31 硬蕾劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TR-1 111) 聚異丁烯(益克遜化學公司産製) 流動石螵 松香酯衍生物(商品名:KE-311) 3-L-MP 酮蒱凡(Ketoprofen) 仿實施例8之製法,做成硬膏劑。 啻施例32 硬音劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TR-1111) ? 聚異丁烯(益克遜化學公司産製) ^ 流動石蠟 松香酯衍生物(商品名:KE-311) 3-L-MP 33 . 0重量% 60 . 0重量% 5 . 0 Μ 量 % 1 . 5重董% 0 . 5重量% 20 . 0重:Κ % 5 . 0重量% 55 . 0重量% 10 . 0重量% 8 . 0重量% 2 . 0重量% 1 5 . 0重量% 14 . 0重量% 38 . 0重躉% 25 . 0重量% 5 . 0重量% 請 先 聞 注窨 例 30 Plaster styrene-isoprene-styrene segmented copolymer (trade name: Gary Fricus TR-1111) Flowing stone cypress pine pankan derivative (trade name: Liver 105 ) 3-L-MP Kotorak followed the manufacturing method of Example 11 to make a hard luxury agent. Examination Example 31 Hard bud styrene-isoprene-styrene segmented copolymer (trade name: Gary Fricus TR-1 111) Polyisobutylene (manufactured by Yixun Chemical Co., Ltd.) Flowing ballast Rosin ester derivative (trade name: KE-311) 3-L-MP Ketoprofen Follow the method of Example 8 to make a plaster.啻 Example 32 Hard tone agent styrene-isoprene-styrene segmented copolymer (trade name: Gary Fricus TR-1111)? Polyisobutylene (manufactured by Yixun Chemical Co., Ltd.) ^ Flow paraffin Rosin ester derivative (trade name: KE-311) 3-L-MP 33. 0% by weight 60. 0% by weight 5.0% Amount by weight 1.5% by weight 0.5% by weight 20.0% by weight: Κ 5.0% by weight 55.0% by weight 10.0% by weight 8.0% by weight 2.0% by weight 15.0% by weight 14.0% by weight 38.0% by weight 25.0% by weight 5 0% by weight Please note first

I 頁 訂 28- 本紙張尺度逋用中國國家揉準(CNS ) Λ4规格(210X297公釐) A7 B7 五、發明説明(27 ) 經濟部4-央揉準局貝工消费合作社印製 酮 m 凡 (K etoprofen) 3 .0重 量 % 仿 實 施 例9之製法, 做成 硬 膏 劑〇 實 m 33 .硬蕾薄 苯 乙 烯 -異戊間二烯-苯乙烯 分 段 共聚物 22 .0重 量 % (商品名: 加里弗力庫 斯TR- 11 11 ) - 聚 異 丁 烯 (益克遜化學 公司産製) 8 • 0重 董 % 流 動 石 饑 46 .0重 量 % 松 香 酯 衍 生物(商品名 :KE- 3 1 1) 14 • 0重 量 % 3- L- MP 8 • 0重 童 % 柯 托 拉 克 2 • 0重 量 % 仿 實 施 例10之製法, 做成 硬 啬 劑。 SL 旃 例 34 _硬蕾劑 苯 乙 烯 -異戊間二烯-苯乙烯 分 段 共聚物 1 5 . 0重 量 % (商品名: 加里弗力庫 斯TR- 11 11 ) 聚 異- 丁 烯 (益克遜化學 公司産製> 12 .0重 量 % 流 動 石 蟠 27 .0重 董 % 松 香 酯 衍 生物(商品名 :KE- 3 1 1) 38 .0重 量 % 3- L- MP 4 • 0重 董 % 柯 托 拉 克 4 • 0重 董 % 仿 實 施 例10之製法, 做成 硬 膏 劑。 f W m 1 35 硬資蝌 苯 乙 烯 -異戊間二烯-苯乙烯 分 段 共聚物 20 .0重 董 % (商品名: 加里弗力庫 斯Τϋ- 11 07 ) 流 動 石 蟠 45 , .5重 置 % -29- (婧先《讀背面之注f項再填寫本X) ( 訂 本纸張尺度逍用中國國家揉準(CNS ) A4规格(2丨0><297公釐) 五、發明説明(28 ) A7 B7 經濟部中央橾準局負工消费合作社印裝 松番_衍生物(商品名:0-311) 3-L-MP 富比那克 仿實施例10之製法,做成硬膏劑》 奮掄例36 硬蕾薄 ‘苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TR-1111) 聚異丁烯(益克遜化學公司産製) 流動石蠟 松番_衍生物(商品名:KE-311) 3-L-MP 富比那克 仿實施例12之製法,做成硬膏劑。 奮旃例37 硬膏爾 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TR-1107) 聚異丁烯(益克遜化學公司産製) 流動石蟠 松番酯衍生物(商品名:哈考林D> 3-L-MP 富比那克 仿實施例11之製法,做成硬膏劑^ 奮掄例38 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 30 . 5重量% 3 . 0重量% 1 . 0重 ft % 15 . 0重量% 14 . 0重量% 28.0重董% 26 . 0重 11 % 5 . 0重量% 2 . 0重董% 2 2 . 0重覺% .5 . 0 重 ft % 52 . 0重 ft % 1 2 . 0重量% 7 . 0重董% 2 . 0重里% 28 . 0重量% t 面 之一 注 項 再 f 本 頁 訂 -30 本紙張尺度適用中國國家揉準(€呢>入4規格(210><297公釐> 五、發明説明(29 ) A7 B7 經濟部中央標準局負工消费合作社印裝 (商品名:索兒普蓮418> 聚丁烯 流動石蠛 松番酯衍生物(商品名:KE-311) 3-L-MP 斯普湮汾 仿實施例12之製法,做成硬膏劑。 奮施例39 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TB-1111) 流動石蠘 松香酯衍生物(商品名:K E - 3 1 1) 3-L-MP 斯普鏵汾 仿實施例9之製法,做成硬蓍劑。 奮施例40 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段聚合物 (商品名:加里弗力庫斯TR-1107) 聚異丁烯(商品名:匹斯達尼克斯) 流動石嫌 * 松香酯衍生物(商品名:KE-311) 3-L-MP 益斯逹拉二醇(e s t r a d i ο 1 ) 仿實施例8之製法,做成硬膏劑e 5 . 0重董% 5 7 . 0重量% 7 . 5重 1; % 2 . 0½ 董% 0 . 5 重 flt % 20 . 0重量% 4 0 . 0重量% 34 . 0重量% 4 . 0重量% 2 . 0重量% 20 . 0重蛋% 5 . 0重量% 45 . Q重量% 20 . 0重董% 9 . 0重量% 1 . 0重量% 3 1 - (請先《讀背面_之注f項再填寫本育)I Page 28- This paper size is based on the Chinese National Standard (CNS) Λ4 size (210X297 mm) A7 B7 V. Description of the invention (27) Ministry of Economic Affairs 4-Central Bureau Standard Bureau Shellfish Consumer Cooperative printed ketone m Fan (K etoprofen) 3.0% by weight According to the method of Example 9, a plaster was prepared. The solid m 33. Hard bud thin styrene-isoprene-styrene segmented copolymer 22.0% by weight (commodity Name: Gary Fricus TR- 11 11)-Polyisobutylene (manufactured by Yixun Chemical Co., Ltd.) 8 • 0% Dong Dong Flowing Stone Hungry 46.0% wt. Rosin Ester Derivative (Product Name: KE- 3 1 1) 14 • 0% by weight 3- L- MP 8 • 0% by weight Kotolak 2 • 0% by weight The method of Example 10 was used to make a hard tincture. SL 旃 例 34 _Hard bud agent styrene-isoprene-styrene segmented copolymer 15.0% by weight (trade name: Gary Fricus TR- 11 11) polyiso-butene (benefit Manufactured by Kexun Chemical Co., Ltd.> 12.0% by weight Flowing stone 72.7% by weight% Rosin ester derivative (trade name: KE- 3 1 1) 38.0% by weight 3- L- MP 4 • 0% Dong% Kotorak 4 • 0 wt. Dong% Follow the method of Example 10 to make a plaster. F W m 1 35 Hard-bonded styrene-isoprene-styrene segmented copolymer 20.0 wt. Dong% (Trade name: Gary Flickus T-11- 07) Flowing stone 45, .5 reset% -29- (Jing first "read the note f on the back side and then fill in this X) (revised paper size Free use of the Chinese National Standard (CNS) A4 (2 丨 0 > < 297 mm) V. Description of the invention (28) A7 B7 Printed pine fan_derivatives (commodities) (Name: 0-311) 3-L-MP Fulbinac is made in the same manner as in Example 10 to make a plaster. Fenchi Example 36 Hard Bud Thin 'Styrene-isoprene-styrene segmented copolymer (trade name: Gary Fricus TR-1111) polyisobutylene (produced by Yixun Chemical Co., Ltd.) flow paraffin pine derivative _ derivative (trade name : KE-311) 3-L-MP Furbinac was prepared in the same manner as in Example 12 to make a plaster. Fentium Example 37 Plaster styrene-isoprene-styrene segmented copolymer (trade name) : Gary Fricus TR-1107) Polyisobutylene (manufactured by Yixun Chemical Co., Ltd.) Flow lycoarsinone derivative (trade name: Harcolin D > 3-L-MP Fulbinaco) Preparation method of 11 to make a plaster ^ Fentium Example 38 Plaster styrene-isoprene-styrene segmented copolymer 30.5% by weight 3.0% by weight 1.0% by weight ft% 15.0% by weight % 14.0% by weight 28.0% by weight 26.0% by weight 11% 5.0% by weight 2.0% by weight% 22.2% by weight% 5.0% by weight ft% 52.0% by weight ft% 1 2. 0% by weight 7.0% by weight 2% by weight 2.0% by weight 28.0% by weight t Note on one side and then f on this page-30 This paper size is applicable to Chinese national standards (€?> 4 specifications (210 &gt); < 297 mm > 5. Description of the invention (29) A7 B7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economy Spufenfen imitates the method of Example 12 to make a plaster. Fenshi Example 39 Plaster styrene-isoprene-styrene segmented copolymer (Trade name: Gary Fricus TB-1111) Flowing stone rosin ester derivative (Trade name: KE-3 1 1 ) 3-L-MP Spufenfen imitates the method of Example 9 to make a hard tincture. Fenshi Example 40 Plaster styrene-isoprene-styrene segmented polymer (Trade name: Gary Fricus TR-1107) Polyisobutylene (Trade name: Pistanix) Flowing stone * Rosin ester derivative (trade name: KE-311) 3-L-MP estradiol (estradi ο 1) Following the method of Example 8, a plaster e 5 .0 wt% 5 7 0 Weight% 7.5 weight 1;% 2.0% Dong% 0.5 weight flt% 20.0 weight% 40.0 weight% 34.0 weight% 4.0 weight% 2.0 weight% 20.0 weight Egg% 5.0% by weight 45. Q% by weight 20.0% by weight 9% by weight 1.0% by weight 3 1-(Please read "Note f on the back _ before filling in this education")

本紙張尺度適用中國國家揉準(CNS ) A4规格(2丨0><297公釐) I五、發明説明(3〇 ) A7 B7 經濟部中央揉準局貞工消費合作社印製 奮掄例41 硬膏繭 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TB-1111) 聚異丁烯(益克遜化學公司産製) 流動石蠟 松香醱衍生物(商品名:酯隳H) 3-L-MP 益斯達拉二酵(estradiol) 仿實施例9之製法,做成硬膏痢。 蓄施例42 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商喆名:加里弗力庫斯TB-1111) 聚異丁螂(商品名:匹斯達尼克斯> 流動石蠼 松番酯f»生物(商品名:富拉兒105) 3-L-M.P 普羅吉斯得陵(progesterone) 仿實施例10之製法,做成硬膏爾β 奮施例43 硬膏劑 笨乙烯-異戊間二烯-苯乙烯分段共聚物f (商品名:加里弗力庫斯:TR-1107) ' 聚異丁烯(益克遜化學处司産製) 流動石蠼 松香酯衍生物(商品名:KE-311) 20 . 0重量% 12.0重最% .2 0 . 0 * * % 37 . 0重 Μ % 10 . 0重量% 1 . 0重量% 22 . 0重量% 6 . 0重量% 45 . 0重量% 23 . 0重董% 3 . 0重 ft % 1 . 0重量% 15. 0重躉% 10 . 0重貴% 39 . 0重量% 30 . 0重量% 面· 之 注 再 訂 -32- 本纸張尺度適用中國國家揉準(CNS ) Α4规格(2丨0><297公釐) 五、發明説明(3i) A7 B7 經濟部中央橾準局員工消費合作社印«. 3-L-MP 普籮吉斯得皤(progesterone) 仿實施例11之製法,做成硬蕾莆。 實掄例44 硬膏劑 苯乙烯-異戊蔺二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TR-1111) 聚異;Γ烯(商品名:匹斯達尼克斯) 流動石蠛 松香酯衍生物(商品名:KE-311) 3-L-MP 諾益斯史堤龍醋酸鹽 (norethisterone acetate) 仿實施例12之製法,做成硬膏劑。 實施例45 硬資劑 苯乙烯-異戊間烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯Τϋ-1111) 聚異丁烯(益克遜化學公司産製) 流動石皤 松香酯衍生物(商品名:酯膠Η) 3-L-MP 諾益斯史特龍(norethisterone) 仿實施例10之製法,做成硬膏劑。 富施例46 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 5 . 0重躉% 1 . 0重纛% 2 0 . 0重景% 5. 0重:S % 47 . 0重貴% 17 . 0 重 Jt % 10 . D重置% 1 . 0重董% 20 . 0重景% 11 . 0重覺% 25 · 0重董% 30. 0重:B % 13 . 0重量% 1 . 0重:K % 20 . 0重量% 請 先 Η Λ- 之 注This paper size is applicable to the Chinese National Standard (CNS) A4 specification (2 丨 0 > < 297 mm) I. Explanation of the invention (30) A7 B7 Example printed by Zhengong Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs 41 Stucco cocoon styrene-isoprene-styrene segmented copolymer (trade name: Gary Fricus TB-1111) polyisobutylene (produced by Yixun Chemical Co., Ltd.) Flow paraffin rosin derivative (commodity Name: Esters 隳 H) 3-L-MP estradiol Following the method of Example 9 to make a plaster. Example 42: Plaster styrene-isoprene-styrene segmented copolymer (commercial name: Gary Frikus TB-1111) polyisobutyl dung beetle (brand name: Pistanix >) Flown lycoxanthinate f »biological (trade name: Fulla 105) 3-LM.P Progesterone Following the method of Example 10, it is made into plaster plaster β Fen Example 43 plaster plaster stupid- Isoprene-styrene segmented copolymer f (trade name: Gary Fricus: TR-1107) '' polyisobutylene (manufactured by Exxon Chemicals Division) mobile rosin rosin ester derivative (trade name : KE-311) 20.0% by weight 12.0% by weight. 20.0% by weight * 3.0% by weight% 10.0% by weight 1.0% by weight 22.0% by weight 6.0% by weight 45%. 0% by weight 23.0% by weight 3% by weight ft% 1.0% by weight 15.0% by weight 10.0% by weight 39.0% by weight 33.0% by weight Noodles · Re-ordering note -32- This paper size is applicable to China National Standard (CNS) A4 (2 丨 0 > < 297 mm) V. Description of the invention (3i) A7 B7 Printed by the Consumers' Cooperatives of the Central Procurement Bureau, Ministry of Economic Affairs «. 3-L- MP Purgist Success (p rogesterone) was made in the same manner as in Example 11 to make a hard bud. Example 44 Plaster styrene-isoprene-styrene segmented copolymer (trade name: Gary Fricus TR-1111) Iso; Γ ene (trade name: Pistanix) flow lysin rosin ester derivative (trade name: KE-311) 3-L-MP norethisterone acetate Example 12 Example 45: Hardener styrene-isoprene-styrene segmented copolymer (trade name: Gary Flicks T-1111) Polyisobutylene (produced by Yixun Chemical Co., Ltd.) Production) Flowing stone rosin ester derivative (trade name: ester gum) 3-L-MP norethisterone The method of Example 10 was used to make a plaster. Rich Example 46 Plaster benzene Ethylene-isoprene-styrene segmented copolymer 5.0% by weight 1.0% by weight 2.0% by weight 5.0% by weight: S% 47.0% by weight 17.0% by weight Jt% 10. D reset% 1.0 heavy weight% 20.0 heavy weight% 11.0 heavy weight% 25 · 0 heavy weight% 30. 0 weight: B% 13.0 weight% 1.0 weight: K % 20. 0% by weight please first注 Λ- of Note

I 頁 訂 % -33- 本紙張逍用中國國家揉準(CNS )八4胁(210X297公釐) 五、發明説明(32 ) A7 B7 經濟部中央揉準局属工消費合作社印製 (商品名:加里弗力庫斯TR-1112〉 聚異丁烯(益克遜化學公司産製) 流動石蟠 松香酯衍生物(商品名:富拉兒105) 3-L-MP 事脂酮(testosterone) 仿實施例9之製法,做成硬蕾爾。 m tULM n.硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯TR-1107) 聚異丁烯(商品名:匹斯逹尼克斯) 流動石蠛 松香酯衍生物(商品名:JUE-311) 3 - L - Μ P 華脂酮(testosterone) 仿實施例12之製法,做成硬膏劑。 比較例6 硬膏劑 苯乙烯-異戊間二烯-苯乙烯分段共聚物 (商品名:加里弗力庫斯T 8 - U 0 7 ) 流動石蠛 # * 聚異丁烯(商品名:匹斯達尼克斯) 松香酯衍生物(商品名:ΚΕ-311) 二枯努勿那克(diclofenac) 以攪拌楢混合上逑處方,預先將其延展 12 .0重量% 30 . 0重董% 30 . 0重貴% 7 .0重量% 1 . 0重曇% 22 . 0重量% 5 . 0重量% 45 . 0重量% 22 . 0重量% 5 . 0重覺% 1 . 0重量% 20 . 0重:ft % 43 . 5重蠹% 10 . 0重量% 25 . 5重量% 1 . 〇重量% 在施予剝離處 請 先 閱 之 注I Page Order% -33- This paper is free to use Chinese National Standards (CNS) VIII 4 threats (210X297 mm) V. Description of the invention (32) A7 B7 Printed by the Central Government Standards Bureau of the Ministry of Economic Affairs and printed by the Industrial and Consumer Cooperatives (trade name) : Gary Fricus TR-1112> Polyisobutylene (manufactured by Exxon Chemical Co., Ltd.) Flowing stone rosin ester derivative (trade name: Fulla 105) 3-L-MP testosterone The method of Example 9 was used to make hard lei. M tULM n. Plaster styrene-isoprene-styrene segmented copolymer (trade name: Gary Fricus TR-1107) polyisobutylene (trade name : Pitts Knicks) Flowing stone rosin ester derivative (trade name: JUE-311) 3-L-MP Posterosterone (testosterone) The method of Example 12 was used to make a plaster. Comparative Example 6 Hard Plaster styrene-isoprene-styrene segmented copolymer (trade name: Gary Fricus T 8-U 0 7) flow stone ## polyisobutylene (trade name: Pistanix) rosin Ester derivative (brand name: ΕΕ-311) dilofenac is mixed with 逑 and mixed with a prescription, and it is extended in advance 12.0% by weight 30.0% by weight 30% 0% by weight 7.0% by weight 1.0% by weight 22.0% by weight 5.0% by weight 45.0% by weight 22.0% by weight 5 0% weight% 1.0 weight% 20.0 weight: ft% 43.5 weight% 10% 0% weight 25. 5% weight 1.0% weight% Please read the note before applying the peeling

I 旁 訂 34- 本紙張尺度速用中國國家搮準(CNS ) Λ4規格(210X297公釐〉 A7 B7 經濟部中央揉準局属工消费合作社印製 五、發明説明 (33 ) 理 之 塑 m 膜 * 上 部 覆 設 以 聚 醣 加 以 壓 著 轉 寫 做 成 m 蕾 m 。又將實 例 9 之 3- L- MP溶 解 蘭嫌做 為 比 較 例 6 0 1 其 次 ♦ 針 對 軟 蕾 說 明 之 〇 軟 膏 基 薄 可 遘 商 習 知 或 通 常 讀 1、 1 所 使 用 者 P 例 如 离 级 贈 肪 酸 或 其 m 類 ( 例 如 己 二 酸 參 讀 肉 豆 蔻 酸 * 棕 檷 酸 * 硬 脂 酸 ., 油 酸 * 己 二 酸 醋 費 ή 豆 寇 背 A 1 之 酸 醋 » 棕 欐 酸 酯 » 癸 二 酸 二 乙 酯 » 月 桂 酸 己 酯 9 異 辛 酸 注 1 I 十 —Ις 院 醏 ) » 蟠 類 ( 例 如 » m 蠼 9 蜜 蠟 » 地 蟠 等 ) 9 高 項 - .| | 级 酵 ( 例 如 資 鯨 蠟 酵 9 梗 脂 醯 酵 9 鯨 蠛 硬 脂 酵 酵 等 ) ♦ 再 | α 1 I 矽 酮 油 ( 例 如 ·· 二 甲 基 聚 矽 氧 院 » 甲 苯 基 聚 矽 氣 烷 9 乙 I 二 酵 甲 基 聚 矽 氣 院 » 矽 酮 乙 二 醇 聚 合 物 等 ) > 碩 化 氬 類 1 1 ( 例 如 : 親 水 凡 士 林 9 白 色 凡 士 林 精 製 羊 毛 脂 f 流 動 石 1 1 蟻 等 ) > 水 9 吸 收 促 進 m ( 例 如 硪 酸 丙 烯 9 二 異 丙 基 己 1 Ί 訂 1 二 酸 酷 » 克 勞 他 命 頓 9 埃 藏 <S> 等 ) 9 保 濕 m ( 例 如 甘 油 9 丙 二 醇 9 丁 二 酵 » 山 梨 糖 酵 等 ) 9 斑 疹 防 止 剤 9 其 他 1 I 添 加 物 ( 例 如 * 水 楊 酸 » 水 揚 m 甲 酯 9 水 欐 酸 乙 二 酵 9 1 1 SL -薄荷酵, 樟腦, 薄荷油等) 〇 1 1 在 以 上 各 基 m 攙 混 以 蕖 效 成 分 9 如 有 必 要 時 可 適 宜 潺 Jf 合 安 定 化 劑 9 抗 氣 化 薄 9 紫 外 線 吸 吸 劑 9 防 腐 薄 9 抗 m 1 1 m 等 » 依 此 可 獲 得 本 發 明 之 軟 膏 剤 〇 - \ 其 次 9 玆 欲 軟 蕾 薄 製 造 例 之 一 種 以 供 參 Λ 考 〇 1 I 将 0 . 1〜5 簠 董 % 藥 效 成 分 溶 解 於 1 Λ / 2 0重量% 3 -L -MP 1 所 生 成 之 混 合 物 9 在 室 溫 或 加 濕 下 混 合 以 0 . 0 1 r\y 5重量 1 I % 紫 外 線 趿 牧 劑 或 0 . 0 1 3重量%抗氣化爾, 添加4 10 1 1 重 董 % 蠟 類 > 40 80重 量 % 硪 化 氳 類 加 m 或 加 熱 熔 解 > 1 1 I -35- - I 1 1 1 本紙張尺度適用中國國家揉準(CNS ) A4规格(210X297公釐) 五、發明説明(34 A7 B7I Side-by-side 34- Quick-use of this paper standard China National Standards (CNS) Λ4 specifications (210X297 mm) A7 B7 Printed by the Central Government Bureau of the Ministry of Economic Affairs and printed by the Industrial and Consumer Cooperatives * The upper part is covered with glycan and transliterated to make m bud m. The 3-L-MP dissolving blue of Example 9 is also used as a comparative example 6 0 1 Secondly ♦ The ointment base is thin for the soft bud. The quotient is familiar or usually read by users 1, such as graded donated fatty acid or its m type (for example, adipic acid reads myristic acid * palmitic acid * stearic acid., Oleic acid * adipic acid Price of vinegar vinegar back A 1 acid vinegar »palmitate» diethyl sebacate »hexyl laurate 9 isooctanoic acid Note 1 I 10 — I ς 醏» »» (for example »m 蠼 9 honey Wax »Dioscorea etc. 9 High-level items-. | | Grade fermentation (for example, whale wax fermentation 9 stem fat fermentation 9 whale stearase fermentation, etc.) ♦ re | α 1 I silicone oil (Eg ·· Dimethicone Academy »Tolylpolysilazane 9 ethane I Dimethylase Polysilicone Academy» Silicone Glycol Polymers, etc.) > Shuohua Argon 1 1 (eg: Hydrophilic petroleum jelly 9 White petroleum jelly refined lanolin f mobile stone 1 1 ants etc.) > Water 9 absorption promotion m (such as propylene acetate 9 diisopropyl hexadecane 1 订 order 1 diacid cool »Clautonon 9 Izo < S > etc. 9 Moisturizing m (eg glycerin 9 propylene glycol 9 succinase »sorbase, etc.) 9 spotted rash prevention 9 other 1 I additives (eg * salicylic acid» salicylic acid m methyl ester 9 leech Acid Ethanol Enzyme 9 1 1 SL-Peppermint Yeast, Camphor, Peppermint Oil, etc.) 〇1 1 Mix the above ingredients with effective ingredients 9 If necessary, Jf and stabilizers 9 Anti-gasification thin 9 Ultraviolet absorbent 9 Anti-corrosive thin 9 Anti-m 1 1 m etc. »According to this, the ointment of the present invention can be obtained. 〇- \ Second 9 One of Lei's manufacturing examples for reference Λ1 〇1 I dissolve 0.1 to 5% of the active ingredients in 1 Λ / 20 0% by weight 3 -L -MP 1 The mixture 9 at room temperature or Under humidification, mix with 0. 01 r \ y 5 wt. 1 I% UV herbicide or 0. 1 3 wt.% Anti-gasification, add 4 10 1 1 wt.% Waxes > 40 80 wt.% Addition of methane or methane or melting by heating> 1 1 I -35--I 1 1 1 This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) 5. Description of the invention (34 A7 B7

並保持於5〇~ιο〇·〇β於整釀成分變成透明溶解液後用 均讁機混合均勻《然後,經由*拌並降低至室溫時則可 獲得本發明之軟膏又,以上之製造例僅為其中之一 實例,其他尚可由習知或類似方法及處方加以製造。又 ,各混合物的混合順序等並無特別之限制β (以¥,各 種製劑之處方例,製造例亦適用以上之條件) 實」fe例48·軟膏薄I 白色凡士林 單硬脂酸甘油 牛脂 矽釅油 3-L-MP 弗露比普羅汾(flurbiprofen) 76 . 0重置% 10 . 0重量% 10 . 0 重 JK % 1 . 0重董% 2 . 0重量% 1 . 〇重量% 攪拌混合以上各成分,豳製成含有弗露比普羅汾軟蕾 軟音劑 銼濟部中央揉準局貞工消费合作杜印«.And keep it at 50 ~ ιο〇 · 〇β. After the whole brewing ingredients turn into a transparent dissolving solution, use a homogenizer to mix well. Then, when the mixture is reduced to room temperature through * mixing, the ointment of the present invention can be obtained. The manufacturing examples are only one example, and the others can be manufactured by conventional or similar methods and prescriptions. In addition, there is no particular limitation on the mixing order of each mixture. Β (in ¥, various preparations, and manufacturing examples are also applicable to the above conditions) Example "fe Example 48 · Ointment Thin I White Vaseline Monostearate Glycerin Tallow Silicon Emu Oil 3-L-MP flurbiprofen 76. 0 Reset% 10. 0% by weight 10.0 Weight JK% 1. 0% by weight% 2.0% by weight 1.0% by weight Stir and mix The above ingredients are made into Fruby Profen soft bud softener file, the Ministry of Economic Affairs of the Central Ministry of Rubbing and Probationary Consumer Cooperation Du Yin «.

白色凡士林 癸二酸二乙酯 鲸蟠 聚氣乙烯月桂基醚磷酸鈉 2- 羥基-4-甲氣苯並苯酮 對羥基苯酸丁酯 3- L-MP 7 6 . 9 5重量% 5 . 0重量% 5 . 0重麗% 4 . 0重量% 1 一重量% 身 01. 05重蛋% 2.0重量% 酮蒲凡(ketoprof en) 3 . 0 重量 96 攪拌混合以上各成分,調製成含有酮蒲凡軟音。 -36- 本纸ft尺度逋用中國國家棵準(CNS ) Μ规格(210X297公釐) L---_----.--i------1T------涞- (請先Η讀背*.之注意事項再«寫本買) A7 B7 經濟部中央揉率局WC工消費合作社印製 82 . 95重量% 8 . 0重量% 3 . 0重暹% 2 .0重量% 0 . 05重量% 3 . 0重量% ) 3 . Q重量% 諝製成含有因諾美逹辛軟膏β 説明之。凝膠基劑可由習知或 ,例如包括有,低级醇(如乙 化劑(例如:羧乙烯聚合物, 維素,褐藻酸丙二醇酯等), ,二異丙醇胺,壑氧化納等) 油酸山梨糖醇酐,三油酸山梨 酐,單硬脂酸山梨糖醇酐,單 脂酸聚乙二醇,聚氧乙烯壬苯 ,聚氣乙烯月桂基醚等),吸 烯,癸二酸二乙酯,己二酸二 藏丙二醇f),斑疹防止 * 揚酸,水楊酸甲水楊酸乙 薄荷油等)。在以上各基劑 時可適宜混合以紫外線吸收劑 之凝膠劑。 -37- 五、發明説明(35) 窖施例50 軟膏薄| 白色凡士林 肉豆蔻酸異丙酯 鲸蠟 聚氧乙烯月桂基嫌磷酸納White petrolatum diethyl sebacate cetyl polyethene sodium lauryl ether phosphate 2-hydroxy-4-methyl benzophenone p-hydroxybenzoate 3-L-MP 7 6. 9 5 wt% 5. 0% by weight 5.0% by weight 4.0% by weight 1% by weight 01.05% by weight 2.0% by weight ketoprof en 3.0% by weight 96 The above ingredients are stirred and mixed to prepare a ketone Pu Fan soft sound. -36- This paper is in ft size, using China National Standards (CNS) M specifications (210X297 mm) L ---_----.-- i ------ 1T ------ 涞-(Please read the back of the note *. Before you buy the copy) A7 B7 Printed by the Central Government Bureau of the Ministry of Economic Affairs, WC Industrial Consumer Cooperative, 82. 95% by weight 8. 0% by weight 3.0% by weight 2.0 0.05% by weight (3.0% by weight) 3. Q% by weight 谞 is made with inomepramine ointment β as explained. Gel bases can be known or include, for example, lower alcohols (such as acetylating agents (for example: carboxyvinyl polymers, vitamins, alginic acid propylene glycol esters, etc.), diisopropanolamine, sodium oxide, etc) Sorbitol oleate, sorbitan trioleate, sorbitan monostearate, polyethylene glycol monostearate, polyoxyethylene nonylbenzene, polyoxyethylene lauryl ether, etc.) Diethyl acid, propylene glycol adipic acid f), spot rash prevention * salicylic acid, salicylic acid methyl salicylic acid ethyl peppermint oil, etc.). For each of the above bases, a gelling agent with an ultraviolet absorber can be appropriately mixed. -37- V. Description of the Invention (35) Cellar Example 50 Ointment Thin | White Vaseline Isopropyl Myristate Cetyl Wax Polyoxyethylene Lauryl Sulfate

對羥基苯酸丁酯 3-L-MP 因諾美逹辛(indometacin 攪拌混合以上各成分, 其次,針對凝膠劑詳加 常用之各種基劑加以選擇 酵,異丙醇等),水,膠 羥乙基纗維素,羥丙基纖 中和劑(例如:三乙醇胺 ,界面活性劑(如:倍半 糖酵酐,單油酸山梨糖醇 月桂酸山梨糖醇酐,單硬 基醚,聚氣乙烯鲸蟠基醱 收促進劑(例如:磷酸丙 異丙酯,克勞他命頓,埃 劑,其他添加物(例如水 二酵,JI-薄荷醇,樟腦, 添加蕖效成分。如有必要 或抗氣化劑而獲得本發明 本紙張尺度逋用中國國家揉準(CNS ) A4规格(210X297公釐) (请先《讀背面之注$項再填寫本夏)Butyl p-hydroxybenzoate 3-L-MP Indometacin (Indometacin is mixed by mixing the above ingredients. Secondly, for the gelling agent, various commonly used bases are added to select yeast, isopropyl alcohol, etc.), water, gum Hydroxyethyl lutein, hydroxypropyl cellulose neutralizers (eg, triethanolamine, surfactants (eg, sesquiglycolic anhydride, sorbitan monooleate, sorbitan laurate, monostearyl ether, Polyethylene cetyl hydrazone recovery accelerator (eg: propyl isopropyl phosphate, clautonin, estrogen, other additives (eg, hydrazine, JI-menthol, camphor, added effective ingredients) such as It is necessary or anti-gasification agent to obtain the paper size of the present invention, using the Chinese National Standard (CNS) A4 size (210X297 mm) (please read the "$" on the back side before filling in this summer)

經濟部中央揉準爲貝工消费合作社印装 A7 B7 五、發明説明(36 ) 玆將凝腠劑之製造例例舉如下: (A)添加水含量在60重量%以下之膠化劑0.5〜5重量 %加以膨潤,一方面(B)將0.1〜5重量%藥效成分以0.1 〜20重置%3-L-MP予以溶解所形成之混合物,必要時混 合以0.01〜5重量%紫外線吸收或0.01〜3重雇%抗 氣化劑,以含有40重量%以下乙二酵類與60重量%以下 低级酵的混合物加以溶解,其次將(B)加入於(A)添加中 和劑,諏整PH至4〜7而獲得本發明之凝膠剤。 奮掄例51 凝膠;刻 羧乙烯聚合物 2.0重量% 羥丙基纖維素 2.0重量% 乙醇 37.0重量% 丙二酵 15.0重量% 己二酸二異丙酯 2.0重量% 二異丙醇胺_ 2. 5重量% 2- 羥基-4-甲氧苯並苯酮 〇.5重董% 3- L-MP 3 . 0重量 % 掘蒱凡(fcetoprofen) 3.0重量 % 精製水 33.0重量% 攪拌混合以上各成分諏製成含有SS蒲凤凝膠爾。 * 實施-例5 2_ 凝膠劑 羧乙烯聚合物 1.5重量% 羥丙基纗維素 2.0重董% 乙醇 1 7 . 0重量% 38- 本紙張尺度逍用中國國家標準(CNS > A4规格(210X297公釐) (請先《讀背面之注f項再填寫本頁)The central government of the Ministry of Economic Affairs has printed A7 B7 for the shellfish consumer cooperative. V. Description of the invention (36) The production examples of gel tinctures are exemplified as follows: (A) Adding gelling agent with water content below 60% by weight 0.5 ~ Swell at 5% by weight. On the one hand, (B) a mixture formed by dissolving 0.1 to 5% by weight of the active ingredient at 0.1 to 20% of 3-L-MP, and if necessary, absorbing 0.01 to 5% by weight of ultraviolet light. Or 0.01% to 3% of anti-gasification agent, dissolve with a mixture containing adioxins below 40% by weight and lower enzyme below 60% by weight, and then add (B) to (A) add a neutralizing agent, 诹Adjust the pH to 4 to 7 to obtain the gelatin of the present invention. Example 51 Gel; Carboxy vinyl polymer 2.0% by weight Hydroxypropyl cellulose 2.0% by weight Ethanol 37.0% by weight Malonase 15.0% by weight Diisopropyl adipate 2.0% by weight Diisopropanolamine 2 5% by weight 2-hydroxy-4-methoxybenzophenone 0.5% by weight 3- L-MP 3.0% by weight cetoprofen 3.0% by weight purified water 33.0% by weight Stir and mix each of the above Ingredients 诹 made with SS Pufeng gel. * Example-Example 5 2_ gelling agent carboxyvinyl polymer 1.5% by weight hydroxypropyl stilbene 2.0% by weight% ethanol 17.0% by weight 38- This paper uses Chinese National Standards (CNS > A4 specifications ( 210X297 mm) (please read "Note f on the back side before filling out this page)

經濟部中央揉率局貝工消费合作社印製 A7 ______B7 五、發明説明(37 ) 丙二醇 硪酸丙烯 三乙酵胺 3-L-MP 因諾美達辛(i.ndoietacin) 精製水 嫌拌混合以上各成分諝製成含 實」fe例5 3 凝謬劑 羧乙烯聚合物 乙酵 丙二醇 二異丙酵胺 (請先《讀背面之注f項再填寫本頁)Printed by A7 ____B7, Shellfish Consumer Cooperative, Central Bureau of the Ministry of Economic Affairs. 5. Description of the Invention (37) Propylene Glycol, Propylene Triethyl Enzyme 3-L-MP, Innomedacin (i.ndoietacin) The ingredients are made into solid ingredients. ”Example 5 3 Coagulant Carboxylic polymer acetic acid propylene glycol diisopropionamine (please read" Note f on the back side before filling this page ")

Q 訂 -資- 3-L-MP 弗霉比普 精製水 懺拌混 其次, 丙烷-1 , 合物,加 促進劑, 紫外線吸 詳言之 硬脂酵, 化氫類有 羅汾(flurbiprofen) 合以上各成分諏製成含 針對乳薄説明之,其像 2-二酵,高级酵類,磺 水均勻乳化而製成。其 保豭劑,油脂類,脂肪 收》等β ,本發明所使用之高级 乙醒硬脂酵,己基癸酵 白色凡士林,三十硪烷 30.0重量% 10 . 0重量% 0 . 2重量% 3 . 0重置% 1 . 0童躉% 35 . 3重量% 有因諾美達辛凝謬» 1.0重麗% 35 . 0重量% 10 . 0重量% 3 . 0重躉% 3 . 0重 ft % 1 . 0重翅:% 49 . 0重量% 有弗露比普羅汾凝騮雨 将藥效成分,3-L-甲氣 化氬類,乳化薄做成混 中可攙混以所需之吸收 酸,中和爾,防腐_ , t 酵類,包括有鲸繅酵, ,辛基十二烷酵等,磺 ,流動石蟠等,至於乳 -39- 本紙張尺度逋用中國國家橾準(CNS ) A4规格(210X297公釐) A7 ___B7 _ 五、發明説明(38 ) 化嫌缠用者為聚氣乙烯烷基醚,山梨糖酵酐脂肪酸酯, 聚氣乙烯山梨耱酵酐脂肪酸酯,聚氣乙烯烷苯基醚類等 ,以月桂基醚,鲸蠟基醚,硬脂基醚,油山莕醚等 為最佳·如有霈要時可加入對羥基苯酸酯β其含量即以 5〜15重量%高级酵類,10〜2 0重董%硪化氫類,1〜3 重董%乳化繭者為佳β至於水的涯合量以51.5〜82.4重 量%者最具適用,防腐劑則似加入0 . 1〜0 . 5重董%為佳。 其次,僳以硪酸丙烯,癸酸二乙酯,己二酸二異丙酯 等做為吸收促進劑β至於保墉劑包括有甘油,丙二酵, 山梨耱酵等β藥效成分含量為0.5〜5重量%則能充分期 待其具有效果。 又,做成具有乳劑與凝膠劑中間性質之凝膠狀乳薄, 卽将上述乳剤中以羧乙烯聚合物,羥乙基雄雒素,理丙 基繼維素,乙基繼維素,羧甲基纖雄素等做為凝騵蘭, 以及以二異丙醇胺,三乙酵胺,氬氧化銷等做為中和两 ,将ΡΗ讕整至4〜8,最好為5〜6.5,而可播得本發明之 凝驩狀乳劑。以下僳代表一種凝繆狀乳剷之製造例。Q Order-Information- 3-L-MP Furnace Bip Refined Leech Mix Secondly, Propane-1, Compound, Add Accelerator, Ultraviolet Absorptive Stearase, Hydrogen Type: Flurbiprofen Combined with the above ingredients, it is made with the instructions for thin milk, which are like 2-secondary yeast, high-grade yeast, and sulphur water evenly emulsified. Its tinctures, oils, fats, etc. β, the high-grade acetogenic stearate used in the present invention, hexyldecanoate white vaseline, triclosan 30.0% by weight 10.0% by weight 0.2% by weight 3 .0 Reset% 1. 0 Childhood% 35.3% by weight Innomethacin Condensate »1.0% by weight 35.0% by weight 10.0.0% by weight 3.0% by weight 3.0% by weight ft % 1.0 Heavy wing:% 49. 0% by weight. It has Fruby-Profen condensate. The medicinal ingredient, 3-L-formaldehyde gasified argon, emulsified thinly, can be mixed with the desired one. Acid absorption, neutralization, antiseptic, t fermentation, including whale fermentation, octyldodecane fermentation, sulphur, mobile stone, etc., as for milk-39- This paper is in accordance with Chinese national standard (CNS) A4 specification (210X297 mm) A7 ___B7 _ V. Description of the invention (38) The suspected users are polyalkylene glycol ethers, sorbitan fatty acid esters, and polygas ethylene sorbitan fatty acids Ester, Polyvinyl Ethylene Alkyl Phenyl Ethers, etc., Lauryl Ether, Cetyl Ether, Stearyl Ether, Yushen Ether, etc. are the best The amount is 5 to 15% by weight of high-grade yeasts, 10 to 20% by weight of Tungsten hydrochloride, and 1 to 3% of% by weight emulsified cocoons. It is suitable, and the preservative seems to add 0.1 to 0.5% by weight. Second, 僳 uses propylene acetate, diethyl decanoate, diisopropyl adipate, etc. as absorption enhancers β. As for the preservatives including glycerol, malonate, sorbic acid, etc. 0.5 to 5% by weight can fully expect its effect. In addition, a gel-like milk having an intermediate property between an emulsion and a gel was prepared. The above-mentioned milk was mixed with a carboxyvinyl polymer, hydroxyethylandrosin, ricyldividin, ethyldividin, carboxylate Methyl cellulose and other compounds are used as cypress, and diisopropanolamine, triethylenylamine, and argon oxidation pin are used as the neutralization two, and the pH is adjusted to 4 ~ 8, preferably 5 ~ 6.5 , And can broadcast the gel-like emulsion of the present invention. The following example represents a manufacturing example of a condensed milk shovel.

(A>將0.1〜5重量%藥效成分以0.1〜20重Μ % 3-L-HP 溶解所生成之混合物,必要時溶解以0.01…5重量i紫 外線吸收劑,或如有必要将D.〜3重夤#抗氧化嫌溶 > 解於25重量96以下高级脂肪酸酯與4 0重ί %以下低级酵 之混合物,並加入0.5重M%以下防腐_,以下 乳化劑。另一方面(B)加0.5〜5重量X凝醪賴於水中使之 膨潤,其次将(B)加入於(A)中以均化器均句乳化,乳化 -40- 本紙張歧逋用中國國家揉準(CNS ) A4规格(2丨0X297公釐) - ( (請先閱讀背面之注意事項再填寫* 本頁) 經濟部中央樑率局負工消费合作社印製 A7 B7 經濟部中央橾準局貞工消费合作社印裝 五、發明説明(39) 後加入中和劑,諝整pH值為4〜8, 即可獲得本發明之凝 暖狀乳爾》 奮掄别54 乳獼 流動石播 10 . 0重蛋% 中鍵脂.肪酸甘油三酸酯 5 ‘ 0 鲎 * % 單硬脂酸聚乙二酵 3 . 0重蛋% 丙三酵 5 . 0重量% 羧乙烯聚合物 1 . 0重量% 二異丙醇胺 0 . 4重量% 對羥基苯酸甲酯 0 . 2重量% 因語美逹辛(indonetacin) 1 . 0重鼉% 3 - L - Μ P 5 . 0重 * % 精製水 殘董 攪拌混合以上各成分調製成含有因諾美達辛乳劑。 奮掄俐55 乳商( 中鐽脂肪酸甘油三酸_ 3 . 0重最% 丙三酵 1 0 . 0重董% 羧乙烯聚合物 1 . 0重量% 二奠丙酵按 0 . 4重置% 3-L-MP t 5 . 0 重 Μ % 弗露比普羅汾(f 1 u r b i ρ r 〇 f e η ) 1 . 0重量% 精製水 殘量 攪拌混合以上各成分調製成含有 弗露比普羅汾乳膏。 賣施.例5 6 乳劑 -41- 本紙張尺度適用中囲國家橾本(CNS > A4规格(210X297公釐) A7 B7 五、發明説明(4〇 ) 經濟部中央標率局貞工消費合作社印裝 鯨 蠟 酵 3 • 0重 景 % 硬 脂 酵 醇 3 .0重 量 % 聚 氣 乙 烯 醚 2 • 0重 * % (尼可兒BC- 20Τί :, Β 光 化 學 公 司 産 製 ) 白 色 凡 士 林 16 .0鲎 量 % 流 動 石 蠟 * 2 • 0重 Jt % 對 羥 基 苯 酸 甲 酷 0 .2重 董 % 3- L- MP 2 .0重 董 % mm 凡 (K e t 〇Ε ,r 〇 丨 f e η ) 2 .0重 量 % 精 製 水 69 • θ重 量 % 攪 拌 混 合 以 上 各 成 分 調 製 成 含 有 m 蒲 凡 乳 膏 〇 菁 旅 5 7 乳 爾 乙 醯 硬 脂 醇 7 • 0重 量 % (N AA -48, 日本油脂公司産製) 聚 氣 乙 烯 月 桂 酸 甘 油 m 醚 2 • 5重 量 % (尼可兒BL- 25 > Β 光 化 學 公 司 産 製 ) 白 色 凡 土 林 1 0 . 0重 董 % 流 動 石 蠟 5 ' .0重 量 % 對 m 基 苯 酸 甲 酯 0 · 2重 量 % 3- L- MP 3 . .0重 量 % 酮 m 凡 (k e t op Γ 0 f e η) 〆 3 . .0重 量 % 精 製 水 69 _ .3重 量 % m 拌 混 合 以 上 各 成 分 諝 製 成 含 有 醑 蒲 凡 乳 音« * W 旃 例 5 8 乳 劑 -42- ii—id— (請先《讀背面之注意事項再4寫本頁) 訂 本紙張尺度逍用中國困家橾準(CNS M4规格(21〇Χ297公釐) 經濟部中央揉準局貝工消費合作社印裝 A7 B7 五、發明説明(41 ) 鲸 蟠 酵 4 • 0重 量 % 硬 脂 醏 酵 4 • 0重 量 % 聚 氣 乙 烯 鲸 m 酵 2 • 0重 Μ % 白 色 凡 士 林 14 .0童 量 % 流 動 石 蟠 2 .0童 量 % 對 羥 基 苯 酸 甲 酯 0 .2重 * % 3- L- MP 2 .0重 ft % 柯 托 拉 克 3 • 0重 量 % 精 製 水 67 .8重 量 % m 拌 混 合 以 上各成 分調製成含有柯托拉克乳 賣β s_ m 例 5 9 乳 劑 鯨 m 酵 4 • 0重 董 % 硬 脂 醯 酵 4 .0重 董 % 聚 氧 乙 烯 鯨 蠟 醚 2 .0重 量 % 白 色 凡 士 林 12 .0重 量 % 流 動 石 蠟 3 0重 量 % 對 羥 基 苯 酸 甲 m 0 • 2重 量 % 3- L- MP 4 • 0重 量 % 柯 托 拉 克 3 • 〇重 童 % 精製水 # 6 5. 8重量% 攪拌混合以上各成分,讕製成含有柯ίε拉克乳膏。 奮掄俐fiO 乳劑 鯨蟠酵 3 . Q重量% 硬脂醯醇 4 . 0重量% -4 3 - 本纸張尺度逋用中國國家揉準(CNS > A4规格(210X297公釐) (請先《讀背面_之注意Ϋ-項存填寫本頁)(A > The resulting mixture is dissolved by 0.1 to 5% by weight of the medicinal ingredient at 0.1 to 20% by weight of 3-L-HP, and if necessary, it is dissolved by 0.01 ... 5% by weight of an ultraviolet absorber, or D. if necessary. ~ 3 重 夤 #Antioxidant susceptible to dissolve It is a mixture of higher fatty acid esters of less than 25 weights and 96 and lower enzymes of less than 40 weight%, and added 0.5% by weight of preservatives and emulsifiers. (B) Add 0.5 ~ 5 weight X coagulant to swell in water, then add (B) to (A) and emulsify with homogenizer, emulsify -40- This paper is mixed with Chinese national standard (CNS) A4 specification (2 丨 0X297mm)-((Please read the notes on the back before filling in this page *) Printed by the Ministry of Economic Affairs, Central Liangshou Bureau, Consumer Cooperative, A7 B7 5. Printed by the consumer cooperative. 5. Description of the invention (39) After adding a neutralizing agent, and adjusting the pH value to 4 ~ 8, you can obtain the condensed warm milk of the present invention. Fat egg% Middle bond fat. Fatty acid triglyceride 5 '0 鲎 *% Monostearate polyethylene glycolase 3.0 Fat egg% glycerol yeast 5.0% by weight Ethylene polymer 1.0 wt% diisopropanolamine 0.4 wt% methyl parahydroxybenzoate 0.2 wt% indonetacin 1.0 wt% 3-L-Μ P 5 0 weight *% refined water residues are stirred and mixed with the above ingredients to prepare an Innomethacin emulsion. Fenzhili 55 Dairy maker (Medium Fatty Acid Triglyceride _ 3.0 weight most% glycerin 10. 0% by weight of carboxyvinyl polymer 1.0% by weight of dimethylpropionate reset by 0.4% 3-L-MP t 5.0% by weight %% Frubyprofen (f 1 urbi ρ r 〇fe η ) 1. 0% by weight of the purified water residue is stirred and mixed with the above ingredients to prepare a frobiprofen cream. Sale application. Example 5 6 Emulsion-41- This paper size is applicable to the Chinese national standard (CNS > A4) Specifications (210X297 mm) A7 B7 V. Description of the invention (40) The printing of whale yeast 3 by the Central Standards Bureau of the Ministry of Economic Affairs, Zhengong Consumer Cooperative, 3 • 0% of the scene% of stearyl alcohol 3.0% by weight of polyvinyl ether 2 • 0 weight *% (Nicole BC-20Τί:, Β manufactured by Photochemical Co., Ltd. ) White petroleum jelly 16.0.0% by volume Flow paraffin * 2 • 0 weight Jt% paraben benzoate 0.2 weight% 3- L- MP 2.0 weight weight%% Fan (K et 〇Ε, r 〇 丨 fe η) 2.0% by weight of purified water 69 • θ% by weight The above ingredients are stirred and mixed to prepare m Pufan cream 〇cyanate 5 7 Milk acetostearyl alcohol 7 • 0% by weight (N AA -48, manufactured by Japan Oil & Fat Co., Ltd.) Polyethylene laurate glycerol m ether 2 • 5% by weight (manufactured by Nikol BL-25 > Β Photochemical Co., Ltd.) White Fantulin 10. 0% by weight% flow Paraffin 5 '.0% by weight p-methyl benzoate 0.2% by weight 3- L- MP 3. 0% by weight ketone m Fan (ket op Γ 0 fe η) 〆 3.0% by weight purified water 69 _ .3% by weight m Each ingredient is made to contain 醑 Pufan milk sound «* W 旃 例 5 8 乳 乳 -42- ii—id— (please read the precautions on the back and then write this page) Standard (CNS M4 (21 × 297 mm) Printed by the Central Government Bureau of the Ministry of Economic Affairs, printed by the Shellfish Consumer Cooperative A7 B7 V. Description of the invention (41) Whale leaven 4 • 0% by weight Stearin leaven 4 • 0 weight % Polyethylene whale m ferment 2 • 0 weight Μ% white petrolatum 14. 0 child% mobile lithules 2.0 child%% methylparaben 0.2 weight *% 3- L- MP 2.0 Weight ft% Kotorak 3 • 0% by weight purified water 67.8% by weight m Mix and mix the above ingredients to prepare Kotorak milk to sell β s_ m Example 5 9 Emulsion whale m leaven 4 • 0 wt% stearin Fermentation 4.0% by weight% Polyoxyethylene cetyl ether 2.0% by weight White petroleum jelly 12.0% by weight Flow paraffin 3 0% by weight parabens m 0 • 2% by weight 3- L- MP 4 • 0% by weight G 3 • billion children weight% purified water # 6 5.8% by weight or more ingredients mixed with stirring, a cream containing Ke Lan ίε la. Fen Li FiO Emulsion Whale Yeast 3. Q% by weight Stearyl Alcohol 4.0% by weight -4 3-This paper size is based on Chinese national standards (CNS > A4 size (210X297mm) (please first "Read the back _ of the note 项-item deposit to complete this page)

A7 B7 五、發明説明(42 ) 聚氣乙烯油醚 (尼可兒B0-20,日光化學公司産製 白色凡士林 流動石蟠 對羥基苯酸甲酯 2 . 0重量% 10 . 0重 ft % 6 . 0重麗% 0 . 2童躉% 經濟部中央橾率局負工消费合作社印製 3 - L - Μ P. 酮蒲凡(ketoprofen) 精製水 攪拌混合以上各成分 奮掄锎(Π 乳劑 乙酵硬脂醇 (NAA-48 p本油脂公司 聚氣乙烯鲸蟠基醚 白色凡士林 流動石蟠 對羥基苯酸甲酯 3-L-MP _ 蒲凡 '(ketoprofen) 精製水 攪拌混合以上各成分 其次,玆對儲量型阽 附劑,乃由3-L-MP ,乙 子所生成之凝膠基劑, 凝膠基劑,或由石蟠類 3 . 0重量% 1 . 〇重量% 70 . 8重董% 調製成含有酮蒲凡乳膏。 5 . 0重董% 産製 2 . 0重 Μ % 10 . 0重量% 4 . 0重量% 0 . 2重量% 8.0重量% 3 . 0重量% 67 . 8重畺% 諏製成含有_蒲$乳膏β 附劑詳逑之。本_明之儲量型貼 二醇,低级醇,水及水溶性高分 或由脂肪族酵及多元醇所生成之 ,矽酮類之凝膠基劑所形成之具 -44- (請先酺讀背面之注ny再填寫本I)A7 B7 V. Description of the invention (42) Polyethylene vinyl ether (Nicole B0-20, white petroleum jelly made from Nikko Chemical Co., Ltd., white petroleum jelly, para-hydroxybenzoic acid methyl ester 2.0% by weight, 1.0% by weight ft% 6 0% Li% 0.2% Tongren% Printed by the Central Ministry of Economic Affairs Bureau of the Ministry of Economic Affairs and Consumer Cooperatives to print 3-L-Μ P. Ketoprofen refined water mixing and mixing the above ingredients Fen (II emulsion B Fermented stearyl alcohol (NAA-48 p, this oil company's poly (ethylene vinyl cetyl ether), white petrolatum mobile stone, p-hydroxybenzoic acid methyl 3-L-MP _ ketoprofen, purified water, mixing and mixing the above ingredients next Herein, the reserve-type attachment agent is a gel base, a gel base made from 3-L-MP, acetone, or a stone gangue 3.0 wt% 1.0 wt% 70. 8 5% by weight is prepared to contain ketopufan cream. 5.0% by weight is produced by 2.0% by weight% by 1.0% by weight is 4.0% by weight is 0.2% by weight 8.0% by weight 3.0% by weight 67 8% 畺% 诹 is made with _ Pu $ cream cream β appendix in detail. The _ Ming reserves of the type of patch diol, lower alcohol, water and water-soluble high content or by fatty fermentation and more Produced by alcohols, formed by silicone-based gel bases -44- (Please read the note on the back before filling in this I)

本纸張尺度逍用中國國家橾準(CNS ) A4规格(210X297公釐) 經濟部中央樑率局員工消费合作社印製 A7 B7 五、發明説明(43 ) 有藥物貯檐之健董型貼附W,其藥雨成分為毎一張鍺量 型貼附蕹宜含有10〜l〇〇«g,如含有成分未滿1〇·β時則 無法獲得有持鑛性的鎮痛效果,但如超過lODlg時因有 對消化管及皮虜引發障礙之可能性而不宜逋用》 將蕖效成分經皮投輿之本發明餘量型貼附Μ,供由薄 效成分及凝驪基_所形成之蕖薄(貯槽,使第1«逋用於皮 虜表面之投與裝置所構成》 首先,依藥薄而言,其像以對治療有效用量之蕖效成 分可獲得皮虜透過性為必要條件,其中最好傜對皮虜少 有剌激性而有優異之安全性,在保存中不引起實霣上的 化學變化者為佳,藥爾貯槽除含有第效成分外,因應其 所需可在基劑成分中混合經皮吸收促進薄,睡化W,殺 菌剤,氣化防止剤,紫外線吸收爾,埔充劑,增黏劑, 乳化劑,ΡΗ讁整劑,減低皮虜剌激爾,防腐薄保濕劑 ,水,溶解剤等習知之添加爾做為外用劑。 在此等添加劑中關於經皮吸收促進劑,其_效成分之 皮虜透遇速度,如傺屬_效成分之局部作用,即可設定 為30〜3QQ#g/hr速度,如僳屬於全身性之治療效果時 ,則可將其速度設定為150〜2500# g/hre其中如透過 速度未谋30;ug/hr時無法獾得充分之局φ作用,但如超 遇2 50 0 // g/hr時則有黯皮醱或消化管引^副作用之虞而 不宜逋用。經皮吸收促進薄可使用習知之乙酵,油酸, 1-十二烷基吖環庚烷-2-酮,JI-薄荷酵,d-檸檬烯。 閘於醪化劑乃至增拈薄最好傺將藥劑粘度混配在 -4 5 - 本紙張尺度適用中國困家揉準(CNS ) A4规格(210X297公釐) (請先H讀背面之注$項再填寫本頁) 訂 經濟部中夾揲率局貝工消費合作社印裝 Α7 Β7 五、發明説明(44 ) 50 0〜2 00 00 cps之範醣。如藥薄粘度未滿500 cps畤,當 貼附爾張阽在皮虜上缸時,則蕖劑易於從蕖薄貯藏槽獮 出而不宜適用》如藥_粘度超遇2 0 0 0 0 CPS時,則頗難以 獲樗所霈藥甯之皮虜透遇性。鏐化薄乃至增粘雨,僳在 藥繭条攙混以可溶性高分子,.例如褐藻酸,羧甲塞鑛Ji 素納,寒天,明隳,羥丙基繼維素,聚丙烯酸,聚丙烯 酸銷,聚乙烯酵,聚乙烯吡咯烷酮,甲基繼维素,甲乙 烯醚-馬來酸酐共聚物等/ 至於pH調整爾,最好供將藥雨条之PH範圍混配在3〜8 。如藥薄条之PH低於3時,會對皮虜産生剌激而不宜使 用〇又,如PH高於8時,因具有剌檄性而不利於阽附在 皮嫌使用,同時對藥劑成分的皮纛透過性亦欠佳PH調 整劑可採用習知之檸樣酸,醑酸,磷酸納等》 做成藥劑貯槽之基劑處方,其中之一實施樣態包括有 乙二醇類,低级酵,水及水溶性聚合物所生成之基薄。 其中,乙二酵類對皮慮有保蔴作用,除可缓和一般性 蕖物對皮虜之剌激性外,可提离屬於主劑蕖效成分在蕖 劑中之溶解濃度,間時復具有提高藥荆之皮虜透遇性作 用》乙二酵類,具黼而言,宜使用乙二酵,丙二酵,丁 二酵,聚乙二酵,聚丙二酵等β乙二酵釋之混合量,最 » 好介於5〜9D重量%之範困。如未滿5童董%時,對皮 虜會産生剌撖而不宜使用,但如超遇90重量%時則蕖爾 對皮*之透遇性不良亦不宜逋用。 低级醇,主要者傈用以提高主劑之經皮趿收性為目的 -4 6 - 本紙張尺度適用中國國家揉準(CNS ) A4规格(210X297公釐} (請先聞讀背面之注f項再填寫本頁) 訂 A7 B7 經濟部中央搮準局負工消费合作社印裝 五、發明説明(43 ) 。低级酵的具讎例,包括有乙黷,丙酵,丁酵,烯丙酵 ,己酵等。低级酵的混合量,最好係介於5〜50重量% 之範醑》如未滿5重量%時則無法獲得所霈藥劑之皮虜 透遍性》如超遇50重曇%時,因__對皮虜産生刺檄而 不宜楝用。 水溶性聚合物,可諏整藥薄之粘性,可防止適用於轚 貼在皮虜之貼附爾漏出藥薄。此時,所讚之水溶性聚合 物對本實施搛態之藥劑条表示可資溶解之聚合物》可用 習知之聚合物做為外用劑,可適用褐藻酸,羧甲基雄維 素銷,瓊脂,明謬,羥丙基繼Μ素,聚丙烯酸,聚丙烯 酸銷,聚乙烯酵,聚乙烯毗咯烷酮,甲基雄維素,甲乙 烯醚-馬來酸酐共聚物- 朗於本實施樣態_剤之調整法,例如可由(a)用水膨 潤水溶性聚合物,(b)以3-LP-MP溶解藥效成分,其次將 (M加入於(a)後使pH值變為_性予以凝謬化而獲得。 又,做為蕖劑貯藏槽之基劑,其另一實施樣態則包括 含有脂肪族酵與多元醇之凝臛基»β 脂肪族酵,包括月桂基酵,肉豆蔻基醇,嫁蠟酵,硬 脂醯酵,異硬脂睡醇,芳烷基酵,油醇等ο其中以磺原 子數少之脂肪族酵較之月桂基酵,因對库庸之剌撖性較 » 強而不宜適用。另一方面硕原子數較多之脂肪族酵較之 芳烷基酵,由於在藥劑中生成嫌狀之塊狀物而不宜使用 β脂肪族酵之混合董最好像介於10〜5 0重量%之範國。 如少於10重量%時,由於藥薄(的流動性高,當貼箸在皮 請 之 注 項 再 I本 1 I d 訂 4 7- 本紙張尺度逍用中國國家橾準(CNS ) A4规格(210X297公釐) 經濟部中央揉牟局貝工消费合作社印«. A7 _ B7______ 五、發明説明(46 ) 窳時,製》1中之藥物有獮出於適用面以外之廣。而多於 50重量5時則對皮虜之刺瀲性變高而不宜逋用》 多元酵之丙二酵,丁二酵,聚乙二酵,聚丙二酵,丙 三酵,聚丙三酵等由於對皮虜之刺激性少故頗宜使用。 、 多元酵的鹿合量最好像介於25〜60重量%之範酾❶如少 於25重量%時,由於藥爾的流動性遇小對於蓁效成分之 蘀放性棰為不利》如高於60重董%時,相反地由於蕖_ 流動性遇高而會有引起藥薄之漏洩性問題· 依本實施樣簾而言,如有必要時可混合橄攬油•巴西 棕櫊蟠,硬化油,胡麻油,大豆油,蓖麻油,羊毛脂, 流動石蟠,凡士林等之油脂類,己二酸二異丙酯,肉豆 寇酸異丙棕檷酸異丙酯,或為甘油-油酸酯,甘油 -肉豆寇酸酯,甘油-月桂酸酯等脂肪酸酯。 鼷於本實施態搛藥劑之調整法,例如將脂肪族酵及多 元酵加入於藥效成分在6(TC下加熱均勻溶解。接著,缓 慢攪拌施予冷卻而可獲得譎整。 再者,成為藥劑貯槽之基_之另一實施樣態,包括含 有石锄類,矽酮類之凝騣基薄》 石蟠類,基於安金性之考量以流動石蟠(藥局方), 流動聚異丁烯,三十磺烷,凡士林(_學方,化粧品基 0 薄)等最具適用。矽酮類,雖無特別限^,惟以聚二甲 基矽氣烷在安全性上為最佳》 就本實施樣態之混合比率而言,可藉由凡士林或二甲 基矽氣烷等之軟蟠成分與其他之液狀成分比例而調整蕖 -48- 本纸張尺度逋用中國國家揉率(CNS > A4规格(210X297公釐) (請先M讀背面之注意事項再填寫本頁) 訂 經濟部中央搮準房貞工消费合作社印裝 Α7 Β7 五、發明説明(47 ) m 之 黏 性·》 軟 蟠 成 分 輿 液 狀 成 分 之 bb 例 最 好 介 於 5 :1 至 2 :3之間 m 於 本實 施 例 樣 態 m _ 之 讕 整 法 » 例 如 僳 將 藥 效 成 分 在 3- L- ΜΡ之 溶 解 阐 中 經 由 加 熱 溶 解 t 將 其 均 勻 混 合 於 石 蟠 中 * 同時 添 加 軟 蟠 成 分 予 以 混 合 而 調 整 〇 富 Μ 例 ILL· 儲 量 型 貼 附 劑 * 1) 裡 襯 材料 層 聚 酯 条 膜 〇 2) 蕖 劑 貯槽 層 密 封 以 4 克 如 下 所 示 組 成 物 〇 柯 托 拉 克 5 份 3- L-MP 3 份 羧 乙 烯 聚合 物 2 份 丙 二 酵 30 份 檸 樣 酸 三乙 酯 19 份 精 製 水 39 .4份 2- 羥 基 -4-甲氧苯並苯_ 0 .5份 二 異 丙 酵按 1 • 1份 100 重 ft % 用 23份精 製 水 膨 潤 1 份 羧 乙 烯 聚 合 物 加 人 混 合 有 30 份 丙 二 酵, 20份 檸 樣 酸 ZT 乙 酯 » 5 份 柯 托 拉 克 » 5 份 3 -L-MP以及0.5份2-羥基-4-甲氣苯並苯酮两生成之溶液 f 後加以攪拌,其次再加入以16.4份精製'水溶解1·1份二 異丙酵胺所生成之溶液,攪拌至整齷形成為均勻液而獲 得凝謬劑》 3)釋出藥薄I材料層 杜拉皆得 -49- 本紙張尺度逍用中國國家梂準(CNS ) Α4規格(210X297公釐) (請先閱讀背面之注$項再埃寫本頁)The size of this paper is in accordance with China National Standards (CNS) A4 (210X297 mm). Printed by the Consumer Cooperatives of the Central Liangsong Bureau of the Ministry of Economic Affairs. A7 B7. 5. Description of the invention. W. Its medicinal rain component is a sheet of germanium amount type sticker. It should contain 10 ~ 100 «g. If the content is less than 10 · β, the analgesic effect of mineral retention cannot be obtained, but if it exceeds 1 ODlg Due to the possibility of causing obstacles to the digestive tract and the skin, it is not appropriate to use it. The remaining type of the present invention is affixed to the active ingredient through the skin. Thin (reservoir to make the 1st 逋 administering device for the surface of the skin) First, according to the medicine thin, it is necessary to obtain skin permeability through effective ingredients of a therapeutically effective amount, Among them, it is best to have little irritation to the skin and have excellent safety, and it is better that it does not cause actual chemical changes during storage. In addition to the second effective ingredient, the drug tank can be used in accordance with its needs. Transdermal absorption is mixed in the base ingredients to promote thinning, sleepiness, sterilization, and gasification prevention, UV absorbers, fillers, tackifiers, emulsifiers, emulsifiers, creases, and other conventional additives such as reducing skin irritants, anti-corrosive thin moisturizers, water, and solubilizing agents are used as external agents. Regarding the percutaneous absorption enhancer, the rate of penetration of the active ingredients of the skin, such as the local effect of the active ingredients, can be set to a speed of 30 ~ 3QQ # g / hr, such as the systemic therapeutic effect When the speed is set to 150 ~ 2500 # g / hre, if the transmission speed is not 30, the full φ effect cannot be obtained at ug / hr, but if it exceeds 2 50 0 // g / hr However, it is not suitable for use because it may cause side effects such as dark skin or digestive tract. Transdermal absorption can be promoted by using the known acetic enzyme, oleic acid, 1-dodecylazepine-2-one, JI- Peppermint ferment, d-limonene. It is best to mix with thinner and thinner. Mix the viscosity of the agent at -4 5-This paper size is applicable to China Standards (CNS) A4 (210X297 mm) (Please First read the note $ on the back and then fill out this page.) Order the printed version of the Shellfish Consumer Cooperative in the Ministry of Economic Affairs A7 B7 V. Description of the invention (44) 5 0 0 ~ 2 00 00 cps of the standard sugar. If the viscosity of the medicine is less than 500 cps 畤, when the adhesive is applied to the skin of the skin, the tincture is easy to come out of the thin storage tank and it is not suitable to apply. When the viscosity of the drug exceeds 2000 CPS, it is difficult to obtain the permeability of the skin of the drug Ning. The thinning and even the thickening rain, mixing the soluble polymer in the drug cocoon strip. For example, alginic acid, carboxymethazine, Ji Suna, Han Tian, Ming Zhi, hydroxypropyl Jivin, polyacrylic acid, polyacrylic acid pin, polyvinyl ferment, polyvinylpyrrolidone, methylmethyvin, methylvinyl ether-horse For anhydride copolymers, etc. / As for the pH adjustment, it is best to mix the pH range of the drug bar to 3 ~ 8. If the pH of the drug strip is lower than 3, it will cause irritation to the skin, and it is not suitable to use it. If the pH is higher than 8, it is not suitable to be attached to the skin due to its sexual nature. The permeability of the peptone is also poor. The pH adjusting agent can use the conventional citrate-like acid, osmic acid, sodium phosphate, etc. "to make the base formulation of the pharmaceutical tank. One of the implementation modes includes glycols, lower enzymes. , Water and water-soluble polymers are formed by a thin base. Among them, the adipic enzymes have a numbing effect on skin anxiety. In addition to alleviating the general irritability of the skin to the skin, it can also increase the dissolved concentration of the active ingredient in the tincture, which can be recovered from time to time. It has the effect of improving the permeability of the skin of medicinal herbs. ”In the case of betaine, it is suitable to use betaine, such as lyase, malonate, succinate, polyethylenease, and polypropylenease. The mixing amount is preferably between 5 and 9D% by weight. If it is less than 5%, it will not be suitable for use on the skin, but if it exceeds 90% by weight, it will not be suitable for use when the penetration of the skin is poor. Lower alcohol, the main one is for the purpose of improving the transdermal recovery of the main agent-4 6-This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) (Please read the note f on the back first) Please fill in this page again) Order A7 B7 Printed by the Central Laboratories Bureau of the Ministry of Economic Affairs of the Consumers' Cooperatives Co., Ltd. 5. Description of Invention (43). Examples of low-grade yeast, including ethyl acetate, propionate, butanase, allylase , Self-fermentation, etc. The mixing amount of low-level yeast should preferably be within the range of 5 to 50% by weight. "If it is less than 5% by weight, the permeation of the skin can not be obtained." At 昙%, it is not suitable to use __ because it causes thorns on the skin. Water-soluble polymers can reduce the viscosity of the thin film and prevent the thin film from leaking when applied to the skin. "The praised water-soluble polymer indicates a polymer that can be dissolved in the medicament strip in this state." The conventional polymer can be used as an external agent, and alginic acid, carboxymethyl androsterin, agar, and absurdity can be applied. , Hydroxypropyl metamer, polyacrylic acid, polyacrylic acid pin, polyvinyl ferment, polyvinylpyrrolidone, methyl Vitamins, methyl vinyl ether-maleic anhydride copolymer-Long in this embodiment, the adjustment method of 剤, for example, (a) the water-soluble polymer can be swollen with water, (b) the active ingredient can be dissolved with 3-LP-MP Secondly, it is obtained by adding (M to (a) to change the pH value to sexuality.) As a base for tincture storage tanks, another embodiment includes an enzyme containing an aliphatic enzyme and Polyether alcohols »β Aliphatic fermentation, including lauryl fermentation, myristyl alcohol, dow wax fermentation, stearic fermentation, isostearyl alcohol, aralkyl fermentation, oleyl alcohol and others Compared with lauryl-based yeast, the smaller number of fatty yeasts is not suitable because it is more susceptible to Kuyong. On the other hand, fatty yeasts with larger atomic numbers are produced in pharmaceuticals than aralkyl-based yeasts. It is best to use β-aliphatic fermentation mixtures that are too lumpy like 10 to 50% by weight. If it is less than 10% by weight, the drug is thin (the liquidity is high, when paste Remarks on the skin please re-book 1 I d order 4 7- This paper size is free to use China National Standard (CNS) A4 specification (210X297 mm) Economy Printed by the Central Labor Bureau, Shellfish Consumer Cooperatives «. A7 _ B7______ V. Description of the Invention (46) Time, the drug in" System 1 "is out of the scope of application. When it is more than 50 weight 5, it is on the skin The thorny nature of the prisoner becomes high and it is not suitable for use. "The multi-fermentation malonate, succinate, polyglycol, polymalonate, glycerol, polytriol, etc. are quite irritating to the skin. It should be used. , The amount of deer fermentation is preferably like the range between 25 ~ 60% by weight. If it is less than 25% by weight, the release of the effective ingredients due to the small fluidity of the drug is "Unfavorable" If it is higher than 60% by weight, on the contrary, due to the high fluidity, there will be leakage of the drug. According to the sample curtain of this implementation, olive oil can be mixed if necessary. • Brazil Palm oil, hardened oil, flax oil, soybean oil, castor oil, lanolin, oils such as flow stone, petroleum jelly, diisopropyl adipate, isopropyl palmitate isopropyl palmitate, or Fatty acid esters such as glycerol-oleate, glycerol-myristate, and glycerol-laurate.鼷 In this embodiment, the method of adjusting the medicament is, for example, adding aliphatic yeast and polyzyme to the medicinal ingredients and heating and dissolving at 6 ° C. Then, slowly stir and apply cooling to obtain the trimming. Furthermore, it becomes Another embodiment of the base of the medicine storage tank, including a thin coagulum base containing scopolamines and silicones. The scopolamines, based on the consideration of the safety of gold, use mobile scopolamine (pharmaceutical formula), and flow polyisobutylene. , Thirty sulfane, petroleum jelly (_ Xuefang, cosmetic base 0 thin), etc. are most applicable. Silicones, although there are no special restrictions ^, but polydimethylsilane is the best in terms of safety. In terms of the mixing ratio of this embodiment, it can be adjusted by the ratio of soft palate components such as petroleum jelly or dimethylsilane to other liquid components. CNS > A4 size (210X297mm) (Please read the notes on the back before filling this page) Order printed by the Central Ministry of Economic Affairs and the Junfangzhengong Cooperative Consumer Cooperative Association A7 Β7 V. Description of the invention (47) m viscosity ·》 Best case of soft palate component and liquid component is better than 5 : 1 to 2: 3 m in this example m _ the method of reorganization »For example, the medicinal ingredient is dissolved in 3-L-MP by heating and dissolved in t * Simultaneously add and mix the soft palate ingredients to adjust it. Rich Illustrative ILL · Storage Type Adhesives * 1) Lining material layer polyester strip film. 2) The tincture tank layer is sealed with 4 g of the composition shown below. Torac 5 parts 3-L-MP 3 parts carboxyvinyl polymer 2 parts malonase 30 parts triethyl citrate 19 parts purified water 39.4 parts 2-hydroxy-4-methoxybenzobenzo_ 0. 5 parts of diisopropionate 1 • 1 part of 100 wt ft% Swelled with 23 parts of purified water 1 part of carboxyvinyl polymer mixed with 30 parts of malonase and 20 parts of citrate ZT ethyl ester »5 Kotorac »5 parts of 3-L-MP and 0.5 parts of 2-hydroxy-4-methylbenzophenone solution f, and then stirred, followed by the addition of 16.4 parts of purified 'water dissolve 1.1 parts of two The solution produced by isopromamine is stirred until the whole is formed into a homogeneous liquid to obtain a gelling agent. 3) The drug thin layer I material layer is released. Durajota-49- This paper is based on China National Standards (CNS) ) Α4 size (210X297 mm) (Please read the note on the back before writing this page)

A7 __B7_ 五、發明説明(48 ) 4)戚壓拉著劑層丙烯酸条黏著剤(支持體周邊部) 由1)〜4)構成儲覺型貼附薄(,在剝離内雇形成有_剤 釋放面及其周围之威壓接著劑面作成外靥積物。 實掄例63 儲董型貼附劑 .1)裡襯材料層 聚酯膜 2) 藥薄I貯槽靥 封入4克同實施例62之組成物。 3) 蘀放藥剤材料層 杜拉皆得 4) 戚壓接著爾層 矽酮粘箸劑 由1)〜4)構成儲量型阽附劑,在威壓接著劑面具有剝 離内襯作成外層積物β 奮施例64 儲量型阽附劑 1)裡襯材料層 聚酯条薄膜 2) 蕖 劑 貯 槽 層 封入 以 4 克如下所示 油性凝 膠 組成 酮 蒱 凡 U e t oprofen) 3 份 流 動 石 蠟 70 份 硬 脂 醏 酵 20 份 d- 檸 m 烯 2 份 3- L- MP 5 份 1 00重量% 3 ) 釋 放 m 劑 材料靥 考 得 蘭 f 4) 成 壓 性 接 著劑層 SI S条黏箸劑(支 持體周 邊 部) 經濟部中夬揉準局貝工消費合作社印裝 (請先聞讀背面之注意事項再填寫本頁) 由1)〜4)構成儲量型貼附劑,在藥莆釋放面及威壓接 著劑面具有剝離層作成外層積物。 奮旅例65 儲量型貼附劑 -50- 本纸張尺度逋用中國國家標準(CNS ) Λ4规格(210X297公釐) A7 _B7 _ 五、發明説明(49 ) 1) 裡襯材料層 聚酯条薄膜 2) 藥剤貯槽層 封入4克實施例64之組成物β 3) 釋放蕖劑材料層 考得蘭 4) 烕壓性接著劑層 聚異丁烯条粘著爾 由1)〜4>構成儲置型貼附劑,在威壓性接箸劑面具有 剝離層作成外層稹物。 窗施例66 儲量型貼附劑 1) 裡襯材料雇 鋁積層聚酯条薄膜。 2) 蕖劑貯槽層 封入4克如下凝膠組成物〇 因朵美達辛(indoaetacin) 5份 矽酮 80份 丙三醇單月桂酸酯 5份 3-L-HP 10份 3) 釋放藥劑材料層 考得蘭 4) 感豔性接著劑層 矽酮条粘箸劑(亥持體周邊部) 由1)〜4)構成儲量型貼附劑,在烕壓性接著劑層具有 剝離層作成外層積物。 冒施例67 儲量型貼附劑 1)裡拋材料層 鋁積層聚酯糸薄膜》 經濟部中央揉準局貝工消费合作社印製 (請先閱讀背面之注$項再換窝本頁) 2>藥薄貯槽層 封入4克實施例66之凝_組成物。 二氯芬那卡鈉 5份 矽醑 80份 甘油單月桂酸酯 5份 JI -薄荷酵 5份 -51- 本紙張尺度適用中鬮國家揉準(CNS ) A4規格(210X297公釐) I A7 B7 五、發明説明(5〇) 鋰濟部中央橾準局貝工消费合作社印製 5份 100重量% 3) 釋放__材料層 考得蘭 4) 戚屋性接著剤層 矽酮粘鬌劑 由1)〜4)構成鏟量型阽附劑,在威壓性接箸则齒具有 剝離層作成外靥稹物》 啻掄俐68 儲量型貼附薄 1)裡襯材料層 鋁稹層聚酯条薄膜· 2}蕖劑貯槽層 封人4克如下所示凝醪薄。 餘布雄落兒鹽酸(t u 1 obut er ο 1 hydroch 1 or ide) 5份 3A7 __B7_ V. Description of the invention (48) 4) Acrylic strip adhesive (戚 peripheral part of the support) of the pressure-pressing agent layer is composed of 1) ~ 4), which is a storage-type attachment thin film (__ is formed by peeling internally) The release surface and the surrounding pressure-sensitive adhesive surface were made into external deposits. Example 63 Storage-type adhesive patch. 1) Lining material layer polyester film 2) Medicine thin I storage tank sealed with 4 g of the same example Composition of 62. 3) The drug layer and the material layer are all durah. 4) The silicone adhesive is composed of 1) ~ 4). It is a reserve type adhesive. It has a peeling lining on the surface of the adhesive to form an outer layer. Product β Fen Example 64 Storage-type adhering agent 1) Lining material layer polyester strip film 2) The elixir tank layer is sealed with 4 g of oily gel composition ketone (U et oprofen) as shown below 3 parts flowing paraffin 70 Parts stearyl ferment 20 parts d-citrate mene 2 parts 3-L- MP 5 parts 100% by weight 3) release agent material 靥 codella f 4) pressure-sensitive adhesive layer SI S strip adhesive (Peripheral support body) Printed by the Ministry of Economic Affairs of the Ministry of Economic Affairs of the Kazunori Bureau Shellfish Consumer Cooperative (please read the precautions on the back before filling out this page) 1) to 4) constitute a reserve-type patch and release it on the drug The surface and the pressure-sensitive adhesive surface have a release layer as an outer layer. Fenju Example 65 Storage type adhesive-50-This paper uses Chinese National Standard (CNS) Λ4 specification (210X297 mm) A7 _B7 _ V. Description of the invention (49) 1) Lining material layer polyester strip Film 2) 4 g of the composition of Example 64 was sealed in the drug tank layer 3) Caudran 4 was released as the elixir material layer 4) Polyisobutylene strip adhesive on the pressure-sensitive adhesive layer was composed of 1) ~ 4 > The adhesive has a release layer on the surface of the pressure-sensitive adhesive to form an outer layer. Window Example 66 Storage Type Adhesive 1) Lining material employed Aluminum laminated polyester strip film. 2) The tincture tank layer is sealed with 4 g of the following gel composition. Indooaetacin 5 parts silicone 80 parts glycerol monolaurate 5 parts 3-L-HP 10 parts Layers of Corderland 4) Sensitive adhesive layer silicone stripe adhesive (peripheral part of the holder) It consists of 1) to 4) and is a storage type adhesive. The pressure-sensitive adhesive layer has a release layer as an outer layer. Accumulation. Example 67 Storage-type adhesive agent 1) Linpo material layer, aluminum laminated polyester film, printed by the Central Government Bureau of the Ministry of Economic Affairs, printed by Shelley Consumer Cooperative (please read the note on the back before changing the nest page) 2 & gt 4 g of the coagulation composition of Example 66 was sealed in the thin tank layer. Diclofenac sodium 5 parts Silicic acid 80 parts Glycerol monolaurate 5 parts JI-Peppermint leave 5 parts-51- This paper size is suitable for China National Standards (CNS) A4 (210X297 mm) I A7 B7 V. Description of the invention (50) 5 copies of 100% by weight printed by the Shellfish Consumer Cooperative of the Central Bureau of Standards, Lithium Ministry of Lithium 3) Release __ material layer of Caudran 4) Qi Wuxing, followed by a layer of silicone adhesive 1) ~ 4) Form a shovel-type adhesive agent. In the case of pressure contact, the tooth has a peeling layer to form an external object. 啻 抡 68 68 reserve type adhesive thin 1) Lining material layer aluminum aluminum layer polyester A thin film of 2 g liniment tank layer was sealed 4 g as shown below. Yubuxiong Luoer Hydrochloric Acid (t u 1 obut er ο 1 hydroch 1 or ide) 5 servings 3

MP 面-,之注MP side-, note

2I 頁2I page

硬脂醯醇 鲸蟠醇 山¥酵 丙二醇 1,3-丁二酵 月桂酸酵 3-L-MP 10份 10份 10份 20份 35份 5份 5份 100重置% 3>釋放藥劑材料層 考得蘭 4)威壓性接著黼層 矽鬭粘著劑(支持髓满邊部) » 由U〜構成儲董型貼附劑,在藥劑釋放層及威暖性 接著_層具有剝離層作成外層積物〇 其次就擦劑詳述之,本發明之擦劑得混合10〜70重量 %之乙醇,丙醇,異丙醇等一元醇,聚乙二酵,丙二酵 -52- 本紙St尺度迪用中國國家橾準(CNS ) Μ规格(210X297公釐) 訂 A7 B7 五、發明説明(5工) 經濟部中央揉隼局貝工消費合作社印製 9 丁 二 酵 等 多 元 酵 做為 酵 類 9 55 ί重 量 % 以 下 水 ,6 0重 量 % 以 下 之 己 二 酸 * 癸二 酸 肉 豆 蔻 酸 等 脂 肪 酸 酷, 添 加 0 · 5〜1 0重量%藥效成分, 0 丨.5 ί〜 2fl 丨重 董 % 3- • L - MP , 有 必 要 時 可 再 混 合 以 0 . fl 1〜 5 重 量 % 紫 外 線 吸 收 爾 而獲 得 擦 _ 〇 據 由 以 上 處 方 劑 及製 造 例 得 由 習 知 擦 劑 之製 造法 而 可 獲 得 本 發 明 之 擦 劑 。又 f 有 需 要 時 可 混 合 調 整 PH所 需 之 中 和 劑 或 甲 基 m 維 , 羧 乙 烯 聚 合 物 y 羥 丙 基 纖維 素 等 之 黏 性 賦 與 剤 » 斑 疹防 止 劑 » . 或 其 他 之 添 加 物 (例 如 ; 水 楊 敢 > 水 楊 酸 甲 酯, 水 楊 酸 乙 二 酵 9 立 -薄荷酵, 樟 腦 > 薄 荷 油 » 辣 椒 油精 * 壬 酸 香 草 基 酵 胺 9 百 里香 酚 • 克 魯 他 命 頓 9 益 遜 <B> > 磺 酸 丙 烯 己 二 酸 二 異 丙酯 等 ) 曹 .旃 例 69 擦 劑 乙 酵 4 5 • 0重 量 % 2- 羥 基 -4 -甲氣苯並苯酣 0 .6重 量 % 己 二 酸 二 異 丙 酯 30 .0重 量 % Ύ -生育酚 1 .0重 置 % 羥 丙 基 m 維 素 1 5重 董 % 3- L- MP 4 .0重 量 % 酮 m 凡 (k e t op r 〇 f e η ) # 2 .0重 量 % 精 製 水 i' 15 . 9重 量 % 攪 拌 混 合 以 上 各 成分 調 製 成 含 有 m m 凡 擦 劑 〇 *_ 1 例 70 擦 劑 丙 二 醇 10 .0重 量 % -53- (請先《讀背面之注意事項再填寫本頁) 本紙張尺度逋用中國國家標準(CNS ) Λ4规格(210X297公釐) A7 B7 五、發明説明(52 ) 2- 羥 基 -4 -甲氣苹並苯酚 0 .2重 JI % 單 月 桂 酸 聚乙二_ 10 .〇重 鼉 % 克 魯 他 命 領 0 .5竃 量 % 丙 m 18 • 0重 覺 % 酒 精 20 0董 * %. 乙 酵 • 28 .8簠 m % 3- L- MP 2 .0簠 量 % 酮 蒲 凡 (k etoprofen) 0 .5重 量 % 精 製 水 10 .0重 量 % 檯 拌 混 合上述成分調製成含 有_鞴凡擦剤》 旃 例 71 .擦劑 聚 乙 二 醇 4 00 10 .0重 量 % 2- 羥 基 -4 -甲氣苯並苯酚 0 .5重 量 % Ύ -生育酚 1 .0重 量 % 異 丙 酵 31 .5重 量 % 乙 酵 40 .0重 置 % 3- L - MP 7 .0重 量 % 柯 托 拉 克 5 .0重 量 % 糖 製 水 5 .0重 量 % (請先聞讀背面之注$項再填寫本頁) 、·ιτ 經濟部中央橾準局Ϊ消费合作社印装 攪拌上述各成分調製成含有柯托拉克輝劑 * 謇掄例72 擦劑 單月桂酸聚乙二酵 2, 2-二羥基-4-甲氣苯並笨酚 己二酸二異丙酯 5 4 - 本紙張尺度逋用中國國家搮準(CNS〉Α4规格(210X297公釐) U . 0重量% 〇 . 7重 Μ % 4 · 0重蠹% A7 ___B7_ 五、發明説明(53) 3-乙醯化Μ耱變性酒精 49.6重量% 3-L-MP 5 . 0重量 % (請先《讀背面之注$項再填寫本頁) ____-· 柯托拉克 3 . 0重量% «拌混合以上各成分諝製成含有柯托拉克擦_〇 其次躭·《霧薄詳加説明之β本發明之噴霧_你七藥效 成分溶解以3-L-MP,乙酵,異丙酵等低级酵所形成之溶 液加水及弗曄氣體,二甲醚,液化製油氣體等喷霧劑或 丙二酵,丁二醇,聚乙二酵等乙二酵類而製成為噴潺劑 ,如有需要時可挽混以樺腦,薄荷油,二苯基酵胺等藥 物補肋剤或滑石等賦形劑,抗《化防止劑,防腐紫 外線吸收劑等。 ;g_jfe 例丄s mmm 将3份酮蒱凡(fcetoprofen)溶解於5份3-L-MP,其次 混合以4份樺腦及3份乙酵,加2 6份水於該混合溶液後 焴充在氣溶醪容器内,加入4份滑石讕整原液,打壓输 入以13份二甲醚及12份液化石油氣之混合物做為噴霧劑 ,裝著以〇·4ηη淤渣孔徑之0.6··管徑之0.4m直徑低栓 的管件,其次裝著以機械停止按鈕而獲得消炎鎮痛薄之 氣溶醪涮·> 經濟部中央樑率局負工消费合作社印製 將而 甘 可合 , 劑混 酵 水類 二 粧酵 丙 化二 , 之..,,乙 油 明或 甘 發 \ , 本及 醇 。水 级 之, 低 述酵 等 詳级 醇 _ 低 乙。 水, 用類 粧NP可醇 化L-,二 對 3 中乙 針與 劑酯 兹分 基酸 次成。述醴 其效成上單 麵製 油 本纸張尺度逋用中國國家橾準(CNS ) Λ4规格(210X297公釐) 經濟部中央梂準局WC工消費合作社印«. A7 _B7_五、發明説明(54 ) 再者,如有痛要時,同硬脂酸一般可適量配合石皤, 硼砂,明礬,硫酸鋅,磺皤或光量,氣化防止劑,防腐 薄I,中和劑等β v m Μ74 化粧水薄 乙酵 精製水 丙二醇 3-L-MP 酮蒲凡(k e t 〇 p r 〇 f e η ) 5 7 . 〇k 蛋 % 34 . 0重量% 5 . 0重董% 3 . 0重蛋% I . 0重驀% 攪拌混合以上各成分調製成含有酮蒱凡化粧水劑 實施例75 化粧水剤 乙醇 精製水 丙二醇 3-L-MP 因諾美達辛(ind 〇 b e t a c i η ) 攪拌混合以上各成分調製成含因朵美達辛化粧水劑 g施例76 化粧水劑 乙醇 精製水 丙二醇 甲基纖維素 3-L-MP 弗露普羅汾(flurbiprofen) 5 6- 本紙張尺度逍用中國®家棣準(CNS ) Α4規格(210X297公釐) (請先Μ讀背面之注意事項再填寫本頁) 38 . 0重量% 50 . 0重量% 6 . 0重量% 5 . G重量% 1 . 0重量% 38 . 0重量% 50 . 0重置% 6 . 0重董% 〇 . 8重量% 7 . 0重量% 2 . 0重量% 訂 懷,- 五、發明説明(55 ) A7B7 經濟部中央椹準局貝工消费合作社印装 魇伴混合以上各成分調製成含有弗露比普羅汾化粧水 _ » 其次,玆對袋裝薄逐加說明之,本發明之袋裝薄傈以 3-L-MP做為脂溶性粉末有效成分之溶解爾。 其中醐於脂溶性粉末,傜指對水不溶或難溶之粉末, 有B!於袋裝I»所用有效成分,各種添加繭雖任何皆可適 用,惟最好像遘擇使用甘草素,甘草酸硬脂酸酯,甘草 酸,L-抗壤血酸硬脂酸酯,L_抗壤血酸棕檷酸酯,0化 酚,«骨化酵,生物素,異苯基甲基酚等β此等睇溶性 粉末偽以3-L-MP做為溶解劑可在基劑中安定溶解並可形 成一種無奥而絨霣良好具有清涼戚之袋裝爾。 闢於袋裝剤3-L-MP之含量,最好僳介於0.001〜5重量 %之範圍,如未滿0.001重量%時則無法充分發揮溶解 劑之功效,而超過5重量%時則頗難獲得具有良好物性 與使用感之裝劑。 此袋装劑,只要為以往習知之劑型並無特別限制包括 有洗臉(乳狀,粉土狀,泡沫狀)袋裝,片材(拈箸薄| 型,含浸型)袋裝,剝取狀(形成被膜型)袋裝等β當 然混合以習知之《充劑,番料等,則不受任何限制β 實·施-例77 乳狀袋裝爾 声 » 流動石蠟 10.0重量% 鲸蟠醇 1 . 0重量% 山梨糖酵酐軍硬脂酸酯 3.0重量% Ρ0Ε (20)山梨糖醇酐單硬脂酸酯 3.0重置% -57- 本紙張尺度適用中國两家搮準(CNS ) Α4规格(210X297公釐) 請 先 Μ 面' 之 注Stearyl Alcohol Cetyl Alcohol Mountain ¥ Fermented Propylene Glycol 1,3-Butanedihydrolaurate 3-L-MP 10 parts 10 parts 10 parts 20 parts 35 parts 5 parts 5 parts 100 Reset% 3 > Release agent material layer Cowderland 4) Pressure-sensitive adhesive layer silicon adhesive (supports the edge of the spinal cord) »U ~ constitutes a storage-type adhesive, and has a release layer in the drug release layer and the warm adhesive layer. The outer layer 〇 Secondly, the cleaning agent will be described in detail. The cleaning agent of the present invention must be mixed with 10 to 70% by weight of ethanol, propanol, isopropanol and other monoalcohols, polyethylene glycol, malonase-52- 本 纸 St Standard Di uses the Chinese National Standard (CNS) M specifications (210X297 mm) A7 B7 V. Description of invention (5 labors) Printed by the Central Labor Bureau of the Ministry of Economic Affairs, Shellfish Consumer Cooperatives 9 Multi-fermentation enzymes such as succinic acid and fermented yeast Class 9 55 wt% or less water, 60 wt% or less adipic acid * Sebacic acid myristic acid and other fatty acids, add 0.5-5 ~ 10 wt% medicinal ingredients, 0 丨. 5 ί ~ 2fl 丨Tung% 3- • L-MP, if necessary, can be remixed with 0. fl 1 ~ 5 wt% UV absorber The obtained rubbing _ 〇 According to the above prescriptions and manufacturing methods obtained from the conventional manufacturing method of the rubbing agent can be obtained according to the present invention. If necessary, you can mix the neutralizing agent or methyl m-dimension required to adjust the pH, carboxyvinyl polymer, hydroxypropyl cellulose, and other viscosity imparting agents »spotting agent». Or other additives (For example; Salicylic Acid > Methyl Salicylate, Ethyl Salicylic Acid 9 Lithium-menthol, Camphor > Peppermint Oil »Capsule Oil * Vanillyl Enzyme Nonanoic Acid 9 Thymol • Crutamine Dayton 9 Yixun < B > > Propylene sulfonate adipic acid, etc.) Cao. Example 69 Etchant 4 5 • 0% by weight 2-hydroxy-4 -methylbenzobenzophenone 0 .6% by weight of diisopropyl adipate 30.0% by weight of hydrazone-tocopherol 1.0 reset% hydroxypropyl m vitamine 15% by weight of 3-% L-MP 4.0% by weight of ketone m where (ket op r 〇fe η) # 2.0% by weight of purified water i '15.9% by weight The above ingredients are mixed by mixing to prepare mm All wipes 0 * _ 1 Example 70 Cleaner propylene glycol 10.0% by weight -53- (Please read the "Cautions on the back before filling this page") This paper uses the Chinese National Standard (CNS) Λ4 specification (210X297 (Mm) A7 B7 V. Description of the invention (52) 2-Hydroxy-4-methanhydrin phenol 0.2 weight JI% monolaurate polyethylene glycol -10. 0 weight% Crutamin collar 0.5 Volume% Propion m 18 • 0 Gravity% Alcohol 20 0 Tung *%. Ethyl Fermentation • 28.8 μm% 3- L- MP 2.0% Volume% Ketoprofen 0.5% by weight Refined water 10. 0% by weight Taiwan mixed with the above ingredients to prepare _ 鞴 Fan rubbing 剤 71 Example 71. Wipes polyethylene glycol 4 00 10. 0% by weight 2-hydroxy-4 -methylbenzophenone 0 .5% by weight Ύ-tocopherol 1.0% by weight isopropion 31.5% by weight acetic acid 40.0 reset% 3- L-MP 7.0% by weight Kotolac 5.0% by weight sugar water 5.0% by weight (please read the note on the back before filling in this page) Printed by the Local Consumer Cooperative, stir the above ingredients to prepare Kotorac Brightener * * 例 72 Emulsion Monolaurate Polyoxalase 2,2-Dihydroxy-4-methylbenzobenzyl adipate Diisopropyl 5 4-This paper is based on the Chinese National Standard (CNS> A4 specification (210X297 mm) U. 0% by weight 〇. 7% by weight% 4 · 0% by weight A7 ___B7_ 5. Description of the invention ( 53) 3-Acetylated Benzene Modified Alcohol 49.6% by weight 3-L-MP 5.0% by weight (please read the "$" on the back side before filling out this page) ____- · Kotorak 3.0% by weight «Mix the above ingredients and make them with Kotorak rub_〇Second 躭" "Mist thin detailed description of the spray of the present invention _ you seven medicinal ingredients dissolved in 3-L-MP, acetic acid, isopropyl The solution formed by low-level yeast and other yeasts is added with water and vulgar gas, dimethyl ether, liquefied petroleum gas and other sprays or ethylene glycol such as malonase, butanediol, polyethylene glycol, etc. If necessary, it can be mixed with excipients such as betulin, peppermint oil, diphenyl zymotamine, etc., or talc, anti-chemical agents, anti-ultraviolet absorption Wait. g_jfe Example 丄 s mmm Dissolve 3 parts of fcetoprofen in 5 parts of 3-L-MP, then mix with 4 parts of birch brain and 3 parts of acetic acid, add 2 6 parts of water to the mixed solution and charge In a gas-soluble concrete container, add 4 parts of talc concrete solution, press and enter a mixture of 13 parts of dimethyl ether and 12 parts of liquefied petroleum gas as a spray, and install a 0.6 ·· tube with a pore size of 0.4 ηη sludge. The 0.4m diameter low-bolt pipe fittings are secondly equipped with a mechanical stop button to obtain anti-inflammatory and analgesic thin air-soluble 醪 涮 · > Printed by the Ministry of Economic Affairs Central Liangsong Bureau Off-line Consumer Cooperative, which can be mixed, and mixed Fermented water class two makeup enzymes propylated two, .. ,, yiyouming or ganfa \, this and alcohol. Water-grade, low-grade alcohol and other detailed alcohols _ low B. Water, using makeup NP can alcoholize L-, two pairs of 3 ethyl acetate and agent ester secondary acid. Description: Its effect is on the single-sided oil-based paper size, which is in accordance with the Chinese National Standard (CNS) Λ4 specification (210X297 mm). Printed by the WC Industrial Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs «A7 _B7_ V. Description of the invention ( 54) In addition, if it is necessary, it can be combined with stearic acid, such as shovel, borax, alum, zinc sulfate, sulfonium or light, anti-gasification agent, anticorrosive thinner I, neutralizer, etc. β vm Μ74 Lotion thin acetonitrile refined water propylene glycol 3-L-MP keto pufan (ket 〇pr 〇fe η) 57. 〇k egg% 34.0% by weight 5.0% by weight% 3.0% by weight% I. 0% 蓦% Stir and mix the above ingredients to prepare a ketone containing lotion Example 75 Lotion 剤 Ethanol Refined Water Propylene Glycol 3-L-MP Innodacin (ind 〇betaci η) Stir and mix the above ingredients to prepare Indomethacin lotion g Example 76 Toner lotion ethanol refined water propylene glycol methylcellulose 3-L-MP flurbiprofen 5 6- This paper is a standard Chinese standard (CNS) Α4 specification (210X297 mm) (Please read the precautions on the back before filling in this ) 38.0% by weight 50.0% by weight 6.0% by weight 5 G% by weight 1.0% by weight 38.0% by weight 50% 0 Reset% 6.0% by weight 0.8% 7% by weight 0% by weight 2.0% by weight Prescription,-V. Description of the invention (55) A7B7 Printed by the Central Bureau of Standards of the Ministry of Economic Affairs, Shellfish Consumer Cooperatives, mixed with the above ingredients to prepare a lotion containing Fröbiprofen_ » Secondly, it is explained that the thin bag is thin, and the thin bag of the present invention uses 3-L-MP as the dissolving agent of the active ingredient of the fat-soluble powder. Among them are fat-soluble powder, which means powder that is insoluble or hardly soluble in water. There are B! Active ingredients used in the bag I », although all kinds of added cocoons can be used, it is best to use licorice root and licorice. Acid stearate, glycyrrhizic acid, L-ascorbic acid stearate, L-ascorbic acid palmitate, 0-phenol, «osteochemical, biotin, isophenylmethylphenol, etc. β These soluble powders pseudo-L-MP as a dissolving agent can be stably dissolved in the base and can form a kind of bag which has no mystery and has a good cooling effect. The content of 3-L-MP in the bag is preferably in the range of 0.001 to 5% by weight. If it is less than 0.001% by weight, the effect of the dissolving agent cannot be fully exerted, and when it exceeds 5% by weight, it is quite It is difficult to obtain a filler having good physical properties and usability. This bagging agent is not particularly limited as long as it is a conventionally known dosage form, including face washing (milky, silt, foamy) bags, sheet (拈 箸 thin | type, impregnated) bags, exfoliated forms (Forming a film type) Of course, β, such as bags, are of course mixed with the conventionally known "fillings, pancakes, etc., without any restrictions β. Practice-Example 77 Milky bagged vocal» Flow paraffin 10.0% by weight cetyl alcohol 1 0% by weight Sorbitol Anhydride Army Stearate 3.0% by weight POE (20) Sorbitan Anhydride Monostearate 3.0 Reset% -57- This paper size applies to two Chinese standards (CNS) Α4 (210X297 mm) Please note first.

I 訂 A7 B7I order A7 B7

五、發明説明(56 ) 1,3-丁二醇 甘油 對羥基笨甲酸甲酯 甘草酸硬脂酸酯 3-.L-MP 精製水 攪 窖掄 5 . 0重量% 3 . 0重蛋% 0 . 2重蛋% 0 . 1重量% 1 . 0 S 蛋 % 73 . 7重量% 請 先 Μ •St- 之 注 高嶺 滑石 甘油 丙二 羧甲 POE 對羥 L-抗 拌混合上逑成分諝製成乳狀袋裝劑 例78 粉土狀袋裝劑 土 醇 基纖維素 (20)山梨糖醇酐單油酸酯 基苯甲酸甲酯 壤血酸硬脂酸酯V. Description of the invention (56) 1,3-butanediol glycerol p-hydroxybenylate methyl glycyrrhizin stearate 3-.L-MP refined water stirred cellar 5.0% by weight 3.0% by weight egg 0 2% egg% 0.1% weight 1.0 S egg% 73.7% weight Please make M • St- injection of kaolin talc glycerin glyceryl dicarboxymethane POE made of hydroxy L-mixed ingredients Example of milky bagging agent 78 Powdery soil bagging agent Soil alcohol cellulose (20) Sorbitol anhydride monooleate methyl benzoate soil blood acid stearate

3-L-MP 20 . 0重量% 8 . 0重 ft % 3 . 0重量% 3 . 0重量% 0 . 3重量% 2 . 0重量% 0 . 1重量% 0 . 2重 ft % 3 . 0重量%3-L-MP 20.0% by weight 8% by weight ft% 3.0% by weight 3.0% by weight 0.3% by weight 2.0% by weight 0.1% by weight 0.2% ft% 3.0 weight%

I 頁 訂 經濟部中央揉準局貞工消費合作社印装 精製水, 60 . 4重量% 攪拌混合上述各成分調製成粉土狀袋裝剤》 g mm 7 9 泡沫狀袋裝剤 f » 硬脂酸 5 . 0重董% 山¥酸 5 . 0重量% 鯨蟠醇 1 . 0重量% 三十碩烷 4 . 0重量% -58- 本紙張尺度適用中國困家揉隼(CNS ) Λ4规格(210X297公釐) 五、發明説明(57) 甘 油 1 5 · 0 重 曼 % Ρ0Ε (4 0) 單 硬 脂 酸 酯 1.0重 量 % 對 羥 基 苯 甲 酸 乙 酯 0.1重 量 % L - 抗 壤 血 酸 棕 櫚 酸 m 0 . 05重 量 % 3- L-MP 0 · 5 a 蛋 % 精 製 水 • 68.35重 量 % 攪 拌 混 合 以 上 各 成 分,諝製原液後, 同時裝埔以 液 化 石 油 氣 做 成 泡 沫 狀 袋 裝劑〇 W 旃 例 30 黏着劑型片狀袋裝劑 明 膠 8 . 0重 董 % 甘 油 25 . 0重 量 % 山 梨 糖 醇 7 · 0重 量 % 聚 丙 烯 酸 納 2 . 0重 量 % 氫 氣 化 鋁 2 . fl重 量 % 對 羥 基 苯 甲 酸 甲 酯 1 . 0重 量 % 異 丙 甲 基 酚 0 . 0 1重 量 % 3- L-MP 0 · 0 0 5重 量 % 精 製 水 54 · 9 3 5重 量 % 經濟部中央樑準局貝工消費合作杜印製 以裝 蓋袋 覆狀 , 片 後型 面著 上粘·, 布成 纗製 '不 0 在, 展狀 延形 ,定 分設 成所 各成 上切 is as 以裁 合 , 混膜 拌薄 攪型。 離剤 例 掄 奮 油 甘 劑 裝 袋 狀 片 型 浸 含 醇 二 丁 % % 量蛋 3 本紙張尺度適用中國國家橾準(CNS > Μ規格(210X297公釐〉 經濟部中央揉準局貝工消費合作社印製 A7 B7 修正本6 補充 * 五、發明说明(58 ) 透明質酸銷 〇 . 1重量% 對羥基苯甲酸甲酯 0 . 1重蛋% 甘草酸 0 . 0 1重里% 3-L-MP 0 . 0 5重量% 精製水 7». 74童量 % . 撅拌混’合以上成分,含浸在不雜 布後,g設以離型膜 。裁切成所定形狀調製為含浸型片 狀袋裝劑。 营掄俐82 鈿取型络奘割 聚乙烯醇 20 · 0重量% 羧甲基鐵雒素 3 . 0重童% 氣化鈦 8 . 0重量% 1 , 3-丁二酵 5 . 0重量% 三十碩烷 3 . 0重量% POE ( 10)壬基苯醚 〇 . 5重置% 對羥基苯甲酸甲酯 0 . 1重量% 鈣化酚 〇 . 〇 1重置% 3-L-MP 0 . 1重量% 精製水 60 . 29重量% 搜拌混合以上成分調製成剥取型袋裝劑。 th較例7 乳狀袋裝劑 除不混合3 - L - Μ P以外,仿實施例 4 1相同混合及裂法調 製成乳狀袋裝剤。 fch較例8 粘箸劑型Η狀袋裝劑 除不混合3 - L - Μ Ρ以外,仿實施例 80相同混合及製法調 -60- (請先W讀背面之注意事項再填寫本頁) 本紙張尺度逍用中國國家橾準(CNS ) A4規格(210X297公釐) A7 B7 五、發明説明(59 ) 製成粘著剤型Η狀袋裝剤。 試酴俐1 將實施例7之硬膏製剤及比較例4〜5之硬蕾製劑在5 eC下保存2星期,經時觀察藥效成分之結晶化。結果如 表1所示 表 1I Page Order Printed and purified water from the Central Ministry of Economic Affairs, the Central Working Group of the Jeonggong Consumer Cooperative, 60. 4% by weight, mixing the above ingredients to prepare a powdered bag. G mm 7 9 foam bag. F »stearin Acid 5.0% by weight Dongshan Mountain acid 5.0% by weight cetyl alcohol 1.0% by weight 30 sessane 4.0% by weight -58- This paper size is applicable to Chinese impoverished family members (CNS) Λ4 specifications ( 210X297 mm) V. Description of the invention (57) Glycerin 1 5 · 0 Heavy manganese % ΡOE (4 0) Monostearate 1.0% by weight ethyl parahydroxybenzoate 0.1% by weight L-Ascorbic acid palmitic acid m 0.05 wt% 3- L-MP 0 · 5 a egg% refined water • 68.35 wt% Stir and mix the above ingredients, prepare the original solution, and simultaneously fill with liquefied petroleum gas to make a foamed bagging agent 〇W 旃Example 30 Adhesive sheet-like bagging agent gelatin 8. 0% by weight% glycerin 25.0% by weight sorbitol 7. 0% by weight sodium polyacrylate 2.0% by weight aluminum hydroxide 2. fl weight Amount% methyl parahydroxybenzoate 1.0% by weight isopropyl phenol 0.01% by weight 3- L-MP 0 · 0 0 5% by weight purified water 54 · 9 3 5% by weight Central Ministry of Economic Affairs The local shellfish consumer cooperation du printed the cover with a cover bag, the surface after the film is sticky, and the cloth is made of 'no 0', the shape is stretched, and the points are set to cut into as Fit and mix the film and stir. Example: Fen oil and saccharine-packed flakes impregnated with dibutyl alcohol %% of the amount of eggs 3 This paper size is applicable to China National Standards (CNS > M size (210X297 mm)) Printed by the consumer cooperative A7 B7 Amendment 6 Supplement * V. Description of the invention (58) Hyaluronic acid sales 0.1% by weight methyl parahydroxybenzoate 0.1 weight egg% glycyrrhizic acid 0.1 weight% 3-L -MP 0. 0 5 wt% purified water 7 ». 74 children's amount%. Mix and mix the above ingredients, impregnated with non-miscellaneous cloth, g is set with a release film. Cut into a predetermined shape to prepare an impregnated sheet Packing agent in the shape of a bag. Ying Lili 82 Scooping castrate polyvinyl alcohol 20 · 0% by weight Carboxymethyl ferricin 3.0% by weight Child gasification titanium 8. 0% by weight 5.0% by weight Triacontane 3.0% by weight POE (10) Nonylphenyl ether 0.5 Reset% methyl parahydroxybenzoate 0.1% by weight Calcified phenol 0.0% Reset 3- L-MP 0.1% by weight purified water 60.29% by weight Search and mix the above ingredients to prepare a peelable bagging agent. Th Comparative Example 7 Milky bagging agent Except that 3-L-MP was not mixed, the same mixing and cracking method as in Example 41 was used to prepare a milky pouch. Fch Comparative Example 8 A viscous pouch type sachet was not mixed with 3-L-MP Except for the same mixing and preparation method as Example 80-60 (please read the precautions on the back before filling this page) This paper size is in accordance with China National Standards (CNS) A4 specifications (210X297 mm) A7 B7 5 Explanation of the invention (59) It is made into an adhesive-shaped Η-shaped bag. Test 1 Li 1 The plaster of Example 7 and the hard bud preparations of Comparative Examples 4 to 5 were stored at 5 eC for 2 weeks and observed over time. Crystallization of medicinal ingredients. Results are shown in Table 1. Table 1

樣品項目 初期 1天 3天 7天 14天 實施例7硬膏劑 〇 〇 〇 〇 〇 比較例4硬蕾劑 X X X X X 比較例5硬膏劑 〇 X X X X Ο :經觀察無結晶化 X :經觀察有結晶化 由以上結果可瞭解,不添加有溶解劑之比較例4,使 用肉豆蔻故異丙酯之比較例5在基劑中會産生克魯尼新 經濟部中夬揉準局負工消費合作社印裝 (請先S讀背面之注意事項再填寫本頁) 的結晶化,使用3-L-MP之實施例7,即律在2星期後在 * 基薄I中尚有溶解藥物之存在。因此可證i3-L-MP做為溶 解劑確具有其實用性在〇 試驗例2 (粘箸力試驗) 針對實施例1〜4及比較例1〜3之粥劑諝査其黏著力及 -6 1 - 本紙張尺度逋用中國國家搮準(CNS〉Λ4规格(210X297公釐〉 A7 B7 五、發明説明(6〇 ) 黏箸力的經時變化*並基於Hichiban Rolling Ball法 進行實驗《此方法傜從一定高度以30度角度描晝正弦曲 線而使球轉動,而澍定自試料到箸點起所前進之距離》 亦即距離愈短或鼷球愈大則其黏著力愈為優異表示有良 好之黏箸性〇在本試驗中,僳將試樣之長度裁斷咸140 m,使黏鬌面張阽形成表钿狀態,旋轉不銹銅球(20/ 32时:JIS規格),測定其前進距離。結果如表2所示。 表 2 ( 請*^8讀背面之注$項再4寫本頁) -- 經濟部中央揉率局貝工消費合作社印製 粥 劑 初期粘著力(™ ) 4 0 °C , 6僱月後(明) 實施例1 50 48 實施例2 30 33 實施例3 35 38 實施例4 4 3 4 1 比較例1 98 95 比較例2 78 ,82 比較例3 通 遇 通 過 如上所述,實施例1〜4之粥劑,其黏箸性良好可接受 經時之變化》 訂 -y., 本紙張尺度逋用中國國家揉準(CNS ) A4规格U10X297公釐) 修正 # #每4.含.屬曰 A7 補充 B? 五、發明説明(奴) 试驗例A (皮虜安全性試驗) 針對實施例1~ 4及比較例1〜3之粥繭•進行皮虜安全 試驗》 就身讓康僅之男女2 5名進行封明式間歎試驗,觀察Μ 雄後1小畤及經通24小時後皮虜之變化程度,依卞述標 華評估皮虜《激程度,结果如表3〜4所示·· -:在皮虜上不雄有變化 +··皮虜上有明顯红色 ±:在皮虜上發生檝薄紅色++:皮虜上有鑀重之斑疹 表 3 (#¾¾ 由之注 f本買 i袁· 艟濟?夹揲率為Λ工坊费合作社印«. 利離後之 經遇時間 評估 試櫬 + + + 士 一 合計 (人; 性宰(%> 士以上 1小時 實施拥1 0 0 0 25 25 0.0 1小時 實施例2 0 0 1 24 25 4.0 1小時 實鉋锊3 0 0 0 25 25 0.0 1小畤 實施例4 0 0 0 25 25 0.0 1小時 比較#i 1 0 0 2 24 25 8.0 1小時 比較供2 0 0 1 24 25 4.0 1小畤 比較拥3 0 0 3 25 25 12.0 -63- 訂 -良. 本纸張尺度逋用中國國家橾準(CNS》Α4规格(2丨0X297公釐) A7 B7 修正 本於年法 月1日 五、發明説明(62 ) 表 剝離後之 經過時間 評估 試樣 + + + 土 — 合計 (人) 陲性率(% ) 士以上 2 4小時 實施例1 0 0 0 25 25 0.0 2 4小時 實施例2 0 0 0 2 5 25 0.0 2 4小時 實施例3 0 0 0 25 25 0.0 2 4小時 實施例4 0 0 0 25 25 0.0 2 4小時 比較例1 0 0 1 24 25 4.0 24小時 fcb較例2 0 0 0 25 25 0.0 2 4小時 比較例3 0 0 1 24 25 4.0 請 A Η A 之· 注 項 再 f 本 頁 订 如上所述,本實施例1〜4之粥劑對皮虜之安全性極高 試醅例4 (對人之經皮吸收性試驗) 將實施例4,比較例2之檢體打眼成3X3C· 2並貼附Sample item: 1 day, 3 days, 7 days, 14 days. Example 7: Plaster: 20000; Comparative Example: 4: Hard Bud; XXXXX; Comparative Example: 5: Plaster: XXXXXX: No crystallization observed; X: Crystallized by observation. From the above results, it can be understood that Comparative Example 4 without the addition of a dissolving agent, and Comparative Example 5 using nutmeg and isopropyl ester in the base agent will produce Clooney New Economy Ministry's Subcontracting Consumer Work Cooperatives (Please First read the precautions on the back of the page and then fill in this page). Use the 7-L-MP in Example 7, which means that there will still be a dissolved drug in the base * 1 after 2 weeks. Therefore, it can be proved that i3-L-MP has practicality as a dissolving agent. Test Example 2 (Adhesion Test) For the porridge of Examples 1 to 4 and Comparative Examples 1 to 3, check its adhesion and- 6 1-This paper is based on the Chinese National Standard (CNS> Λ4 size (210X297 mm) A7 B7 V. Description of the invention (60) Time-dependent change in adhesive strength * and experiments based on the Hichiban Rolling Ball method "This Method: Draw a day sine curve from a certain height at an angle of 30 degrees to make the ball rotate, and determine the distance traveled from the sample to the point》, that is, the shorter the distance or the larger the ball, the better the adhesion. Good adhesion. In this test, the length of the sample was cut to 140 m to make the adhesive surface stretch to form a surface state. The stainless copper ball was rotated (20/32: JIS standard) and measured. The forward distance. The results are shown in Table 2. Table 2 (Please read * ^ 8 on the back of the note and write this page again)-the initial adhesion of the porridge produced by the shelling consumer cooperative of the Central Rubbing Bureau of the Ministry of Economic Affairs ( ™) 40 ° C, after 6 months (Ming) Example 1 50 48 Example 2 30 33 Example 3 35 38 Example 4 4 3 4 1 Comparative Example 1 98 95 Comparative Example 2 78, 82 Comparative Example 3 The porridge of Examples 1 to 4 passed through as described above has good stickiness and acceptable changes over time. Standards: Chinese National Standard (CNS) A4 specification U10X297 mm) Amendment # #Each 4. Contains. Is A7 Supplement B? V. Description of the invention (slave) Test example A (piper safety test) For implementation The porridge cocoons of Examples 1 to 4 and Comparative Examples 1 to 3 • Peel safety test was performed. 25 males and females of Kang Zhi were subjected to a closed-type sigh test to observe the male male and 1 male and 24 hours after menstruation. The degree of change of the post-piper, according to the description of Biaohua, evaluates the degree of irritation of the piper, and the results are shown in Tables 3 to 4--: There is a change in the virility on the piper + ... There is a significant red on the piper ±: A thin red ++ appears on the prisoner: there are heavy spot rashes on the skin. Table 3 (# ¾¾ Note from this book? Yuan? Help? The rate of stamping is Λ Workshop Fee Cooperative Cooperative Seal «. After the departure Time-to-Evaluation Test + + + Total number of persons (person; Sexual slaughter (% >) 1 hour or more to implement 1 0 0 0 25 25 0.0 1 hour example 2 0 0 1 24 25 4.0 1 Real-time planing 3 0 0 0 25 25 0.0 1 Small Example 4 0 0 0 25 25 0.0 1 hour comparison #i 1 0 0 2 24 25 8.0 1 hour comparison for 2 0 0 1 24 25 4.0 1 small comparison Hold 3 0 0 3 25 25 12.0 -63-order-good. This paper size is in accordance with Chinese National Standards (CNS) A4 (2 丨 0X297 mm) A7 B7 Revised on January 1, 2005 Explanation (62) Table elapsed time after the peeling of the evaluation sample + + + soil-total (person) 陲 rate (%) person or more 2 4 hours Example 1 0 0 0 25 25 0.0 2 4 hours Example 2 0 0 0 2 5 25 0.0 2 4 hours example 3 0 0 0 25 25 0.0 2 4 hours example 4 0 0 0 25 25 0.0 2 4 hours comparative example 1 0 0 1 24 25 4.0 24 hours fcb comparative example 2 0 0 0 25 25 0.0 2 4 hours Comparative Example 3 0 0 1 24 25 4.0 Please A Η A · Note Note f This page is as described above. The porridges of Examples 1 to 4 are extremely safe for skin test醅 Example 4 (Percutaneous absorption test for humans) The specimens of Example 4 and Comparative Example 2 were punched into 3X3C · 2 and attached

在健康志願人8名之上背部,經8小時後回收,依HP LC \ 法定置酮蒲凡Uetoprofen)之殘童。两於人體之吸收率 • * 之換算,定*法以及HPLC條件僳如下述· ⑴人體趿收率=(1-殘初期含量)X100 ⑵定麗法:將所回收之檢體以70b1中醇進行2小時之還 流萃取,萃取後之100·1甲酵即做為HPLC用試樣· -64- 本紙張尺度逋用中國國家橾準(CNS > Α4规格(2丨0X297公釐) \ 經濟部中央揉準扃属工消费合作社印装 如表5所示,僳用3-L-MP做為溶解劑之實施例4 ,較 之比較例2顯示有較高之吸收性。 Μ m m B 將實施例9及比較例6之硬蕾劑保存於5 °C,觀察其 結晶化之經時變化。結果如表6所示。 表 6 經濟部中央揉準局貝工消費合作社印製On the upper back of 8 healthy volunteers, they were recovered after 8 hours, and they were disabled children according to HP LC \ Legal Ketone Pufan (Uetoprofen). The absorption rate of the human body • Conversion of *, method of determination and HPLC conditions are as follows: ⑴ Yield of the human body = (1-residual initial content) X100 : Dingli method: the recovered sample is 70b1 in alcohol. After performing reflux extraction for 2 hours, the 100 · 1 formazan after extraction was used as the sample for HPLC · -64- This paper size is in accordance with China National Standards (CNS > Α4 size (2 丨 0X297 mm) \ Economy The prints of the Ministry of Industry and Commerce Cooperative Cooperative are shown in Table 5, and Example 4 using 3-L-MP as a dissolving agent showed higher absorption than Comparative Example 2. MM mm B The hard buds of Example 9 and Comparative Example 6 were stored at 5 ° C, and the change with time of crystallization was observed. The results are shown in Table 6. Table 6 Printed by the Shellfish Consumer Cooperative of the Central Bureau of the Ministry of Economic Affairs

經時試樣 初期 1天 3天 7天 14天 賁施例9 〇 〇 〇 〇 〇 比較例6 〇 〇 X X X A7 _-_B7___ 五、發明説明(63 ) ⑶HPLC條件 移動相:0.2X醃酸水溶液:乙腈= 55: 45 檢出波長:254η· 管柱:TSK凝膠 ODS-80TM 、 流速:1 . 0 # 1 /蘭i η 表 5 人體吸收率(% > 實施例4 12.7 比較例2 5 . 0 本紙張尺度逋用中國國家標準(CNS ) Λ4规格(210Χ-2β®^Ι ) (請先閱讀背面之注$項再填寫本X)The initial sample of time-lapsed samples is 1 day, 3 days, 7 days, and 14 days. Acetonitrile = 55: 45 Detection wavelength: 254η · Column: TSK gel ODS-80TM, Flow rate: 1.0 # 1 / 兰 i η Table 5 Human Absorption Rate (% > Example 4 12.7 Comparative Example 2 5. 0 This paper uses the Chinese National Standard (CNS) Λ4 specification (210 × -2β® ^ Ι) (Please read the note on the back before filling this X)

經濟部中夹揲準局貝工消费合作社印装 A7 ___B7______ 五、發明説明(64 ) 從表6之結果顔然可知,不添加溶解爾之比較例6其 對於二枯勞勿那克(die lofenac)顯現有經時的結晶化作 用,而實施例9則溶解在基薄中。亦即,顦示 解劑之有用性。 試_例6 對人驩的經皮趿收實驗 将實施例9,比較例6之檢體打眼成3X3 c*3大小並 貼附在健康志願者6名之上背部,依HPLC法定量二枯勞 勿那克(diclofenac)之殘量蘭於人體吸收率之換算, 定量法,HPLC條件你如下述。 ⑴人體吸收率=(1-殘量/初期含量> X 1〇〇 0定量法:將所回收之檢體以30b1四氬呋喃進行2 之超音波萃取,萃取後之50·1四氣呋喃做為HPLC用試 樣。 ⑶HPLC條件 移動相:0.2 χ醋酸水溶液··乙腈=1 : 1 檢出波長:275nffl 管柱:TSK凝膠0DS-80TM 流速:I/ain 結果如圖1所示。由圖式表示實施例9較之比較例6 有明顯之高吸收情形β亦即實施例12因由3_L-MP之溶解 ·· 作用,diclofenac因僳以溶解狀態存在故有良好之釋放 現象》 試驗例7 在5 Ό下保存實施例77,實施列80,比較例7,比較例 -6 6 _ 本紙張尺度適用中國國家標準^CNS M4& ( 210X297公釐) — (请先閾讀背面之注意Ϋ項再埃寫本頁) 訂 A7 _B7_五、發明説明(65 ) 8之各袋裝劑2星期,觀察脂溶性粉末之經時結晶化 結果如表7所示^ 表 7Printed by the Ministry of Economic Affairs of the Bureau of Quasi Bureau Shellfish Consumer Cooperatives A7 ___B7______ V. Description of the Invention (64) From the results in Table 6, it can be seen that Comparative Example 6 without the addition of dissolve is more suitable for die lofenac ) Shows the existing crystallization effect with time, while Example 9 was dissolved in the substrate. That is, the effectiveness of the antidote is shown. TEST_EXAMPLE 6 The percutaneous harvesting test of human Huan The specimens of Example 9 and Comparative Example 6 were perforated to a size of 3 × 3 c * 3 and attached to the backs of 6 healthy volunteers. The conversion of the residual amount of diclofenac to the absorption rate of the human body, quantitative method, HPLC conditions are as follows. ⑴Absorption rate of human body = (1-residue / initial content> X 1000) Quantitative method: Perform ultrasonic extraction of 2 with 30b1 tetraargonfuran, and 50 · 1 tetragasfuran after extraction As a sample for HPLC. ⑶ HPLC conditions Mobile phase: 0.2 χ acetic acid aqueous solution · acetonitrile = 1: 1 Detection wavelength: 275 nffl Column: TSK gel 0DS-80TM Flow rate: I / ain The results are shown in Figure 1. The figure shows that Example 9 has a significantly higher absorption situation compared to Comparative Example 6 β, that is, Example 12 has a good release phenomenon due to the dissolution of 3_L-MP, and diclofenac is present in a dissolved state. Test Example 7 Store Example 77, Implementation Example 80, Comparative Example 7, Comparative Example-6 6 under 5Ό _ This paper size applies the Chinese national standard ^ CNS M4 & (210X297 mm) — (Please read the note on the back first Write this page again) Order A7 _B7_ V. Description of the invention (65) 8 for each bag for 2 weeks, observe the crystallization results of fat-soluble powder over time as shown in Table 7 ^ Table 7

- 初期 1天 3天 7天 14天 實施例77 〇 〇 〇 〇 〇 實施例80 〇 〇 〇 〇 〇 比較例7 X X X X X 比較例8 〇 X X X X 請 先 聞 面· 之 注拳- 項 再 訂 經濟部中央標準局貝工消費合作社印裝 〇:不認為有結晶化 X :認為有結晶化 由以上結果可知以3-L-MP做為溶解劑者顯示其有用性 試驗例8_ 以10名女性志願者為對象使用實施例7 7及比較例7之 各袋裝剤實施官能試驗。結果如表8所示。 -6 7 _ 本纸張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) -62-五、發明説明(66) A7 B7 表 8 實施例77 比較例7 臭 味 有 〇人 〇人 無 10人 10人 清涼感 有 10人 〇人 無 〇人 10人 剌激皮慮 有 〇人 〇人 無 10人 10人 發黏感覺 有 〇人 1人 無 10人 9人 不滑溜感 有 1人 8人 無 9人 2人 (請先聞讀背面之注意Ϋ項再填寫本頁) 訂 經濟部中央揉準局負工消費合作社印裂 以上結果潁示實施例之袋裝劑具有清$慼,由於無有 脂溶性粉末之結晶析出,因而有優異之^用感。 發明之效果 本發明由於攙混有以往做為冷感劑使用之3-L -甲氣丙 -6 8 - 本紙張尺度逍用中國國家揉準(CNS ) A4規格(210X297公釐) A7 B7 五、發明説明(67 ) 烷-1, 2 -二醇為有效成分之溶解劑,因而有優異有效成 分之溶解作用,且有高度安全性,安定性與相溶性《而 且做為經皮吸收劑之外用製劑時可提高藥效成分之釋放 性及經皮吸收性〇又,可滅少因反覆貼附外用製劑所引 發之皮虜斑疹等副作用,不剌激皮虜而且其安全性亦高 β此種外用製劑無臭味,且有令人心怡之清涼感β 是以,本發明之外用製劑適用於做為經皮吸收劑或袋 裝劑,其産業上利用價值極高。 圖式之簡單說明 圖1表示實施例9及比較例6硬蕾劑對人體吸收率之 曲線圖。 (請先Η讀背*-之注I項再1本頁) 訂 經濟部中央揉準局貝工消费合作社印製 -69- 本紙張尺度適用中國國家揉準(CNS > Α4規格(210X297公釐) 83.3.10,000 第8310428491♦利案人i ^皮吸收試驗補充例中文本 對人鳗之經皮吸收試驗 試驗方法 在5位健康成人之左右前腕屈倒以白色凡士林作成1.4X 1.4ca之匾劃,在此匾鼷内使液狀製劑之實施例69, 73及 74以微注筒非密封 塗覆部之製劑以含 而插入於25ml燒瓶 重複洗淨回收操作 後即刻進行回收操 m 1定容量再以超音 收液置入於試管, 分別塗覆以2 0 w 1。‘ 有酒精•水(1 : 1 中。套合以漏斗從漏 3次,成為回收液。 作做為初期含量。回 波處理1小時後隔夜 添加50« 1含有内部 t小時後將殘存在 )之纱布檫拭3次 斗脚部注入以酒精 以相岡方式在塗佈 收液以酒精做成25 放置。採取1 Bl回 爱準物質之酒精溶 液,經由ACROLC 13遇濾後依以下所示條件由HPLC測定藥 物置,並基由其殘存量求出經皮吸收量(率)。-Initial day 1 day 3 days 7 days 14 days Example 77 0000 Example 80 0000 Comparative example 7 XXXXX Comparative example 8 XXXXXX Please listen to the noodles · Note boxing-item, and then set the central standard of the Ministry of Economic Affairs Printed by the local shellfish consumer cooperatives 0: No crystallization is considered X: There is crystallization. From the above results, it is known that 3-L-MP is used as a dissolving agent to show its usefulness. Test Example 8_ Targeted at 10 female volunteers Each bag of Example 7 7 and Comparative Example 7 was used to perform a functional test. The results are shown in Table 8. -6 7 _ This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) -62-V. Description of the invention (66) A7 B7 Table 8 Example 77 Comparative Example 7 Odor has 0 person 0 10 people, 10 people, 10 people, 0 people, 0 people, 10 people, irritability, 0 people, 0 people, 10 people, 10 people, sticky feeling, 0 people, 1 person, no 10 people, 9 people, no slippery feeling, 1 person 8 There are no 9 people and 2 people (please read the note on the back before filling this page). The above results are printed by the Central Ministry of Economic Affairs, Central Bureau of Work, Consumer Cooperatives, and the results show that the bags in the examples have a clear price. There is no precipitation of crystals of fat-soluble powder, so it has excellent texture. Effect of the Invention The present invention is mixed with 3-L -methyl propane-6 8 which has been used as a cooling agent in the past. The paper size is in accordance with China National Standard (CNS) A4 (210X297 mm) A7 B7 5 、 Explanation of the invention (67) Alkan-1, 2-diol is a dissolving agent of active ingredients, so it has excellent dissolving effect of active ingredients, and has a high degree of safety, stability and compatibility. It is also used as a percutaneous absorbent. External preparations can improve the release of the active ingredients and transdermal absorption. Also, it can eliminate side effects such as skin rash caused by repeated application of external preparations. It does not irritate the skin and is highly safe. Β This external preparation has no odor and has a pleasant cooling feeling β. Therefore, the external preparation of the present invention is suitable for use as a transdermal absorbent or a bagging agent, and has extremely high industrial application value. Brief Description of the Drawings Fig. 1 is a graph showing absorption rates of the hard buds of Example 9 and Comparative Example 6 on the human body. (Please read back * -Note I and then 1 page) Ordered by the Central Government Bureau of the Ministry of Economic Affairs, printed by Shelley Consumer Cooperatives -69- This paper size is applicable to China National Guidelines (CNS > Α4 size (210X297) 83.3.10,000 Article 8310428491 ♦ Case Study i ^ Skin Absorption Test Supplementary Example of the Test Method for Transdermal Absorption Test on Human Eel in 5 Healthy Adults The forearm is bent with white vaseline as a 1.4X 1.4ca plaque In this plaque, the liquid preparation examples 69, 73, and 74 were filled with the preparation of the non-sealed coating part of the micro-injection cylinder and inserted into a 25 ml flask to repeat the washing and recovery operation. The recovery operation was performed immediately. The volume was put into a test tube with a supersonic liquid collection, and each was coated with 20 w 1. 'Alcohol • water (1: 1). The tube was drained 3 times from the funnel to become the recovery liquid. As the initial content .Echo treatment 1 hour after adding 50 «1 overnight containing the remaining t after g) wipe the gauze 3 times with a bucket foot injection with alcohol in the Aioka method in the coating liquid receiver made of alcohol 25 and placed. 1 Bl Alcoholic solution of quasi-substance, after filtering through ACROLC 13 Set conditions shown drug determined by HPLC, and the amount of the residual group obtained by percutaneous absorption amount (rate).

HPLC之條件 • _ Pump : Model 60C0A (Waters) Injector ·‘ WISP 712 (Waters) Detector i Laubda-ααχ modal (Waters) Integrator ; &-2500 (Hitachi) Column oven i TCM (Waters) Column : TSE-gel ODS-60TM (T0S0) 4.6mtfn X.D.# >< 15cm ( 5pm ) Mobile phase : Acetate buffer (pH 3.2): CH^CN = Flow rate : 1.0 ml/min UV detection ; 254 nm Column temp* : 35 *C 被驗藥劑 ① 實施例69之擦劑 ② 實施例7 3之噴霧劑〔裝填在噴霧容器以前之原液(除做 為噴霧劑之二甲醚及液化石油氣以外)〕 ③ 實施例74之化粧水劑 比較例之製劑 ① 去除3-L-MP之實施例69處方製劑(比較例1 ) ② 去除3-L-MP之實施例73處方製劑(比較例2 ) ③ 去除3-L-MP之實施例74處方製劑(比較例3 ) (結果) *實施例69之製劑 比較例1之製劑 吸收率25 . 3S; 吸收率18 . 5S! *實施例73之製劑 比較例2製劑 吸收率23 . 7¾ 吸收率17 . 8J; *實施例74之製劑 比較例3製劑 吸收率26 . U 吸收率19 . 3¾ 人體吸收率=(1-殘存量/初期含量)X100 對人體之經皮吸收試驗 試驗方法 在5位健康成人之左右前腕屈側黏貼以具有1.4X1.4cro 空間之黏著帶並在分割區内使用撒注筒非密封分別塗佈以 20/i 1之實施例49, 51, 54-A及56之處方藥劑。歴4小時後 -2- 將殘存在塗佈部之製劑以含有酒精·水(1 : 1)之纱布 擦拭3次而插入於25ml燒杯中。對合漏斗從漏斗腳注入酒 精重複洗淨回收操作3次成為回收液。以相同方式在塗佈 後即刻進行回收操作者做為初期含量。回收液加酒精成25 ml定容量再以超音波處理1小時後隔夜放置。採取1 nl回 收液置入於試管,添加50μ1含有内部標準物質之酒精溶液 ,以ACROLC 13過濾後由以下所示條件用HPLC測定藥物置, 並依殘存置求出經皮吸收量(率)。 HPLC之條件Conditions for HPLC • _ Pump: Model 60C0A (Waters) Injector ODS-60TM (T0S0) 4.6mtfn XD # > < 15cm (5pm) Mobile phase: Acetate buffer (pH 3.2): CH ^ CN = Flow rate: 1.0 ml / min UV detection; 254 nm Column temp *: 35 * C. Tested agent ① The rubbing agent of Example 69 ② The spraying agent of Example 7 3 [the original liquid before filling in the spray container (except dimethyl ether and liquefied petroleum gas used as a spraying agent)] ③ The makeup of Example 74 Formulation of aqueous solution ① Formulation of Example 69 except 3-L-MP (Comparative Example 1) ② Formulation of Example 73 without 3-L-MP (Comparative Example 2) ③ Formulation of 3-L-MP Example 74 Formulation (Comparative Example 3) (Results) * The formulation of Example 69 The comparative example 1 The absorption rate of the formulation 25.3S; The absorption rate 18.5S! * The formulation of Example 73 The comparison example 2 The formulation absorption rate 23. 7¾ Absorption rate 17. 8J; * The preparation of Example 74 Comparative Example 3 The absorption of the preparation 26. U absorption rate 19. 3¾ Human absorption rate = (1-residual amount / initial content) X100 Test method for percutaneous absorption of human body Adhesion to the flexion of the forearm on the right and left wrists of 5 healthy adults with a space of 1.4X1.4cro Adhesive tapes were applied to the divided areas in a non-sealed manner using a spray cylinder and coated with 20 / i 1 of Examples 49, 51, 54-A and 56 respectively.歴 4 hours later -2- Wipe the preparation remaining in the application part with a gauze containing alcohol · water (1: 1) 3 times and insert it into a 25ml beaker. The infusion funnel was filled with alcohol from the funnel feet, and the washing and recovery operation was repeated three times to obtain a recovery liquid. In the same manner, the recovery operator performed the initial content immediately after coating. Add the recovered liquid to a fixed volume of 25 ml, and then treat it with ultrasound for 1 hour, then place it overnight. Take 1 nl of the recovered solution and place it in a test tube, add 50 μ1 of an alcohol solution containing an internal standard substance, filter it with ACROLC 13 and measure the drug placement by HPLC under the conditions shown below, and determine the percutaneous absorption (rate) based on the remaining placement. Conditions for HPLC

Pump :hudel 6CC0A (Waters) Injector :WISP 712 (Waters) Detector i Loubde-ioax model (Waters) Integrator :D-2500 (Hitachi) Column όν&η :TCM (Waters) Column :TSK-gel ODS-βΟΤΜ (T0S0) Λ.βιιϊη I.D.# 15cm ( 5pn )Pump: hudel 6CC0A (Waters) Injector: WISP 712 (Waters) Detector i Loubde-ioax model (Waters) Integrator: D-2500 (Hitachi) Column όν & η: TCM (Waters) Column: TSK-gel ODS-βΟΤΜ (T0S0 ) Λ.βιιϊη ID # 15cm (5pn)

Mobile phase : Acecate buffer (pH 3.2): CH^CN - A:6Mobile phase: Acecate buffer (pH 3.2): CH ^ CN-A: 6

Flow rate : 1.0 ml/min UV detection : 254 nmFlow rate: 1.0 ml / min UV detection: 254 nm

Column temp< : 35 °C 被驗藥劑 本發明之製劑 ① 實施例49之軟膏劑 ② 實施例51之凝膠劑 -3- S8G033 ③ 買施例54-A之膠狀乳劑(在實施例54之處方中,使用以 _蒲凡(Ketoprofen)代替因諾美達辛(indometacin) 之處方製劑) ④ 實施例5 6之乳劑 比較例之製劑 ① 去除3-L-MP之實施例 ② 去除3-L-MP之實施例 ③ 去除3-L-MP之實施例 ④ 去除3-L-MP之實施例 (結果) *實施例49之製劑 吸收率19 . 5% *實施例5 1之製劑 吸收率39 . 3¾ *實施例54-A之製劑 吸收率31 . 2¾ *實施例5 6之製劑 吸收率28 . 7S; 人體吸收率=(1 - 49處方製劑(比較例4 ) 51處方製劑(比較例5) 54-A處方製劑(比較例6 ) 56處方製劑(比較例7 ) 比較例4之製劑 吸收率14 . 3¾ 比較例5之製劑 吸收率29 . 7ϋί 比較例6之製劑 吸收率24 . U 比較例7之製劑 吸收率20 . U 存量/初期含量)X 100 4Column temp <: 35 ° C Test agent Preparation of the present invention ① The ointment of Example 49 ② The gel of Example 51 -3- S8G033 ③ Buy the gelatinous emulsion of Example 54-A (in Example 54 In the prescription, ketoprofen was used instead of indometacin. ④ Formulation of Comparative Example of Emulsion of Example 5 6 ① Example of Removing 3-L-MP ② Removing of 3-L Example of -MP ③ Example of removing 3-L-MP ④ Example of removing 3-L-MP (Result) * The absorption rate of the preparation of Example 49 was 19.5% * The absorption rate of the preparation of Example 51 1 39 3¾ * The absorption rate of the preparation of Example 54-A 31. 2¾ * The absorption rate of the preparation of Example 5 6 28.7S; the absorption rate of the human body = (1-49 prescription preparation (Comparative Example 4) 51 prescription preparation (Comparative Example 5 ) 54-A prescription preparation (Comparative Example 6) 56 prescription preparation (Comparative Example 7) The absorption ratio of the preparation of Comparative Example 4 14. 3¾ The absorption ratio of the preparation of Comparative Example 5 29.7 The absorption ratio of the preparation of Comparative Example 6 24. U Compare The absorption rate of the preparation in Example 7 20. U stock / initial content) X 100 4

Claims (1)

癌-本 386033 B8 C8 D8 A8Cancer-Ben 386033 B8 C8 D8 A8 镇請委員切-一’ c'li原實質内.容 鑲濟部中*標率為負工消费合作社印*. ‘申請專利範固 第83104284K「經皮吸收藥學组成物」專利案 (85年8月16日修正) 5申謫専利範圍: 種經皮吸收藥學组成物,你菝自粥劑,硬膏_,軟 膏幫·睡化劑,乳劑,凝謬狀乳爾•化粧用水劑,噴 隳劑•餘《型貼附劑,擦劑等劑型•而其有效成分則 蘧自類固醇条抗炎症糸,非類固酵条抗炎症剤以及其 酯類衍生物,抗變K性,抗組BU4,中樞神經作用劑 ,撖素劑,抗高血由剤,強心劑,抗不整脈用_,冠 狀血管擴張劑,局部麻醉劑,鎮痛劑,骨格筋弛缓劑 ,抗真菌劑,抗惡性腫癯剤,尿失禁症劑,籣瘸藥劑 ,抗巴金生氏病劑,禁煙補助薄,維生素類及前列腺 素類為藥效成份,其特徽為,對該有效成分包含有 0.1〜20重ft%之3-L-|[氧基丙烷-1,2-二酵做為有效 成分之溶解爾者。 2. 如申謫専利範画第1項之經皮吸收藥學组成物,其中 該經皮吸收劑之劑型為粥两時,即於該基«加入3-L-f氧基丙烷-1, 2-二酵與藥效成分並混合至少一種水 溶性聚合物,离级酵及水.者。 3. 如申請専利範顯第1項之經皮吸收蕖學组成物,其中 該經皮吸收_之_型為硬膏两畤•即於該基用加入3-L-t氧基丙烷-1, 2-二酵舆蕖效成分,並混合至少一 種松香酯衍生物,苯乙烯-異戊間二烯-苯乙烯分段聚 本紙張尺度逋用中國國家棵率(CNS)A4规格(210x297公簸) ^------裝----:丨丨訂------A (先先Η讀背ΛΓ之注^•項再4寫本頁)The town invited members to cut-a 'c'li within the original substance. The standard bidding rate in the Ministry of Economics and Trade is the stamp of the consumer cooperative cooperatives. * Application for patent Fangu No. 83104284K "Percutaneous absorption pharmaceutical composition" patent case (85 years (Amended on August 16) 5 Scope of application: Percutaneous absorption of pharmaceutical composition, you can take porridge, ointment _, ointment, sleep agent, emulsion, gel-like milk • lotion, spray Agents • Yu "type patches, wipes and other dosage forms • and its active ingredients are 蘧 from steroid bars anti-inflammatory 糸, non-steroidal bars anti-inflammatory 剤 and its ester derivatives, anti-mutation K resistance, anti-BU4 , Central nervous system agents, tinctures, antihypertensive agents, cardiotonic agents, anti-aggravating pulses, coronary vasodilators, local anesthetics, analgesics, osteopathic relaxants, antifungal agents, anti-malignant swelling, urine Incontinence agent, tincture agent, anti-Parkinson's disease agent, smoking cessation subsidy, vitamins and prostaglandins are medicinal ingredients, and the special emblem is that the active ingredient contains 0.1 to 20 weight ft% of 3- L- | [[Oxypropane-1,2-diase] is used as the soluble ingredient of the active ingredient. 2. The percutaneous absorption pharmaceutical composition as described in item 1 of Shen Zheli Fan Painting, wherein the dosage form of the percutaneous absorption agent is porridge two hours, that is, adding 3-Lf oxypropane-1, 2-di Fermentation and medicinal ingredients combined with at least one water-soluble polymer, stepwise fermentation and water. 3. For example, apply the percutaneous absorption medical composition of No. 1 Fanli Xian, in which the type of percutaneous absorption _ of _ is a plaster ointment. That is, add 3-Lt oxypropane-1, 2- Dienzyme is an effective ingredient, and is mixed with at least one rosin ester derivative, styrene-isoprene-styrene segmented poly paper size, using China National Tree Rate (CNS) A4 specification (210x297 mm) ^ ------ Equipment ---- : 丨 丨 Order ------ A (First read the note of ΛΓ before reading the item ^ 4 and then write this page) 癌-本 386033 B8 C8 D8 A8Cancer-Ben 386033 B8 C8 D8 A8 镇請委員切-一’ c'li原實質内.容 鑲濟部中*標率為負工消费合作社印*. ‘申請專利範固 第83104284K「經皮吸收藥學组成物」專利案 (85年8月16日修正) 5申謫専利範圍: 種經皮吸收藥學组成物,你菝自粥劑,硬膏_,軟 膏幫·睡化劑,乳劑,凝謬狀乳爾•化粧用水劑,噴 隳劑•餘《型貼附劑,擦劑等劑型•而其有效成分則 蘧自類固醇条抗炎症糸,非類固酵条抗炎症剤以及其 酯類衍生物,抗變K性,抗組BU4,中樞神經作用劑 ,撖素劑,抗高血由剤,強心劑,抗不整脈用_,冠 狀血管擴張劑,局部麻醉劑,鎮痛劑,骨格筋弛缓劑 ,抗真菌劑,抗惡性腫癯剤,尿失禁症劑,籣瘸藥劑 ,抗巴金生氏病劑,禁煙補助薄,維生素類及前列腺 素類為藥效成份,其特徽為,對該有效成分包含有 0.1〜20重ft%之3-L-|[氧基丙烷-1,2-二酵做為有效 成分之溶解爾者。 2. 如申謫専利範画第1項之經皮吸收藥學组成物,其中 該經皮吸收劑之劑型為粥两時,即於該基«加入3-L-f氧基丙烷-1, 2-二酵與藥效成分並混合至少一種水 溶性聚合物,离级酵及水.者。 3. 如申請専利範顯第1項之經皮吸收蕖學组成物,其中 該經皮吸收_之_型為硬膏两畤•即於該基用加入3-L-t氧基丙烷-1, 2-二酵舆蕖效成分,並混合至少一 種松香酯衍生物,苯乙烯-異戊間二烯-苯乙烯分段聚 本紙張尺度逋用中國國家棵率(CNS)A4规格(210x297公簸) ^------裝----:丨丨訂------A (先先Η讀背ΛΓ之注^•項再4寫本頁) 經濟部中央標率扃貝工消费合作社印裂 «86033 '—----申請專利範圍 合物或丙烯 4,如申請專利 該經皮吸收 氣基 有高级脂肪 5 ·如申請専利 該經皮吸收 3-L-| «基 有低级酵, 6 .如申請専利 該經皮吸收 L-f氣基丙 离级脂肪酸 7 .如申請專利 該經皮吸收 入3- 氧 合有离级脂 劑者。 8. 如申諳専利 該經皮吸收 入3 · L 氣 合有低级酵 9. 如申誚專利 A8 B8 C8 D8 酸条粘著劑及软化剤者。 範国第1項之經皮吸收_ 製劑之劑型為软蕾爾畤, 丙烷-1, 2-二酵與藥效成 酸或其酯,》類,界面活性 範圍第1項之經皮吸收窠 製劑之剤型為膠化劑時, 丙烷-1, 2-二醪與藥效成 水,醪化劑及中和劑者。 範圍第1項之經皮吸收_ 製劑之劑型為乳爾時,邸 烷-1, 2-二酵與藥效成分 酯,水,硪化氫及乳化劑 範圍第1項之經皮吸收藥 製劑之劑型為醪狀乳劑時 基丙烷-1, 2-二酵與蕖效 肪酸酯,低级酵,乳化爾 學组成物,其中 邸於該基_加入 分,並至少混合 劑及硪化氫者。 學組成物,其中 即於該基劑加入 分,並至少混合 學組成物,其中 於該基劑加入3-,並至少混合有 者。 學組成物,其中 ,即於該基劑加 成分,並至少混 ,中和劑及騵化 範圍第1項之經皮趿收_學組成物,其中 製_之劑型為化粧水劑時,即於該基剤加 基丙烷-1, 2-二酵與蕖效成分,並至少混 ,水及/或乙二酵者。 範匾第1項之經皮吸收藥學組成物,其中 本紙張尺度適用中國國家揲準(CNS > A4規格(2丨0X297公釐) — ϋιϋ I—ί、裝 11 r - - (請先聞讀背面之注$項再f本頁) 訂 a86033 B| D8 々、申請專利範圍 該經皮吸收裂劑之爾型為噴费劑畤,即於該基劑加入 3-L-f^基丙烷-1, 2·•二酵舆藥效成分,並至少混合 有界面活性劑,低级酵及/或乙二酵類,水及噴射劑 者。 10. 如申謫專利範園第1項之經皮吸收藥學组成物,其 中該經皮吸收製雨之爾型為鍺量型貼附爾時,邸於該 基劑加人以3-L-|氣基丙烷-1, 2-二酵與蕖效成分, 並至少混合有乙二酵類,低级酵,水及水溶性聚合物 者。 11. 如申請專利範困第1項之經皮吸收藥學組成物,其 中該經皮吸收裂劑之劑型為擦劑時,即於該基_加入 以3-L-I"氣基丙烷-1, 2-二酵與藥效成分,並至少混 合有酒精及水脂肪酸酯者。 12. 如申讅専利範函第1項之經皮吸收_學组成物,其 中上述藥效成分僳對水不溶或為難溶之脂溶性粉末, 其劑型為粥劑者。 13. 如申請専利範圍第12項之經皮吸收藥學組成物,其 在上述粥劑中像含有0.1〜5重Λ%之基丙烷 1, 2-二醇者。 經濟部中央標準扃負工消費合作社%*. (请先W讀背«Γ之注|項再*寫本頁)· 14. 如申請專利範圍第12項或第13項之經皮吸收藥學组 成物,其中鼷於上述粥劑’,脂溶.性粉末至少僳選自甘 草素,甘草酸硬脂酸酯,甘草酸,L-抗壤血酸硬脂酸 酯,L-抗禳血酸棕禰酸酯,鈣化.齡,K骨化酵,生物 素,異笨基甲基酚者。 本紙張尺度適用中國國家揉率(CNS ) A4規格(210X297公釐)The town invited members to cut-a 'c'li within the original substance. The standard bidding rate in the Ministry of Economics and Trade is the stamp of the consumer cooperative cooperatives. * Application for patent Fangu No. 83104284K "Percutaneous absorption pharmaceutical composition" patent case (85 years (Amended on August 16) 5 Scope of application: Percutaneous absorption of pharmaceutical composition, you can take porridge, ointment _, ointment, sleep agent, emulsion, gel-like milk • lotion, spray Agents • Yu "type patches, wipes and other dosage forms • and its active ingredients are 蘧 from steroid bars anti-inflammatory 糸, non-steroidal bars anti-inflammatory 剤 and its ester derivatives, anti-mutation K resistance, anti-BU4 , Central nervous system agents, tinctures, antihypertensive agents, cardiotonic agents, anti-aggravating pulses, coronary vasodilators, local anesthetics, analgesics, osteopathic relaxants, antifungal agents, anti-malignant swelling, urine Incontinence agent, tincture agent, anti-Parkinson's disease agent, smoking cessation subsidy, vitamins and prostaglandins are medicinal ingredients, and the special emblem is that the active ingredient contains 0.1 to 20 weight ft% of 3- L- | [[Oxypropane-1,2-diase] is used as the soluble ingredient of the active ingredient. 2. The percutaneous absorption pharmaceutical composition as described in item 1 of Shen Zheli Fan Painting, wherein the dosage form of the percutaneous absorption agent is porridge two hours, that is, adding 3-Lf oxypropane-1, 2-di Fermentation and medicinal ingredients combined with at least one water-soluble polymer, stepwise fermentation and water. 3. For example, apply the percutaneous absorption medical composition of No. 1 Fanli Xian, in which the type of percutaneous absorption _ of _ is a plaster ointment. That is, add 3-Lt oxypropane-1, 2- Dienzyme is an effective ingredient, and is mixed with at least one rosin ester derivative, styrene-isoprene-styrene segmented poly paper size, using China National Tree Rate (CNS) A4 specification (210x297 mm) ^ ------ Equipment ----: 丨 丨 Order ------ A (read the note of ΛΓ first and then write this page first) The central standard of the Ministry of Economic Affairs Printing crack «86033 '—---- Applicable patent scope compound or propylene 4. If applying for a patent, the percutaneous absorption of air base has high-level fat 5 · If applying for benefit, the percutaneous absorption of 3-L- | 6. If applying for a patent, the transdermal absorption of Lf gas-based propylated fatty acids 7. If applying for a patent, the transdermal absorption of 3-oxygenated lipids. 8. Ruo Shenli The transdermal absorption of 3 · L gas combined with lower enzymes 9. Ruo Shen patent A8 B8 C8 D8 acid strip adhesive and soften the skin. Transdermal absorption of item 1 of the country _ Preparation of the formulation is soft lei er, propane-1, 2-diase and pharmacologically effective acid or its ester, '' class, percutaneous absorption of item 1 of the interface activity range 窠When the tincture type of the preparation is a gelling agent, propane-1, 2-dioxin forms water with a medicinal effect, a tinting agent and a neutralizing agent. Transdermal absorption of item 1 of the scope _ Preparation of the product in the form of milky, diane-1, 2- dienzyme and medicinal ingredient esters, water, hydrogenated hydrogen and emulsifiers of the transdermal absorption preparation of item 1 of the scope The dosage form is a base emulsion of propane-1, 2-di-enzyme and high-efficiency fatty acid esters, a lower enzyme, and an emulsifying composition. Among them, the base is added, and at least the agent and the hydrogenated compound are mixed. . Add the chemical composition to the base, and mix at least the chemical composition, add 3- to the base, and mix at least one. The chemical composition, that is, adding ingredients to the base agent, and at least mixing, neutralizing agent, and the transdermal drug receiving composition of item 1 of the chemical conversion range, wherein when the dosage form is a lotion, In this base, add propane-1, 2-dienzyme and effective ingredients, and mix at least water and / or aglycone. The percutaneously absorbable pharmaceutical composition of item 1 of the fan plaque, in which the paper size is applicable to the Chinese National Standard (CNS > A4 specification (2 丨 0X297 mm) — ϋιϋ I—ί, containing 11 r--(please listen first Read the note on the back of the page, and then f on this page) Order a86033 B | D8 々, apply for patent scope The type of the percutaneous absorption splitting agent is spraying agent 畤, that is, 3-Lf ^ -based propane-1 is added to the base 2 · • Secondary medicinal ingredients, and at least mixed with surfactants, lower enzymes and / or dioxins, water and propellants. 10. Transdermal absorption as described in item 1 of Shenyang Patent Fanyuan Pharmaceutical composition, in which the percutaneous absorption of the rain type is a germanium amount type attachment, the base is added with 3-L- | air-based propane-1, 2-disease and effective ingredients , And at least mixed with adipic enzymes, lower enzymes, water and water-soluble polymers. 11. For example, the percutaneous absorption pharmaceutical composition of the first patent application, wherein the dosage form of the percutaneous absorption cleaving agent is rubbing When the agent is used, add 3-L-I " air-based propane-1, 2-secondase and medicinal ingredients, and at least alcohol and water fatty acid ester are mixed. Transdermal absorption_scientific composition of item 1 of Shen Lili, where the above medicinal ingredient 效 is water-insoluble or insoluble fat-soluble powder, and the dosage form is porridge. 13. If applying for item 12 of the scope of benefits A percutaneous absorption pharmaceutical composition, which contains 0.1 to 5 weight Λ% of 1,2-propane 1,2-diol in the above-mentioned porridge. The central standard of the Ministry of Economic Affairs and Consumers Cooperatives% *. (Please read first Back «Γ of note | item again * write this page) · 14. If you apply for a percutaneous absorption pharmaceutical composition under the scope of the patent application No. 12 or No. 13, in which the above-mentioned porridge is used, the fat-soluble powder is at least 僳Selected from glycyrrhizin, glycyrrhizin stearate, glycyrrhizic acid, L-ascorbic acid stearate, L-ascorbic acid palmitate, calcification age, K bone enzyme, biotin, iso For benzyl methylphenol. This paper size is applicable to China National Kneading (CNS) A4 size (210X297 mm)
TW83104284A 1994-05-12 1994-05-12 A skin permeant pharmaceutical compositions TW386033B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW83104284A TW386033B (en) 1994-05-12 1994-05-12 A skin permeant pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW83104284A TW386033B (en) 1994-05-12 1994-05-12 A skin permeant pharmaceutical compositions

Publications (1)

Publication Number Publication Date
TW386033B true TW386033B (en) 2000-04-01

Family

ID=21624648

Family Applications (1)

Application Number Title Priority Date Filing Date
TW83104284A TW386033B (en) 1994-05-12 1994-05-12 A skin permeant pharmaceutical compositions

Country Status (1)

Country Link
TW (1) TW386033B (en)

Similar Documents

Publication Publication Date Title
TWI277418B (en) Enhanced drug delivery in transdermal systems
DE69430917T2 (en) 3-L-MENTHOXY-PROPANE-1, 2-DIOL AS SOLUTION AND EXTERNAL PREPARATION THAT CONTAINS THEM
EP0341202B1 (en) Transdermal monolithic systems
TW382599B (en) Transdermal therapeutic system containing estradiol
TW411277B (en) Percutaneous tape preparation containing fentanyl
TW200418433A (en) Adhesive preparation
JP2001503062A (en) Salts of fatty acid esters of lactic acid as permeation enhancers
CN102670567A (en) Flux-enabling compositions and methods for dermal delivery of drugs
JPS60155111A (en) Stable pharmaceutical for external use containing "ketoprofen(r)"
WO2005105150A1 (en) Adhesive material
KR100647480B1 (en) Sheet-form adhesive preparation
WO2004100959A1 (en) External patch containing estrogen and/or progestogen
JP2003533434A (en) Improved transdermal contraceptive delivery systems and methods
JPH1135475A (en) Preparation containing roripa nasturtium-aquaticum extract and used for external use
CN104394858A (en) Percutaneous absorption promoter and skin patch comprising same
JPH05201879A (en) Percutaneous administration pharmaceutical
WO2005102306A1 (en) Anti-inflammatory analgesic adhesive patch
JPH0774152B2 (en) Liquid for external use on skin
TW386033B (en) A skin permeant pharmaceutical compositions
WO2000044336A1 (en) Sheet-type packs
CN101374488A (en) Flux-enabling compositions and methods for dermal delivery of drugs
TWI514999B (en) Transdermal absorption preparation
JP3193161B2 (en) Transdermal absorption preparation
JP2005097132A (en) Low-irritant patch
TWI709418B (en) Patch

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MK4A Expiration of patent term of an invention patent